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Introduction 
 
During the course of my thesis, I investigated the participation of apoptotic and 
autophagic cell death programs in neuropathologies. Neuronal cell death mechanisms are 
known to play a major role in neurodegenerative diseases and the physiopathological 
significance of the interplay between apoptotic and autophagic cascades is still not 
understood. Insights into the complex patterns of neuronal cell death observed in nervous 
system diseases are critically needed to take up the challenge of designing novel 
neurodegenerative disease therapies, specifically targeting cell death pathways. 
 
A million people worldwide are affected by neurodegenerative diseases, a 
heterogeneous group of degenerative conditions affecting specific areas of the central 
nervous system. The majority of neurodegenerative pathologies are age-related disorders, 
and these diseases are becoming an increasing health and socio-economical problem in 
industrialized countries (Mayeux, 2003). Neurodegenerative diseases such as 
amyotrophic lateral sclerosis, Alzheimer, Parkinson, Huntington and prion diseases 
induce progressive cognitive or movement impairment depending on the type of neuronal 
cells undergoing selective degeneration (Troncoso et al., 1996; Cleveland, 1999; 
Nunomura et al., 2007). Although these diseases are phenotypically well described, the 
molecular mechanisms leading ultimately to neuronal death remain unclear, and despite 
vigorous research efforts, therapy options have not been found. 
In Alzheimer (Nakagawa et al., 2000; Nixon et al., 2005), Parkinson (Webb et al., 
2003; Hayley et al., 2004), Huntington (Hickey and Chesselet, 2003) and prion (Lucassen 
et al., 1995; Liberski et al., 2008) diseases, autophagy and apoptosis have been shown to 
be activated in parallel. If apoptosis is an absolute programmed cell death mechanism, in 
most cases, autophagy constitutes cell defense mechanisms towards cellular dysfunction 
or stress. Thus, both apoptosis and autophagy may be triggered by common upstream 
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signals resulting in either combined autophagy and apoptosis or a switch between the two 
mechanisms in a mutually exclusive manner (Chu, 2006; Maiuri et al., 2007). 
 
I focused my investigations on the cerebellar Purkinje cell in mouse models with 
mutations which specifically affect these neurons using a combination of biochemical, 
histological and cytological methods in situ as well as in organotypic cerebellar cultures. 
This approach has provided new insights into the complex molecular and cellular events 
underlying neuronal stress and degeneration.  
The cerebellum presents several advantages for the anatomical study of 
neurodegeneration: i) it consists of the repetition of a single neuronal circuit made up of a 
few types of neurons and afferences centered on the Purkinje cell which emits the only 
output of the cerebellar cortex, ii) cerebellar abnormalities are usually straightforward to 
recognize because cerebellar damage manifests itself as abnormalities in gait and posture 
(ataxia), iii) many spontaneous mutations that affect cerebellar development and function 
have been recognized and lead to Purkinje cell degeneration (Appendix N°1). Purkinje 
cell death was investigated in Lurcher and hotfoot mice with mutations of the Grid2 gene 
coding for the glutamatergic receptor GluR2 on one hand and, in the Nagasaki Prnp0/0 
mutant mouse deficient for the prion protein and overexpressing its neurotoxic paralogue 
Doppel on the other hand. 
The aims of this project were 
1) To determine the mechanisms of Lurcher Purkinje cell death. The Lurcher 
mutation transforms the GluR2 receptor into a constitutively opened channel. In 
Lurcher heterozygous mice, cerebellar Purkinje cells are permanently 
depolarized, a characteristic that has been thought to be the primary cause of their 
postnatal apoptotic death, although autophagy has been suggested to contribute to 
GluR2-induced death (Yue et al., 2002). The more dramatic phenotype of 
Lurcher homozygotes is probably due to a simple gene dosage effect of the 
mutant allele. We have analyzed the phenotype of Lurcher/hotfoot heteroallelic 
mutants bearing only one copy of the Lurcher allele and no wild-type Grid2 to 
determine the effects of the absence of wild-type GluR2 receptors on Purkinje 
cell survival in these mutants. Using a pharmacological approach in organotypic 
cerebellar cultures, I further analyzed the respective contributions of autophagy 
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and excitotoxicity-induced apoptosis in the GluR2-Lurcher Purkinje cell survival 
and growth. 
2) To analyze the involvement of autophagy in the dendritic development and 
synaptogenesis of Purkinje cells. The Purkinje cells of the hotfoot mutant mice 
are lacking GluR2 and display impaired climbing fiber (Kashiwabuchi et al., 
1995) and parallel fiber (Kurihara et al., 1997) innervations indicating that 
GluR2 is involved in Purkinje cell excitatory synaptogenesis. During normal 
development, the postsynaptic spines deafferented by supernumerary climbing 
fiber elimination may involve GluR2-dependent autophagy. In the hotfoot adult 
cerebellum, Purkinje cells display many postsynaptic spines devoid of presynaptic 
innervation (Kashiwabuchi et al., 1995). The persistence of these spines may be 
due to the lack of GluR2-dependent autophagic mechanism. I analyzed Purkinje 
cell development in the hotfoot cerebellum to estimate the contribution of 
GluR2-dependent mechanisms (autophagy?) to the excitatory synaptogenesis of 
Purkinje cells. Firstly, the survival and dendritic development of Purkinje cells 
were compared between hotfoot and wild-type organotypic cerebellar cultures, 
and then climbing fiber development was examined during the postnatal period in 
the hotfoot cerebellum. 
3) To assess which neuronal death mechanisms are activated by Doppel during 
Purkinje cell degeneration in prion protein-deficient Nagasaki mutant mice. 
In the Nagasaki mutant mouse, Purkinje cells prematurely die from toxicity 
induced by Doppel, a prion protein-like protein overexpressed in the absence of 
the cellular prion protein (PrP
C
) (Moore et al., 2001; Wong et al., 2001; Cui et al., 
2003; Sakudo et al., 2005b). To provide insight into the neuroprotective properties 
of PrP
C
, as well as into the cell death programs triggered by Doppel, transgenic 
models were examined by biochemical and anatomical analysis. 
 
The literature review of my thesis is divided into four parts which include an 
overview of apoptosis and autophagy – the molecular basis of programmed cell death - 
an overview of anatomy, development and physiological functions of the brain region 
under the focus of my research - the mouse cerebellum - and an overview of the mutant 
mice models of Purkinje cell degeneration analyzed in my thesis – the hotfoot and the 
Lurcher Grid2 mutant mice – and – the Nagasaki prion protein-deficient mice. The 
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results obtained in the Grid2 mutant mice studies are presented in the format of 
unpublished data and a publication, and the data obtained in the Nagasaki mutant mice 
studies are presented in the format of publications. Afterwards, I shall integrate the results 
obtained from these models, and discuss the results in the light of other neuropathologies 
and highlight the importance of interplay between apoptosis and autophagy in neuronal 
response to pathological insults. 
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1. Molecular basis of programmed neuronal cell death 
Cell death is a fundamental process involved in the regulation of tissue homeostasis 
and necessary for the elimination of supernumerary and diseased cells. This is achieved 
by two major active self-destruction mechanisms: the regulated and the unregulated 
pathways (Fig. 1). The unregulated cell death mechanism is a non-programmed cell death 
pathway often called necrosis and is caused by overwhelming stress. Characteristic 
features of necrosis include organelle swelling, mitochondrial dysfunction, massive 
oxidative stress and plasma membrane permeabilization. Necrosis irreversibly leads to 
the release of intracellular organelles and inflammation (Zong et al., 2004; Ditsworth et 
al., 2007). The regulated cell death mechanisms essentially comprise two programmed 
cell death (PCD) pathways: apoptosis (or type I PCD), the first characterized form of 
PCD, and autophagy (or type II PCD) which has been proposed to be an alternative cell 
death pathway, but is still controversial (Tsujimoto and Shimizu, 2005; Chu, 2006). Both 
are essential for discrete removal of supernumerary cells such as neurons during normal 
development. Under pathological conditions, apoptosis and autophagy may be activated 
in addition to necrosis.  
 
1.1 Apoptosis: the type I programmed cell death 
Apoptosis is a highly conserved and complex cellular mechanism (Kerr et al., 1972). 
In mammals, external signals trigger two major pathways leading to the activation of 
caspases: the mitochondrial pathway (intrinsic pathway) and the death receptor pathway 
(extrinsic pathway). 
 
1.1.1 Caspases, the main effectors of apoptosis 
Caspases are a family of 14 cysteine-dependent aspartate-specific acid proteases that 
mediate and execute the apoptotic cell death program (Yuan et al., 1993; Salvesen and 
Dixit, 1997). All caspases exist as a latent pro-form of a single polypeptide chain, and are 
activated by specific cleavage at aspartic acid residues which leads to the formation of 
active tetramers and initiate apoptosis (Shi, 2002).  
Caspases can be divided into 3 groups with respect to their structure and function 
(reviewed in Degterev et al., 2003): 
Introduction 
 
8 
 
- Group I or inflammatory caspases (Caspases 1, 4, 5, and 11) are not involved in 
apoptosis but play a role in the maturation of cytokines during inflammatory 
processes.  
- Group II or initiator caspases (Caspases 2, 8, 9, 10, and 12) are long prodomain-
containing caspases including DEDs-containing caspases (8 and 10) and CARD-
containing caspases (2 and 9). 
- Group III or effector caspases (Caspases 3, 6 and 7) are executioner caspases. 
These short prodomain-containing caspases are activated by upstream initiator 
caspases and cleave multiple cellular substrates. 
Caspases 13 and 14 are still not characterized and are structurally close to 
inflammatory caspases. 
  
1.1.2 The intrinsic pathway 
The intrinsic apoptotic pathway is initiated in the mitochondria and the endoplasmic 
reticulum. The major event is the mitochondrial outer membrane permeabilization 
(MOMP). MOMP is mainly regulated by a specific class of proteins belonging to the B-
cell/Lymphoma-2 family (Bcl-2 family), which play a pivotal role in the activation of the 
caspase cascade.  
 
1.1.2.1 The Bcl-2 family 
The Bcl-2 family of proteins can be divided into 2 groups: 
- The anti-apoptotic proteins BCL-2, BCL-XL, BCL-w, MCL-1. 
- The pro-apoptotic proteins BAX, BAK, BOK, BID, BIM, BAD. 
All Bcl-2 family members have at least one of the 4 known Bcl-homology domains 
(BH1 to 4) which correspond to -helical segments (Adams and Cory, 1998). Some pro-
apoptotic proteins called “BH3-only” proteins (BID, BIM, BAD) contain only a BH3 
domain (Puthalakath and Strasser, 2002), and others such as “BH123”-containing 
proteins (BAX, BAK, BOK) share BH1 to 3 with BCL-2 (Adams and Cory, 1998). In this 
context, the BH3 domain is presumed to be an essential death domain and both BH3-only 
and BH123 domain proteins are required for the induction of apoptosis (Cheng et al., 
2001).  
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1.1.2.2 The apoptotic mitochondrial cascade 
 In normal conditions, the pro-apoptotic proteins are cytosolic and anti-apoptotic 
proteins (Krajewski et al., 1993) are membrane-bound proteins of the ER and the 
mitochondria (Zhu et al., 1996). In the mitochondria, anti-apoptotic proteins sequester the 
pro-apoptotic ones in stable mitochondrial complexes, thereby preventing the activation 
of BH123 proteins such as BAX and BAK (Cheng et al., 2001). Apoptotic signals  are 
able to activate BID by inducing homodimerization and translocation of BAX and BAK 
to the mitochondria (Fig. 2) (Wolter et al., 1997; Gross et al., 1998; 1999). BAX can be 
activated by another pathway which also involves activation of the transcription factor 
p53 when DNA is damaged (Lane, 1992; Miyashita and Reed, 1995). Homodimerization 
of BAX allows an efflux of cytochrome c due to the constitution of a pore in the 
mitochondrial outer membrane (Fig. 2) (Liu et al., 1996; Newmeyer and Ferguson-Miller, 
2003). The binding of cytochrome c to the apoptosis protease activating factor-1, Apaf1 
(Zou et al., 1997) causes the formation of a complex called the apoptosome in the 
presence of ATP. The subsequent recruitment of procaspase-9 will lead to the activation 
of the effector caspases 3, 6 and 7 (Fig. 2) (Li et al., 1997; Cecconi et al., 1998).  
 
1.1.2.3 The ER stress apoptotic cascade 
Oxidative stress can induce the unfolded protein response (UPR) in the endoplasmic 
reticulum (ER) which permits the elimination of misfolded protein aggregates. The UPR 
can be unable to counteract the stress which leads to the triggering of apoptosis (Fig. 3) 
(Breckenridge et al., 2003; Rao et al., 2004a). This mechanism requires the release of 
calcium from the ER through the binding of a small amount of cytochrome c released 
from the mitochondria. This positive feedback will result in the activation of the caspase 
cascade (Rao et al., 2004b). The Bcl-2 family members BCL-2, BAX and BAK 
themselves can also act at the ER level (Zong et al., 2003). BCL-2 is able to interrupt the 
described above crosstalk between ER and mitochondria, while BAX and BAK regulate 
the Ca²
+
 release from the ER (Scorrano et al., 2003) and promote caspase-12 activation. 
Activated caspase-12 will then translocate from the ER to the cytosol, directly cleave 
procaspase-9 to activate the effector caspase-3 (Szegezdi et al., 2003) and finally cause 
apoptotic cell death. 
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1.1.3 The extrinsic pathway 
The extrinsic pathway is activated by ligand binding to death receptors such as tumor 
necrosis factor receptor 1 TNF-R1 (Tartaglia et al., 1993), fibroblast-associated Fas (Suda 
et al., 1993) and TNF-related apoptosis-inducing ligand receptor TRAIL-R (Griffith et 
al., 1998) which are transmembrane proteins (Fig. 4) with an extracellular cysteine-rich 
domain and an intracellular death domain. The ligand-bound TNF-R1, Fas and TRAIL-R 
transmit apoptotic signals through the binding of their death domain with the death 
domain of the TNF-R-associated death domain protein TRADD (Hussein et al., 2003) or 
the Fas-associated death domain protein FADD (Chinnaiyan et al., 1995; 1996) (Fig. 4). 
The N-terminal death effector domain DED (Lee et al., 2000) and caspase recruitment 
domain CARD (Hofmann et al., 1997) of FADD will be activated leading to the 
activation of caspases 8 and 10 (Fig. 4) (Weber and Vincenz, 2001) and the formation of 
the death-inducing signal complex DISC (Lee et al., 2000; Wang, 2001; Lavrik et al., 
2003). This complex will finally activate effector caspase-3 (Fig. 4) (Stennicke et al., 
1998). The caspase signaling initiated by the death receptors is regulated by the FADD-
like-ICE-inhibitory protein FLIP which competitively inhibits the recruitment of 
procaspase-8 by FADD (Irmler et al., 1997; Scaffidi et al., 1999). 
The c-jun N-terminal protein kinase JNK, a member of the mitogen-activated protein 
kinase (MAPK) is involved in TNF-induced apoptosis and may play a pro-apoptotic role 
in neurons.  JNK can phosphorylate and thereby inactivate BCL-2 and BCL-XL (Fig. 4)  
(Basu and Haldar, 2003) and can activate the proapoptotic BH3-only protein BIM 
(Becker et al., 2004). 
An intrinsic, mitochondrial-dependent apoptotic pathway has been shown to be 
activated by TNF-R1 and Fas (McKenzie et al., 2008) through the cleavage of the Bcl-2 
family member BID by caspase-8 (Li et al., 1998; Scaffidi et al., 1998). The resulting 
truncated form tBID has been shown to induce the release of cytochrome c (Luo et al., 
1998) and apoptosis. On the basis of the recruitment of the mitochondrial pathway by 
death receptors, two types of responses have described. Type I cells respond by activation 
of caspase-8 in the DISC inducing apoptosis. However, type II cells respond by only a 
small amount of FADD and caspase-8 recruitment to the DISC requiring the intrinsic 
pathway to induce apoptosis. Along this line, in Bid
-/-
 mice, hepatocytes behave like type 
II cells after Fas-L treatment, whereas thymocytes respond to Fas-L in a type I manner 
(Zheng and Flavell, 2000).  
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1.1.4 The targets of caspases 
The cleavage and subsequent activation of effector caspases (3, 6 and 7) by the 
initiator caspases 2, 8, 9, 10 and 12 is called the caspase cascade (Degterev et al., 2003). 
In addition, caspase-8 is able to activate the BH3-only BID protein.  
Caspase-3, the predominant effector caspase, activates the signal components that 
affect the morphological changes associated with apoptosis. These components include 
the DNA fragmentation factor 45kDa (DFF45) (Liu et al., 1997) involved in DNA 
degradation (Enari et al., 1998; Mukae et al., 1998) and the subunit of the mitochondrial 
respiratory complex I (NDUFS) which causes the overproduction of reactive oxygen 
species (ROS) and the disruption of electron transport (Ricci et al., 2004). The disruption 
of actin filaments (Kothakota et al., 1997) and cell-to-cell interactions (Ku et al., 1997; 
Schmeiser et al., 1998) also induced by the effector caspases contribute to the dismantling 
of the cellular architecture.  
The caspases are responsible for the activation of pro-apoptotic protein kinases such 
as ROCK1 in response to TNF-R activation (Coleman et al., 2001) and MEKK1 through 
Jun-kinase pathway during Fas-induced apoptosis (Deak et al., 1998). The caspases also 
cleave anti-apoptotic protein kinases including AKT (Bachelder et al., 2001) and FAK in 
response to TRAIL signaling leading to a loss of survival signals (Wen et al., 1997). 
Caspases have been shown to cleave anti-apoptotic Bcl-2 family members such as 
BCL-2, BCL-XL suggesting that a positive feedback mechanism is set off by apoptosis 
(Degterev et al., 2003). 
 
1.1.5 Neuronal apoptosis  
Since the pioneering work of Levi-Montalcini on the survival of developing neurons 
(Hamburger and Levi-Montalcini, 1949), the essential role of apoptosis in the control of 
neuronal numbers during development of the nervous system has been supported by an 
increasing number of data (Becker et al., 2004). Neuronal apoptosis not only has a major 
role in sculpting relationships between neuronal populations in the developing brain, but 
is also the cardinal cell death process in many neurodegenerative diseases (Yuan and 
Yankner, 2000). 
 
 
 
Introduction 
 
12 
 
1.1.5.1 Apoptosis during neuronal development 
Transgenic mouse lines over-expressing or knocked-out for the major factors 
involved in the mitochondrial pathway have been generated, and these models have 
revealed the importance of intrinsic mitochondrial apoptosis during brain development. 
For example, knocking-out the pro-apoptotic factor Bax gene has been shown to result in 
the increase of specific neuronal populations, such as peripheral ganglia, motor pools in 
the spinal cord and trigeminal brainstem nuclear complex (White et al., 1998) and 
Purkinje cells in the cerebellum (Fan et al., 2001) suggesting that these neurons undergo a 
period of naturally occurring, BAX-mediated cell death during brain development. This is 
also in line with the increase of Purkinje cell population observed when BCL-2, the main 
BAX antagonist is overexpressed (Zanjani et al., 1996).  
An interesting study by Krajewska et al (2002) has described the onset of BAX, 
BAK, BCL-2, BID and BCL-XL expression in the developing central nervous system and 
outlined the antagonistic functions of these pro and anti-apoptotic factors in the formation 
of the neuronal tube and in the differentiation of proliferative zones in the developing 
brain.  
   
1.1.5.2 Apoptosis in neurodegenerative diseases 
In ischemic brain tissue, neuronal cell death has been shown to occur by Fas-
dependent, (Northington et al., 2001) caspase-3-mediated apoptosis (Namura et al., 
1998).  
Neuronal death mechanisms have been extensively investigated in a number of 
neurodegenerative diseases including amyloid neuropathologies. In Alzheimer disease, 
the amyloidpeptide is known to induce oxidative stress (Behl et al., 1994) which 
activates caspase-12-mediated apoptosis (Nakagawa et al., 2000). In prion diseases, 
apoptosis is detected in the prion-infected brain tissue (Fairbairn et al., 1994; Lucassen et 
al., 1995). This neuronal loss has been shown to result from the neurotoxicity of the 
abnormal proteinase-resistant forms PrP
res
 of the prion protein PrP
C
 (Forloni et al., 1996). 
More recently, Bax inactivation has been shown to antagonize apoptosis of infected 
cerebellar granule cells in vitro (Chiesa et al., 2005). However, the neurodegenerative 
events induced by the cerebellotropic 22L scrapie strain were changed neither in the Bax
-
/-
 nor in the Hu-bcl-2 overexpressing mice (Bailly, unpublished). Similar results were 
obtained with the 6PB1 bovine spongiform encephalopathy (BSE) strain in Bax
-/-
 mice 
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(Coulpier et al., 2006) and with RML scrapie strain in Bax
-/-
 and Hu-bcl-2 overexpressing 
mice (Steele et al., 2007). In expanded polyglutamine repeats diseases such as Huntington 
disease, abnormal protein aggregates have been shown to activate caspase-8-mediated 
apoptosis (Ona et al., 1999; Sanchez et al., 1999). 
In Parkinson disease, an augmentation of IFN- (Teismann et al., 2003) has been 
shown to upregulate Fas activating the extrinsic apoptotic pathway (Hayley et al., 2004). 
 The mutant superoxide dismutase (SOD) responsible for amyotrophic lateral 
sclerosis forms intra-neuronal aggregates and induces oxidative stress resulting in 
neuropathological features including apoptosis similar to those observed in Alzheimer 
and Huntington diseases (Cleveland, 1999).  
 
1.2 Autophagy 
Normal cellular development and cellular response to changes in the extra- and intra-
cellular media require a balance between synthesis and degradation of protein. 
Autophagy is a lysosomal pathway involved in the degradation of long-lived cytosolic 
proteins (De Duve et al., 1955). In the focus of my thesis, autophagy involving the 
sequestration and subsequent lysosomal degradation of bulk cytosol is macro-autophagy. 
An alternative cellular-to-vacuole targeting pathway is a specific autophagic process 
which permits selective degradation without bulk cytosol (Harding et al., 1996). It will 
not be detailed here although it has led to a better understanding of autophagic 
mechanisms (Wang and Klionsky, 2003).  
 
1.2.1 Induction and regulation of autophagy 
The discovery of TOR (Kunz et al., 1993), a target of the autophagy-inducer 
rapamycin (Blommaart et al., 1997a), initiated the study of mechanisms regulating 
autophagy. TOR inhibits autophagy and is activated by amino acids (Luiken et al., 1994), 
class I phosphoinositide 3-kinase (PI3-K) (Codogno and Meijer, 2005), eIF2a and  Ras 
(Meijer and Codogno, 2004) and is inhibited by class III PI3-K (Blommaart et al., 
1997b). The autophagic cascade is mediated by 31 autophagy genes (ATGs) in 
mammalian cells. Eighteen of these ATGs are involved in the formation of the 
autophagosome (Kabeya et al., 2007). In the initial phase of the autophagic cascade, 
ATG13 normally phosphorylated by TOR, is dephosphorylated, thereby allowing it to 
complex with ATG1 (Fig. 5).  
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Beclin1 (ATG6) belongs to the class III PI3-K complex (Kihara et al., 2001) and is 
able to inhibit TOR and trigger the autophagic cascade. Beclin1 and BCL-2 have been 
shown to interact via their common BH3 domain (Liang et al., 1998). Beclin1 is 
expressed by cortical, hippocampal and cerebellar neurons (Liang et al., 1998; Yue et al., 
2002; Diskin et al., 2005) and its activation is a hallmark of autophagy during 
neurodegeneration (Shibata et al., 2006). 
 
1.2.2 The autophagic sequence 
Our current knowledge about the molecular basis of the autophagic cascade is 
summarized in the Figure 5. 
 
1.2.2.1 Role of ATGs in the autophagosome formation 
The dephosphorylation of ATG13 allows its binding to ATG1. The ATG1-13 
complex then recruits ATGs 11-17-20-24 (Kamada et al., 2000) leading to the formation 
of the autophagosome. The construction of the autophagosome from the pre-
autophagosomal membrane depends on 2 conjugation systems (Ohsumi and Mizushima, 
2004). The first associates ATG16 to ATGs 5-7-10-12 to form the isolation membrane as 
a pre-autophagosome (Mizushima et al., 2003) from cytosolic organelles. The second is 
the ATG8/LC3 system (Mizushima et al., 1998). ATG8/LC3 was first identified as 
microtubule associated protein1-light chain 3 (Mann and Hammarback, 1994). In the 
autophagic process, pro-LC3 is processed into a cytosolic form LC3-I (Kabeya et al., 
2000). LC3-I is activated by ATG7 (Tanida et al., 2001) and cleaved into a LC3-II 
membrane-bound form by ATG4 and conjugated with a phosphatidylethanolamine (PE) 
by ATG3 (Kabeya et al., 2000) (Tanida et al., 2002). Pre-autophagosome membrane-
bound LC3-II-PE seems to be required for completion of the autophagosome (Kabeya et 
al., 2000). Finally, LC3-II delipidation by ATG4 will let it leave the autophagosome 
(Kirisako et al., 2000). 
 
1.2.2.2 The autophagolysosome 
After completion, the autophagosome fuses with lysosomes, a step involving the 
autophagosome-specific GTPase Rab7 (Gutierrez et al., 2004) and the lysosome-specific 
proteins Lamp1 and Lamp2 (Eskelinen et al., 2002). After fusion, the autophagosome 
inner single-membrane vesicle is released inside the vacuole lumen and termed 
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autophagic body and this autophagic body is then degraded by lysosomal enzymes such 
as cathepsins B, D and L (Punnonen et al., 1992; Uchiyama, 2001). Cathepsin B is a 
cysteine protease which belongs to the papain superfamily (Takio et al., 1980), cathepsin 
D is an aspartine protease which belongs to the pepsin superfamily of proteinases 
(Ferguson et al., 1973) and cathepsin L is a thiol protease (Kirschke et al., 1977).  
Once degradation has been completed, monomeric units are exported to the cytosol 
for reuse. ATG22 has been identified as a putative amino acid effluxer (Yang et al., 2006) 
that cooperates with other vacuolar permeases such as the lysosomal amino acid 
transporters LYAAT 1 and 2 (Sagne et al., 2001) 
 
1.2.3 Physiological autophagy 
1.2.3.1 Autophagic degradation of cellular components 
Autophagy is an essential mechanism of cell survival. In response to starvation, cells 
degrade their own cytoplasmic material by an autophagic-dependent mechanism. 
Autophagy is a survival mechanism of mammalian HeLa cells to serum and amino acids 
deprivation. Indeed, blockade of autophagy in this case induces apoptotic cell death 
(Boya et al., 2005). Cultured bone marrow cells deficient for BAX and BAK undergo 
autophagy if the interleukin 3 growth factor is suppressed, allowing extended survival. 
RNAi blocking ATG5 or ATG7 rapidly induces cell death (Lum et al., 2005). In-vivo, 
ATG7 deficiency in the central nervous system provokes apoptosis of cortical, 
hippocampal and cerebellar neurons (Komatsu et al., 2006). 
In the developing brain, constitutive activation of autophagy is implicated in 
neuroprotection and cellular remodeling of neurites and growth cones during neurite 
extension (Hollenbeck, 1993). Autophagy can also selectively degrade cell-surface 
receptors. At neuromuscular junction of Caenorhabditis elegans, presynaptic terminals 
can induce clustering of GABA-A receptors leading to their degradation by a LC3 
homolog-mediated autophagy (Rowland et al., 2006).  
 
1.2.3.2 Autophagy: the type II programmed cell death 
A role for autophagy in regulating cell populations during development of living 
organisms is increasingly considered as a phylogenetically old process. For example, in 
Drosophila, embryonic salivary glands (Lee and Baehrecke, 2001) and the fat body at the 
end of larval stage are eliminated by autophagic programmed cell death (Rusten et al., 
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2004). During moth development, autophagy may be involved in the elimination of larval 
intersegmental muscles (Schwartz et al., 1993).  
This type II programmed cell death is called autophagic cell death (Cao et al., 2006) 
and is characterized by a marked proliferation of autophagic vacuoles and the progressive 
disappearance of cellular organelles (Schweichel and Merker, 1973). In autophagic cell 
death, cells, such as neurons, destined for elimination internalize cytoplasmic components 
into autophagic compartments for self-degradation, and death subsequently occurs by 
hyperactive autophagy (Nixon, 2006). 
 
1.2.4 Autophagy in neuropathologies 
Autophagy has been linked to a number of pathologies including neuropathologies 
(Nishino et al., 2000; Nixon, 2006). Axotomy rapidly induces autophagic activity in 
mouse central neurons, well before the beginning of axonal remodeling (Matthews, 
1973).  
In neurodegenerative diseases including Alzheimer, Parkinson, Huntington and prion 
diseases, mis-aggregated proteins accumulate in spite of autophagic activity and this has 
lead to the concept of autophagic failure or autophagic stress. The specific recognition of 
ubiquitin-positive aggregated proteins has been shown to be mediated by p62/SQSTM1 
(Rideout et al., 2004; Bjorkoy et al., 2005) an adaptor protein between ubiquitinated 
proteins and LC3-expressing autophagosomes (Filimonenko et al., 2007; Pankiv et al., 
2007). Accumulation of autophagic profiles are features of degenerative neurons in 
Alzheimer- and prion-diseased brains (Nixon et al., 2005; Liberski et al., 2008).  In 
Alzheimer disease, autophagy at the synaptic level parallels decreased synaptic activity 
(Sikorska et al., 2004). In Huntington disease too, the abnormal accumulation of 
autophagic vacuoles containing mutated huntingtin (Ravikumar et al., 2005) is believed 
to induce neuronal apoptosis (Hickey and Chesselet, 2003). In Parkinson disease, the cell 
death pattern is complex with features of apoptosis in addition to the accumulation of 
autophagosome-like structures (Stefanis, 2005). Alpha-synuclein mutations that have 
been identified in certain cases of Parkinson disease can induce cell death in association 
with accumulation of autophagic vacuoles that are not completely acidified or missing 
cathepsin D (Stefanis et al., 2001). 
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1.3 Interplay between autophagic and apoptotic pathways 
1.3.1 Apoptosis blockade induces autophagy 
Experiments on Bax
-/-
; Bak
-/-
 double knock-out MEF and bone marrow cell lines 
exposed to either DNA damage or stress signals indicate overactivation of autophagy. In 
MEF cells, massive autophagy delays cell death and can be abrogated by knocking-down 
Beclin1 or ATG5 gene (Shimizu et al., 2004). Conversely, in bone marrow cells, 
increased autophagy favors cell survival whereas knock-down of ATG5 or ATG7 genes 
restores cell death (Lum et al., 2005).  
Blockade of lipopolysaccharide-induced apoptosis by inhibition of caspases triggers 
autophagic cell death of L929 macrophages. This can be abrogated by knocking-down the 
Beclin1 gene (Yu et al., 2004; Xu et al., 2006). This indicates that deficiency or blockade 
of apoptosis can switch the cell response from stress to autophagy. 
 
1.3.2 Blockade of autophagy induces apoptosis 
Cells with deficient autophagic machinery can undergo apoptosis. Along this line, 
Lamp2-deficient HeLa cells can not complete autophagic process, and this results in a 
strong activation of apoptotic cell death (Boya et al., 2005; Gonzalez-Polo et al., 2005). 
These data support the concept of a dual autophagic and apoptotic cell death mechanism 
in the above mentioned neurodegenerative diseases (Chu, 2006; Nixon, 2006). 
 
1.3.3 Crosstalk between apoptosis and autophagy 
1.3.3.1 Regulation of apoptosis by ATGs 
Surprisingly, overexpression of the autophagy gene ATG5 leads to increased 
apoptosis, but not autophagy. Yousefi et al (2006) demonstrated that calpain can cleave 
ATG5 into its truncated form, tATG5.  This tATG5 induces apoptosis and the release of 
mitochondrial cytochrome c. Moreover, tATG5 has been shown to directly bind BCL-XL. 
Thus, ATG5 plays an important role in the regulation of apoptosis because tATG5 is able 
to sequester Bcl-2 anti-apoptotic proteins, thereby allowing the pro-apoptotic 
homodimerization of BAX (Fig. 6) (Yousefi et al., 2006). 
 
1.3.3.2 Regulation of autophagy by Bcl-2 family members and caspases 
Beclin1, a major ATG (see §1.2.1) was initially shown to bind BCL-2 (Liang et al., 
1998). This interaction inhibits autophagy induced by starvation. For a presently 
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unexplained reason, only the ER-bound, but not mitochondria-bound BCL-2 can inhibit 
autophagy (Pattingre et al., 2005).  
Interestingly, caspases are not only used during apoptosis, but also function in the 
regulation of autophagic cell death as in the case of the Drosophila salivary gland (Martin 
and Baehrecke, 2004). Beclin1 and ATG7-dependent autophagic death has also been 
shown to be induced by caspase-8 inhibition (Yu et al., 2004). 
 
1.3.3.3 Regulation of autophagy by the apoptotic extrinsic pathway 
A functional relationship between autophagy and the extrinsic apoptotic pathway 
(Jia et al., 1997) is further supported by the absence of autophagic vacuoles in cultured 
mammary epithelial cells where TRAIL-mediated apoptosis is inhibited (Mills et al., 
2004) and by the induction of autophagy by TNFactivation in T-lymphoblastic cells 
(Jia et al., 1997). In addition,
 
some proteins involved in the extrinsic signaling pathway 
have recently
 
been implicated in autophagy. For example, down-regulation of ATG5 
expression in HeLa cells suppresses cell death and vacuole formation induced by 
IFNand FADD (Pyo et al., 2005).  
These data demonstrate that common upstream signals may trigger autophagy and 
apoptosis, meaning that apoptotic and autophagic machinery share common pathways 
that either link or polarize the cellular response. 
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2. The mouse cerebellum 
The cerebellum is a highly folded hindbrain structure that lies dorsal to the pons and 
medulla. Three pairs of cerebellar peduncles, the inferior, middle and superior peduncles 
connect the cerebellum to the brainstem. 
 
2.1 The cerebellar anatomy 
2.1.1 General organization 
The cerebellum is bilaterally symmetrical: two lateral hemispheres are separated 
medially by the central longitudinal vermis (Larsell, 1952). It is divided into anterior and 
posterior lobes by a transverse primary fissure and a ventral flocullonodular lobe. The 
cerebellum has a folded appearance with fissures separating its antero-posterior extent 
into 10 lobules (Fig. 7A). Two major structures can be discerned: a uniformly structured 
cortex surrounding 3 right and left deep cerebellar nuclei within the central white matter: 
the fastigial (median), the interposed (intermediate) and the dentate (lateral) nuclei (Fig. 
7B) (Larsell, 1952).   
 
2.1.2 The cerebellar cortex 
Each single folium is composed of a cortex or superficial grey matter over a central 
white matter. The cerebellar cortex is histologically homogenous with a uniform 
microstructure throughout the entire cerebellum and has 4 main neurons: the granule, the 
Purkinje (Purkinyé, 1877), the Golgi and the basket/stellate cells. Three layers make up 
the cerebellar cortex (Fig. 7B). The outer molecular layer contains basket/stellate cells 
(Ramón y Cajal, 1911), the Purkinje cell dendritic tree and parallel fibers emanating from 
the granule cells. The Purkinje cell somata form a dense monolayer between the internal 
granular layer and the molecular layer (Palay and Chan-Palay, 1974). The internal 
granular layer contains the granule cells and the Golgi cells (Ramón y Cajal, 1911). The 
deep cerebellar nuclei contain deep cerebellar neurons and interneurons. 
 
2.1.2.1 The Purkinje cell 
Purkinje cells are the principal neurons of the cerebellar cortex (Fig. 7B) and 
serve as the sole output from the cerebellar cortex to the deep cerebellar nuclei (Palay and 
Chan-Palay, 1974; Ito, 1984). Within the Purkinje cell layer, Purkinje cells express 
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biochemical heterogeneity of certain proteins (such as zebrin I and II) that segregate 
Purkinje cells into sagitally organized bands (Hawkes et al., 1985; Sotelo and Wassef, 
1991; Bailly et al., 1995; Sarna and Hawkes, 2003). The Purkinje cell dendritic tree has a 
planar shape oriented in the sagittal plane (Fig. 7B) (perpendicular to the long axis of the 
folium) and is formed from one to two primary branches that further subdivide into 
secondary and tertiary branches (Palay and Chan-Palay, 1974; Ito, 1984). Two types of 
spines are located along the dendritic tree: i) spines that are restricted to the major 
dendritic trunks and bear primarily climbing fiber synapses and i) spines that stem from 
distal tertiary branchlets and make synapses with parallel fibers (Ramón y Cajal, 1911; 
Ito, 1984).  
The axon of the Purkinje cell emerges from the basal pole of the soma, descends 
through the internal granular layer and makes GABAergic synapses mainly on the deep 
cerebellar neurons (Palay and Chan-Palay, 1974). Some Purkinje cell axons from specific 
lobules (lobule X and the floculus) make synapses on the neurons of the vestibular nuclei 
to mediate balance (Ito, 1984). Collaterals are also emitted along the descending Purkinje 
cell axon and re-enter the Purkinje cell layer in the same sagittal plane as the Purkinje cell 
dendrites. These collaterals contribute to supra- and infraganglionic plexuses, which form 
above and below the Purkinje cell layer, thereby inhibiting adjacent Purkinje, Golgi, 
basket and stellate cells (Palay and Chan-Palay, 1974). 
 
2.1.2.2 The granule cells 
The granule cells are found in the internal granular layer (Fig. 7B) and relay 
inputs from mossy fibers to the Purkinje cells. Granule cell somata are 5 to 8 µm in 
diameter and their dendrites, which are generally short, receive mossy fiber terminals 
(rosettes) to form complex synapses (glomeruli) with inhibitory Golgi axon terminals 
(Palay and Chan-Palay, 1974; Ito, 1984; Voogd and Glickstein, 1998). Granule cell axons 
ascend through the molecular layer, bifurcate and run parallel to the longitudinal axis of 
the folium as parallel fibers (Palay and Chan-Palay, 1974; Voogd and Glickstein, 1998) 
forming en passant synapses on the spines of the Purkinje cell tertiary dendrites and on 
the inhibitory interneurons. 
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2.1.2.3 The interneurons 
There are at least five types of interneurons in the cerebellar cortex (Fig. 7B):  the 
basket, the stellate, the Golgi, the Lugaro and the unipolar brush cells (Palay and Chan-
Palay, 1974). All of these interneurons, with the exception of the unipolar brush cells, 
have been shown to be inhibitory (Eccles et al., 1966c; Aoki et al., 1986). The basket and 
stellate axons provide lateral inhibition in the parasagittal plane to adjacent Purkinje cell 
somata and dendrites, respectively (Palay and Chan-Palay, 1974). The Golgi cell 
dendrites receive input from granule cells as well as from mossy fibers and, provide feed-
back inhibition to granule cells (Palay and Chan-Palay, 1974) thereby forming a closed 
inhibitory circuit in the cerebellar cortex. 
 
2.1.3 The cerebellar afferents 
The olivocerebellar fibers (i.e. climbing fibers) and the mossy fiber system constitute 
the two major cerebellar afferent systems. Both systems carry sensorimotor information 
directly to the deep cerebellar nuclei and also to the cerebellar cortex to regulate the 
extent to which the climbing and the mossy fibers activate the deep cerebellar nuclei. The 
differences that emerge in the synaptic strength within the cerebellar cortex are thought to 
form the basis of cerebellar plasticity during learning (De Zeeuw and Yeo, 2005). 
 
2.1.3.1 The olivocerebellar system 
Climbing fibers are one of the main operational inputs into the cerebellar cortex. 
Electrophysiological (Eccles et al., 1966b), autoradiographic (Courville and Faraco-
Cantin, 1978) and degeneration (Desclin, 1974) techniques have shown that climbing 
fibers originate exclusively from neurons in the inferior olive of the medulla. The inferior 
olive sends olivocerebellar axons to the cerebellum, where the final segment of the axon 
takes the form of a climbing fiber in the cerebellar cortex. The olivocerebellar projection 
predominantly crosses the medullary midline, terminating in the contralateral 
hemicerebellum with the addition of very small uncrossed component innervating the 
ipsilateral cerebellum (Chan-Palay et al., 1977; Sugihara et al., 1999). From the inferior 
cerebellar peduncle, axons extend into the white matter and branch into the cortex in the 
parasagittal plane (Azizi and Woodward, 1987) to synapse onto 5 to 7 Purkinje cells 
(Sugihara et al., 2001).  
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In the rat, the olivocerebellar projection has an organized topography that is 
arranged into a pattern of parallel longitudinal zones in the cerebellar cortex (Azizi and 
Woodward, 1987; Sugihara et al., 2001). In general, each subnucleus of the inferior olive 
projects contralateral climbing fibers that closely adhere to one or more parasagittal 
Purkinje cell zones which then projects to a specific part of the deep cerebellar nuclei 
(Campbell and Armstrong, 1983; Wassef et al., 1992; Sugihara et al., 2001). Furthermore, 
each olivary subnucleus gives off collaterals to the deep cerebellar nuclei, which receives 
Purkinje cell input from the same parasagittal zone(s) (Andersson and Armstrong, 1987) 
and in turn, the deep cerebellar neurons project to the same olivary subnuclei from which 
they receive collaterals (Ruigrok and Voogd, 2000). In summary, the Purkinje cells in 
each longitudinal zone receive climbing fibers from a discrete zone within the inferior 
olive and these Purkinje cells send axons to a specific region in the deep cerebellar 
nuclei. A salient feature of the adult murine cerebellum is that each Purkinje cell receives 
input from only one climbing fiber, but every climbing fiber can innervate 5 to 7 Purkinje 
cells. 
In the white matter, the olivocerebellar axons are thick (2 to 3 µm in diameter) 
and myelinated (Palay and Chan-Palay, 1974; Sugihara et al., 1999). However, as they 
ascend towards the internal granular layer, the axons become unmyelinated in the 
Purkinje cell layer and synapse onto the thick dendritic trunks of the Purkinje cells (Palay 
and Chan-Palay, 1974; Sugihara et al., 1999). In the Purkinje cell dendritic tree, climbing 
fiber arborisations emit fine beaded tendrils (including varicosities approximately 2 µm 
thick) that run along the Purkinje cell dendrites and synapse onto spines. These climbing 
fiber-Purkinje cell synapses are entirely covered by sheets of Bergmann glia (Palay and 
Chan-Palay, 1974). In addition to climbing fibers projecting onto Purkinje cells, climbing 
fibers also send collateral branches to the deep cerebellar nuclei (Palay and Chan-Palay, 
1974; Sugihara et al., 1999; Ruigrok and Voogd, 2000; Sugihara et al., 2001). 
 
2.1.3.2 The mossy fiber relay system 
Mossy fibers are the second main cerebellar afferent and have different 
morphological and anatomical characteristics than the climbing fibers. They are derived 
from multiple sensory sources in the brainstem and the spinal cord (e.g. spino-cerebellar, 
vestibulo-cerebellar and lateral reticular, pontine reticulo-tegmental and external cuneate 
nuclei) (Palay and Chan-Palay, 1974; Voogd and Glickstein, 1998). Those mossy fibers 
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that arise from the brainstem or pons enter the cerebellum via the contralateral middle 
cerebellar peduncle (Mihailoff et al., 1981), while spinal mossy fibers enter the 
cerebellum through the inferior and superior peduncles (Chan-Palay et al., 1977). Similar 
to climbing fibers, mossy fibers run a myelinated axon into the white matter and emit 
collaterals to the deep cerebellar nuclei (Arsenio Nunes et al., 1988). From the white 
matter, mossy fibers ascend into the internal granular layer to synapse onto granule cell 
soma and dendrites (Palay and Chan-Palay, 1974). Their synaptic terminals form tapering 
enlargements called rosettes (Arsenio Nunes et al., 1988) that are enveloped by granule 
cell dendrites and Golgi cell axons. 
Mossy fiber terminals were previously thought to have a very different spatial 
distribution in the cerebellar cortex compared to climbing fibers. Yet, new anatomical 
analysis shows the convergence of both afferent systems (Pijpers et al., 2006) such that 
non-adjacent cerebellar zones that receive the same climbing fiber input also share the 
same mossy fiber input. Unlike their distribution, the action of mossy fibers on Purkinje 
cells is different from that of climbing fibers. Firstly, excitatory activation of mossy fibers 
is exerted onto Purkinje cells indirectly by parallel fibers, the granule cell axons. 
Secondly, each parallel fiber contacts many Purkinje cells in the translobular plane and 
has a few synapses with each single Purkinje cell.  
 
2.1.4 The cerebellar efferents 
The major input to the deep cerebellar nuclei is made by the Purkinje cell axons 
(Voogd and Ruigrok, 2004) and the organization of the cortico-nuclear projection gives 
rise to the three functional zones of the cerebellum. Purkinje cells whose axons terminate 
onto the fastigial nucleus are located predominantly in the vermis, ventral paraflocculus 
and flocculus while Purkinje cell axons which terminate in the interposed and dentate 
nuclei primarily compose the paravermis and hemispheres, respectively. In turn, these 
three functional zones differ in the type of afferents received and are assumed to be 
implicated in different aspects of motor activity. For example, the vermis is considered to 
control balance both in stance and locomotion (Thach and Bastian, 2004) whereas goal-
directed and visually-guided movements, in addition to the modulation of rhythmic-
synchronized movements are controlled by the paravermis and hemispheres (Cooper et 
al., 2000). 
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Furthermore, individual deep cerebellar nuclei have characteristic efferent targets. 
The fastigial nuclei send both crossed and uncrossed efferent projections to the vestibular 
nuclei, the inferior olive, the pontine and lateral reticular nuclei. The interposed nuclei 
project primarily to the contralateral red nucleus. The dentate nuclei project principally to 
the contralateral thalamus, the prefrontal cortex and the red nucleus. 
 
2.1.5 The cerebellar circuitry 
The key neuron of the cerebellar circuit is the Purkinje cell, as it integrates a variety 
of inputs and is the sole efferent of the cortex. Purkinje cells receive 2 main excitatory 
inputs (Fig. 8): climbing fibers making synapses directly onto Purkinje cells in a 1 
climbing fiber:1 Purkinje cell ratio and mossy fibers, indirectly via granule cells, in an 
approximately 100, 000 parallel fibers:1 Purkinje cell ratio (Eccles et al., 1966a; Ito, 
1984). Climbing fibers stimulate sagitally oriented bands of Purkinje cells, whilst parallel 
fibers activate a transverse beam. It is presumed that cerebellar function takes place at the 
intersection of these two afferents. Simultaneously, Purkinje cell activity is modulated by 
the basket and stellate axons (Fig. 8) (running in a plan perpendicular to parallel fibers) 
which sharpen the Purkinje cell output by inhibiting sagitally adjacent Purkinje cells. The 
Golgi cells provide feedback inhibition to the mossy fiber-granule cell synapse and 
inhibit the transversally activated Purkinje cell beam (Fig. 8) (Palay and Chan-Palay, 
1974). Then, the Purkinje cell axons exit the cortex and inhibit the deep cerebellar nuclei. 
In turn, the axons of the deep cerebellar neurons exit the cerebellum via the superior and 
inferior peduncles and transmit information to other motor centers (for example, the red 
nucleus and the thalamus). 
 
2.1.6 Development of the cerebellar neurons and afferents 
The first neurons to form are the inferior olivary neurons, followed by the deep 
cerebellar neurons and the Purkinje cells, which leave the ventricular neuroepithelium 
and settle in the developing cortical plate before birth (Altman and Bayer, 1997). The 
inhibitory interneurons also originate from the neuroepithelium of the 4
th
 ventricle, 
migrate like the Purkinje cells but continue to proliferate during their transit through the 
deep cerebellar mass (Schilling, 2000). Similarly, a secondary neuroepithelium, the 
external germinal layer (EGL), is generated prenatally, the precursor cells migrating onto 
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the surface of the cerebellar plate by birth. This latter epithelium produces the granule 
cells (Altman and Bayer, 1997). 
 
2.1.6.1 Development of the Purkinje cells 
The Purkinje cells originate in the neuroepithelium of the 4
th
 ventricle from 
embryonic day 13 (E13) (Altman, 1975). They ascend through the zone of the deep 
cerebellar nuclei to the cortical plate on the surface of the cerebellar primordium anlage 
by E15 (Altman and Bayer, 1978) leaving their axons behind and establishing synaptic 
contacts with deep cerebellar neurons as early as E20 (Eisenman et al., 1991). From E20, 
climbing fibers are present in the Purkinje cell plate (Chedotal and Sotelo, 1992) and 
make transient contacts with Purkinje cells (Morara et al., 2001), suggesting very early 
influence of climbing fibers on Purkinje cells. At birth, the morphological features of 
Purkinje cells are clearly apparent at the inner boundary of the EGL and are arranged in a 
6-12 cell-deep plate (Altman and Bayer, 1997). Their somata contain a large clear 
nucleus and minimal cytoplasm that emit short thin processes across the EGL (Altman 
and Bayer, 1997). 
From birth to postnatal day 2 (P2), transient synapses exist between climbing fiber 
axon terminals and transient emerging dendrites of the Purkinje cells (Armengol and 
Sotelo, 1991; Chedotal and Sotelo, 1993). From P3 to P4, Purkinje cells begin to align in 
a monolayer (Altman and Bayer, 1997) which is thought to be influenced by parallel fiber 
growth from above and granule cell migration to Purkinje cells from below (Goldowitz 
and Hamre, 1998). They display fine somatic processes that receive immature climbing 
fiber arbors (Mason et al., 1990; Armengol and Sotelo, 1991). From P5 to P7, a large 
apical cone develops increasing the Purkinje cell somatic cytoplasm, and extends into the 
molecular layer (Altman and Bayer, 1997). At P7, Purkinje cells begin to develop 
primary dendrites which receive parallel fiber synapses (Scelfo and Strata, 2005) while 
their perisomatic processes receive climbing fiber synapses (Altman and Bayer, 1997). 
The morphology of the Purkinje cells has transformed by P10, with somatic processes 
reabsorbed into the soma and basket cell axons contacting Purkinje cell somata (Berry 
and Bradley, 1976). By P12, the apical dendrites enlarge forming numerous secondary 
and tertiary branches (Altman and Bayer, 1997). From P12 to P15, the Purkinje cell 
dendritic arbor increases in complexity, first laterally and then growing in height in 
parallel with the molecular layer (Berry and Bradley, 1976) and generation of parallel 
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fiber synapses (Altman and Bayer, 1997). By P14, the distal branches of the Purkinje cell 
dendrites and spines located in the lower half of the molecular layer receive parallel 
fibers (Altman and Bayer, 1997). At P15, the Purkinje cell dendritic tree has formed its 
full width and the Purkinje cell soma is synaptically mature (Berry and Bradley, 1976). 
By P21, parallel fibers establish synapses with the distal spines on the dendritic tree in the 
upper half of the molecular layer (Altman and Bayer, 1997). The growth of the Purkinje 
cell dendritic tree continues through the upper molecular layer until P30 as the parallel 
fibers do (Berry and Bradley, 1976).  
 
2.1.6.2 Development of the granule cells 
At birth, the EGL has formed 6 to 8 rows of differentiating granule cell precursors. 
These cells undergo rapid proliferation until P9 and the EGL increases in depth with 8 to 
12 rows of cells (Altman and Bayer, 1997). The EGL displays two distinct zones of cells: 
an outer proliferative zone and an inner premigratory zone of bipolar cells (Altman and 
Bayer, 1997). The bipolar cells of the premigratory zone grow processes that elongate 
laterally and run parallel to the developing pial surface to become parallel fibers whilst 
the bipolar cell somata remain on this plane (Altman and Bayer, 1997). Once the parallel 
fibers have grown their optimal length, the soma migrates vertically to its position in the 
internal granular layer while the parallel fiber remains in the upper region of the 
molecular layer (Altman and Bayer, 1997). By P6, functional synapses exist between 
parallel fibers and Purkinje cells (Scelfo and Strata, 2005). From P7 to P12, the 
generation of granule cell numbers increase reaching a peak from P10 to P11 and 
maximal migration occurs between P9 and P17 (Altman and Bayer, 1997). From P15, the 
granule cells in the internal granular layer develop short claw-like dendrites that envelope 
the immature mossy fiber rosettes (Altman and Bayer, 1997). 
 
2.1.6.3 Development of the climbing fibers 
The development of the climbing fiber is concurrent with the development of the 
cerebellar cortex. The inferior olive neurons are generated in the dorsal neuroepithelium 
of the caudal hindbrain between E12 and E13 (Bourrat and Sotelo, 1991) and their axons 
extend and invade the cerebellar cortical plate by E17 where they are arranged in broad 
sagittal zones resembling the adult climbing fiber distribution and contact Purkinje cells 
(Arsenio Nunes and Sotelo, 1985; Chedotal and Sotelo, 1993). The onset of transient 
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(non-synaptic) contacts between climbing fiber axon terminals and transient Purkinje cell 
somatic processes first occur embryonically (Chedotal and Sotelo, 1993; Morara et al., 
2001). Postnatally, climbing fibers undergo 4 major developmental stages: 
- The “creeper stage” (Fig. 9). By P2 climbing fibers begin to “creep” as mini 
arbors to associate with immature Purkinje cell somata and their transient 
somatic processes via attachment plates within the Purkinje cell plate. 
Although this contact regresses by P3, a large portion of climbing fibers 
maintain contacts onto several adjacent Purkinje cells (Chedotal and Sotelo, 
1993). These early postnatal contacts are functional (Crepel et al., 1976) 
despite their perisomatic location. 
- The “pericellular nest stage” (Fig. 9). By P5, climbing fibers make pericellular 
nests onto the Purkinje cell somata aligned in a monolayer (Chedotal and 
Sotelo, 1993). Each Purkinje cell receives inputs from several climbing fibers, 
with a maximum mean number of 3.5 climbing fibers synapsing onto 
perisomatic processes of each Purkinje cell (Ramón y Cajal, 1911; Crepel et 
al., 1976; Mariani and Changeux, 1981; Lohof et al., 1996).  
- The “capuchon stage” (Fig. 9). Between P8 and P9 a somatodendritic 
translocation occurs and climbing fibers terminate onto the main trunk of the 
developing Purkinje cell dendritic tree (Ramón y Cajal, 1911; Mason et al., 
1990). The regression of multi-innervation that reduces the percentage of 
Purkinje cell innervation by 50% is contemporaneous with the climbing fiber 
translocation (Crepel et al., 1976; Chedotal and Sotelo, 1992). 
- The “young climbing fiber stage” (Fig. 9). From P10 to P15, reorganization of 
climbing fiber terminals occurs (Chedotal and Sotelo, 1992) so the adult 1:1 
relation between climbing fibers and Purkinje cells is reached (Crepel et al., 
1981; Mariani and Changeux, 1981).  
One salient feature of the developing climbing fiber-Purkinje cell synapse is the 
elimination of transient climbing fiber multi-innervation. This mechanism is highly 
dependent on the presence of granule cells and the formation of normal parallel fiber-
Purkinje cell synapses (Mariani and Changeux, 1980; Sugihara et al., 2000). Multiple 
innervations of climbing fibers persists when granule cell numbers are decreased in 
mutant rodents such as weaver and reeler (Appendix N°1) (Mariani et al., 1977; Puro and 
Woodward, 1977). Multiple climbing fiber innervation is also maintained abnormally 
Introduction 
 
28 
 
when parallel fibers are unable to form normal synapses with Purkinje cells in the 
staggerer (Mariani and Changeux, 1980) and the hotfoot mutant mice (§3.5.2).  
 
2.1.6.4 Development of the mossy fibers 
Mossy fibers derived from the brainstem nuclei also develop during embryogenesis 
and emerge into the cerebellar white matter by P3 (Arsenio Nunes and Sotelo, 1985). 
From P3 to P5, they invade the internal granular layer where they make synapses onto 
granule cell dendrites and by P7, mossy fibers are organized in topographical 
arrangement matching that of the adult mossy fiber input (Arsenio Nunes and Sotelo, 
1985). By P15, the mossy fibers forming rosettes with granule cell dendritic branches are 
biochemically mature (Altman and Bayer, 1997). However, the presence of only minimal 
number of glomeruli prevents mossy fiber-granule cell synapses maturity until P21 
(Altman, 1972), even though parallel fiber-Purkinje cell synapses are active at P7 (Scelfo 
and Strata, 2005). 
 
2.2 Functions of the cerebellum 
The anatomical organization of the cerebellum and its afferents and efferents are 
particularly important when considering the role of the cerebellum in different modes of 
information processing. However, the relative contributions of each structure as well as 
the functional changes that occur between these structures and other motor and non-
motor centers of the brain during learning and memory are unclear. Overall, in terms of 
cerebellar efferent flow, there appears to be two close efferent “loops” (Fig. 10): one with 
the red nucleus and the other with the premotor/motor cortex. In the first case, the deep 
cerebellar nuclei project axons to the red nucleus which in turn projects to the 
precerebellar nuclei of the spinal cord, medulla (e.g. external cuneate nucleus and inferior 
olive) and pons (e.g. pontine gray and vestibular nuclei) that also receive peripheral input. 
The precerebellar nuclei innervate the cerebellar cortex and a subset of deep cerebellar 
neurons to form one closed circuit (Altman and Bayer, 1997). As the precerebellar nuclei 
receive peripheral input (by way of the spinal cord) and cerebellar input (by way of the 
deep cerebellar nuclei and red nucleus), they may form part of a regulatory or 
readjustment system between both external and internal input (Palay and Chan-Palay, 
1974; Altman and Bayer, 1997).  
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In the second case, the deep cerebellar nuclei project directly to the thalamus (Fig. 
10) that receives input from the motor cortex, and the premotor, parietal and prefrontal 
cortices. Also, the thalamus and the motor cortex project to the pontine nuclei, which in 
turn project to the deep cerebellar nuclei forming another closed circuit. This massive 
descending path from the cerebral cortex to the pontine nuclei is thought to carry 
information about an extended action (Altman and Bayer, 1997). The structural link 
between the cerebellar cortex-deep cerebellar nuclei and cerebellar function provides a 
site where the process of motor learning and non-motor activities may occur, although the 
mechanisms involved are not fully elucidated. 
 
2.2.1 Motor functions 
The importance of the cerebellum and its components in motor functions are 
demonstrated by studies using cerebellar lesions and mutant mice. The removal of the 
whole cerebellum causes a lack of sensorimotor coordination and impaired equilibrium in 
both neonatal and adult rats (Zion et al., 1990; Caston et al., 1995). Comparatively, the 
removal of half of the cerebellum has a differential effect on adult and neonatal rats 
(Molinari et al., 1990). In adult rats, the effects include asymmetrical gait, deficits in 
dynamic postural adjustments and coordination and a side preference contralateral to the 
lesion (Molinari et al., 1990). However, neonatal hemicerebellectomised rats exhibit a 
normal gait, but a delay in acquiring dynamic postural adjustment and a permanent 
impairment of motor skills (Petrosini et al., 1990). The transition from normal motor 
development to defective motor behavior following neonatal hemicerebellectomy, 
referred to as “growing into a deficit”, is evidenced by the progressive reduction of hind 
limb grasping and a directional bias in posture correction (Petrosini et al., 1990). It has 
been suggested that these motor abnormalities are independent of cerebellar control in 
early development, but as the rat matures, the retention of these motor skills requires a 
cerebellar circuit (Petrosini et al., 1990). 
Further investigations using mutant mice have provided evidence for the relative roles 
of the deep cerebellar nuclei and the cortex in cerebellar function. The mutant mice 
models include Lurcher mice which display cerebellar cortical and inferior olive 
degeneration and Hu-bcl-2-overexpressing mice which exhibit an excess of neurons. 
Lurcher mutant mice are ataxic and limited in equilibrium, motor coordination and 
postural sensorimotor skills in complex motor tasks (Hilber et al., 1998; Hilber and 
Introduction 
 
30 
 
Caston, 2001). As deep cerebellar neuron output is the only part of the cerebellar circuit 
remaining in this mutant, the deep cerebellar neuron activity is apparently adequate for 
simple sensorimotor tasks, but not for more complex tasks. Similarly, transgenic Hu-bcl-
2 mice that possess supernumerary Purkinje, granule and inferior olivary neurons display 
impairment of complex motor abilities, such as synchronized walking movement, but not 
in basic motor tasks (Rondi-Reig et al., 1999). This indicates that one function of the 
deep cerebellar nuclei is to learn and maintain simple sensorimotor behavior, while a 
correct cerebellar cortical circuit is necessary for complex learning.  
 
2.2.2 Cognitive functions 
A role of the cerebellum in cognitive functions is supported by a variety of studies 
based on neuroanatomical, functional imaging, clinical and experimental approaches 
(Schmahmann and Sherman, 1997). The extensive interconnexions between the 
neocortex and lateral cerebellar hemispheres have led to the interpretation that these two 
structures are functionally related hence implying a cerebellar role in cognition 
(Middleton and Strick, 2000). Although these studies demonstrate cerebellar processing 
in non-motor tasks, the specific regions of the vermis and the lateral zone involved in 
these functions remain poorly defined. Generally, lesions to the lateral zone of the rat 
cerebellum induce selective deficits in spatial orientation tasks, but not in visuomotor 
abilities, while lesions to the vermis only impair visuomotor abilities (Joyal et al., 1996). 
Furthermore, vermal lesions induce autistic-like symptoms, such as limited attention 
capacity and decreased anxiety (Bobee et al., 2000).  
The cerebellum is also involved in associative learning as shown by results of 
avoidance-condition tasks. In these tasks, cerebellectomised rats learn as fast as intact rats 
to avoid an electrical shock when given an auditory stimulus. However, retention of the 
acquired conditioned response does not occur, indicating that the cerebellum is required 
to maintain learned avoidance behavior (Dahhaoui et al., 1990).  
 
2.2.3 Spatial functions 
Spatial functions have been reported to be affected by cerebellar pathologies 
(Petrosini et al., 1996; Molinari et al., 1997). Indeed, cerebellar connections with 
structures known to mediate visuospatial abilities such as frontal and parietal regions, 
limbic system and superior colliculus are consistent with this hypothesis (Schmahmann 
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and Pandya, 1989; 1997). Patients with Friedreich's ataxia perform spatial tasks 
deficiently (Fehrenbach et al., 1984) and patients with focal cerebellar lesions develop 
spatial deficits (Wallesch and Horn, 1990).  
Mutant mice such as Lurcher, Pcd, nervous and staggerer mice develop different 
spatial impairments, such as exploratory deficits in mazes and defective spatial memory 
(Lalonde and Botez, 1990). Lurcher mice display deficits in habituation (Lalonde et al., 
1986b) and in controlling the direction of swimming (Lalonde et al., 1988a) in aquatic 
mazes. Selective Purkinje cell degeneration in Pcd mice apparently interferes with the 
acquisition of spatial tasks (Goodlett et al., 1992). Staggerer mutant mice that loose 
Purkinje cells and granule cells, exhibit prolonged exploration of new environments and 
deficits in maze learning (Lalonde et al., 1987; 1988b). In complex environment, nervous 
mutant mice which have damaged Purkinje cells and deep cerebellar neurons lack ability 
to retain the learned behavior compared to controls (Lalonde and Botez, 1985; Lalonde et 
al., 1986a). This suggests that an intact cerebellar cortical circuit and afferents are needed 
for learning and retention of spatially demanding tasks. 
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3. The hotfoot and Lurcher Grid2 mutant mice  
Ionotropic glutamate receptors mediate most of the excitatory synaptic transmission in the 
central nervous system and are essential for synaptic plasticity (Brockie and Maricq, 2006). 
These include AMPA receptor subunits (GluR1-GluR4, GluRA-D), Kainate receptor subunits 
(GluR5-GluR7, KA1 and KA2) and NMDA receptor subunits (NR1, NR2A-NR2D and 
NR3A-NR3B). Two additional members of this superfamily, termed and  have been 
identified in both mouse and rat brain.  
 
3.1 The Grid2 gene 
The glutamate receptor (GluR2) has been identified in both mouse and rats by 
homology screening of mouse cDNA libraries. It is positioned at equal distances in the 
phylogenic tree from NMDA, AMPA and Kainate receptors (Araki et al., 1993; Lomeli et al., 
1993) and is coded by the Grid2 gene which contains 16 exons  over a region of 1.4Mb 
located on chromosome 6 in mice (see review in Yuzaki, 2003). This may be a reason for the 
numerous of spontaneous mutations of this locus. Sixteen of these mutations provoke ataxia. 
The high frequency of Grid2 mutations reflects its hypermutability as underlined by the 
occurrence of two independent translocations recently reported in a relatively small colony 
(Robinson et al., 2005). 
Two natural Grid2 mutant mice have been extensively studied since their discovery in the 
60’s, Lurcher (Phillips, 1960) and hotfoot (Dickie, 1966). Indeed, investigating these two 
mutant mice has brought important insights into the roles of GluR2 in Purkinje cell 
synaptogenesis and programmed cell death (Gounko et al., 2007). 
 
3.2 Structure and localization of GluR2 
3.2.1 GluR2 is an orphan glutamate receptor 
The topology of GluR2 is predicted to be similar to other ionotropic GluRs with an 
extracellular N-terminal region containing LIVBP-like and LAOBP-like domains, three 
transmembrane domains (TM1, TM3 and TM4), an ion channel-forming segment (TM2) and 
a cytoplasmic C-terminal region (Fig. 11A) (Araki et al., 1993; Lomeli et al., 1993).  
GluR2 is an ionotropic glutamate receptor because:  
- it possesses four hydrophobic segments (Araki et al., 1993), 
- it shares amino acid sequence with other GluR channel subunits, 
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- it is localized at the parallel fiber-Purkinje cell synapses (Araki et al., 1993; Mayat 
et al., 1995; Takayama et al., 1995) where it is a receptor of the postsynaptic 
density beard by the Purkinje cell spine (Takayama et al., 1995; Landsend et al., 
1997), 
- it is co-expressed  with AMPA GluR2/3 receptors in the postsynaptic membrane of 
the Purkinje cell synapses (Takayama et al., 1995; Landsend et al., 1997) 
- it has the characteristic ion channel pore of glutamate receptors (Kohda et al., 
2000).  
However, it does not form functional glutamate-gated ion channels when expressed in 
transfected cells and does not bind glutamate analogs (Araki et al., 1993; Lomeli et al., 1993). 
In addition it does not complex with other glutamate receptor subtypes (Mayat et al., 1995). 
For these reasons it is considered to be an orphan glutamate receptor.  
 
3.2.2 The GluR2 of Purkinje cells 
Similarly to other glutamate receptors (Ajima et al., 1991), the distribution of GluR2 
differs at the two main types of excitatory synapses of the Purkinje cell dendritic tree, the 
climbing fiber-Purkinje cell and parallel fiber-Purkinje cell synapses. In the adult cerebellum, 
GluR2 is expressed at the postsynaptic side of the parallel fiber-Purkinje cell synapse, but is 
absent from the climbing fiber-Purkinje cell synapse (Takayama et al., 1996; Landsend et al., 
1997). Nevertheless, in the postnatal rat cerebellum, GluR2 is expressed at both climbing 
fiber-Purkinje cell and parallel fiber-Purkinje cell synapses although it disappears from 
climbing fiber-Purkinje cell synapse as early as P15 (Zhao et al., 1997). At this time, the 
multiple innervations of Purkinje cells by climbing fibers have completely regressed while 
parallel fiber-Purkinje cell synaptogenesis peaks. This specific developmental change in 
synaptic localization of GluR2 suggests that it is involved in parallel and climbing fiber 
synaptogenesis with Purkinje cell (Mayat et al., 1995).  
 
3.3 Molecular partners of GluR2 
As illustrated in Figure 11B, a number of proteins involved in the docking and trafficking, 
as well as in the functional regulation of GluR2 have been identified. 
The cytoplasmic C-terminal tail of all ionotropic GluRs intervenes in synaptic clustering 
(Malinow and Malenka, 2002). The post-synaptic anchoring PDZ proteins specifically 
recognize the C-terminus of their associated receptor (Hung and Sheng, 2002). Along this 
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line, the sequence of the 4 last amino acids of the GluR2 C-terminus has been shown to 
specifically bind the post-synaptic density (PSD)-93 protein, a member of the PSD-95 family 
of PDZ proteins, at the parallel fiber-Purkinje cell synapse (Roche et al., 1999). Finally, yeast 
two hybrid screening revealed that several PDZ-containing proteins interact with GluR2 C-
terminus. These proteins include: 
- the protein-tyrosine phosphatase PTP-MEG (Hironaka et al., 2000) which might play a 
role in the regulation of the activity of GluRs through tyrosine dephosphorylation 
- delphilin which is selectively localized at the post-synaptic side of the parallel fiber-
Purkinje cell synapse (Miyagi et al., 2002) and may link GluR2 with the actin 
cytoskeleton 
- n-PIST  an activator of the autophagy inducer Beclin-1 (Yue et al., 2002) 
- scaffold proteins Shank 1 and 2 (Uemura et al., 2004) which allow GluR2 interaction 
with the main post-synaptic actors of long-term depression: the metabotropic 
glutamate receptor mGluR1, the AMPA-type glutamate receptors and the inositol 
1,4,5-triphosphate receptor (IP3R) 
- PICK1, a protein interacting with C kinase 1 (Yawata et al., 2006). PICK1 has been 
shown to be involved in long term depression (LTD) and interacts with the C-terminus 
of GluR2. This demonstrates the importance of the GluR2 C-terminus in cerebellar 
LTD (Kohda et al., 2007)  
- S-SCAM/MAGI-2, a PDZ domain-containing protein localized at post-synaptic site of 
Purkinje cell synapses. Binding of S-SCAM/MAGI-2 with GluR2 is regulated by 
protein kinase C (PKC)-mediated phosphorylation of the receptor and this may be 
necessary for the trafficking and clustering of GluR2 (Yap et al., 2003a) 
- Spectrin, a member of the actin-binding family of proteins. Thus, spectrin may directly 
act on immobilization and clustering of GluR2 at the parallel fiber-Purkinje cell 
synapse (Hirai and Matsuda, 1999) 
- EMAP, a microtubule-associated protein which binds selectively GluR2 and spectrin 
(Ly et al., 2002) indicating the involvement of cytoskeleton in GluR2 trafficking.  
 
Finally, new insights into the intracellular movement, anchoring and clustering of GluR2 
at the post-synaptic membrane have been provided by the discovery of Region A, a region 
adjacent to the TM4 of GluR2 (Fig. 11B) (Matsuda and Mishina, 2000; Matsuda et al., 
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2004), and of the Adaptor protein complex-4 AP-4 (Yap et al., 2003b). Indeed, the former has 
been shown to target GluR2 from the endoplasmic reticulum to the plasma membrane and 
the latter has been shown to be involved in the intracellular trafficking of GluR2.  
 
3.4 GluR2 in LTD 
Data from treatment of Purkinje cells with either antisense oligonucleotides  (Hirano et 
al., 1994) or antibody against GluR2 (Hirai et al., 2003) also implicate GluR2 as a critical 
element in AMPA receptor trafficking and the induction of LTD at the parallel fiber-Purkinje 
cell synapse. Indeed, the C-terminus of GluR2 has been shown to be phosphorylated by the 
PKC in vitro and a LTD-inducing signal in vivo (Kondo et al., 2005).  GluR2 devoid of C-
terminal PDZ-ligand domains cannot restore the abrogated LTD in Grid2
-/- 
mice (Kohda et al., 
2007; Kakegawa et al., 2008). Transgenic Grid2
-/-
 mice carrying mutant GluR2 with specific 
PDZ-ligand domain deletions have been generated (Uemura et al., 2007; Yasumura et al., 
2008). Deletion of the C-terminal PDZ-ligand domain, the T site (Fig. 11B), revealed an 
impairment of LTD induction at the parallel fiber-Purkinje cell synapse and a distal expansion 
of climbing fiber territory. However, elimination of surplus climbing fiber innervation at 
proximal dendrites appeared to proceed normally (Uemura et al., 2007). Nevertheless, when S 
segment (Fig. 11B), the second PDZ-binding domain of the C-terminus, was deleted, the 
amount of GluR2 in cerebellar PSD fractions was reduced. In addition, mismatched parallel 
fiber and naked spines emerged and the climbing fiber territory expanded to distal regions of 
Purkinje cell dendritic tree (Yasumura et al., 2008). This implies a differential involvement of 
these PDZ-binding domains in diverse GluR2 functions. 
 
3.5 Hotfoot, a natural Grid2 knock-out mouse 
The hotfoot mutation was first described in mouse by Dickie (1966) but has only recently 
been related to GluR2 (Lalouette et al., 1998). The hotfoot mutation causes a natural GluR2 
deficiency due to a deletion in the Grid2 gene. At least, 18 independent hotfoot mutations of 
the Grid2 gene have been documented causing ataxia in the hotfoot mouse (Mouse Genome 
Informatics, 2000). The recessive loss-of-function mutations carried by the hotfoot alleles of 
Grid2 result in ataxia without Purkinje cell death. Two specific hotfoot mutations hotfoot-4J 
(ho-4J) (Lalouette et al., 1998) and hotfoot-Nancy (ho
Nancy
) (Lalouette et al., 2001) are of 
particular interest. The ho-4J mutation results in the loss of 170 amino acids from the 
extracellular N-terminal LIVBP-like domain of GluR2 (Lalouette et al., 1998). This deletion 
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induces the retention of GluR2 in the ER (Matsuda and Yuzaki, 2002; Wang et al., 2003). 
The ho
Nancy
 mouse expresses a truncated transcript lacking TM1, 2 and 3. No protein could be 
detected by Western Blot (Lalouette et al., 2001) indicating that this hotfoot mutant is a 
complete Grid2 knock-out mutant that does not express any GluR2 protein.  
 
3.5.1 The hotfoot behavioral phenotype 
Motor coordination is impaired in all hotfoot mice as early as P12 (Kashiwabuchi et al., 
1995) due to a dysfunction of deficient Purkinje cells. In addition, the GluR2ho/ho mouse 
displays a characteristic involuntary spontaneous eyeblink that can be suppressed by ablation 
of cerebellar floculi. This suggests an abnormal signal output by the cerebellar cortex 
(Yoshida et al., 2004). These motor impairments are likely to result from Purkinje cell 
dysfunction due to the lack of GluR2 at parallel fiber synapses.  
 
3.5.2 Development and synaptogenesis of the Purkinje cells in the hotfoot GluR2ho/ho 
mice 
In the adult cerebellar cortex, GluR2 is exclusively expressed in parallel fiber-Purkinje 
cell synapses (Fig. 12A) (Landsend et al., 1997), although it is transiently expressed in 
developing climbing fiber-Purkinje cell synapses (Zhao et al., 1997).  
GluR2ho/ho Purkinje cell dendrites display naked postsynaptic spines which are 
surrounded by Bergmann glia and are equipped with PSD but are lacking contact with 
presynaptic parallel fiber boutons (Fig. 12B) (Kashiwabuchi et al., 1995). Quantification of 
parallel fiber-Purkinje cell synapses in GluR2ho/ho cerebellar molecular layer indicated a loss 
of parallel fiber synapses (Kurihara et al., 1997). In addition, Grid2 knock-out mice (GluR2-
/-
) selectively devoid of GluR2 proteins in cerebellar Purkinje cells, also had naked spines 
(Fig. 12B) (Takeuchi et al., 2005) and mismatching of parallel fiber boutons and Purkinje cell 
postsynaptic densities on tertiary spines, as previously described in natural hotfoot mutant 
mice (Lalouette et al., 2001). Furthermore, the multiple climbing fiber innervation of Purkinje 
cells persists abnormally in the hotfoot  adult (Kashiwabuchi et al., 1995) whereas the normal 
projection domain of climbing fibers (i.e. the primary and secondary Purkinje cell dendrites) 
extends distally to tertiary spiny branchlets (Fig. 12B). Here, climbing fibers make aberrant 
ectopic synapses on the spiny branchlets of the neighboring Purkinje cells (Ichikawa et al., 
2002). The blockade of electrical activity in wild-type cerebellum induces the formation of 
parallel fiber synapses on primary and secondary dendrites which are normally specific for 
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climbing fiber synapses (Fig. 12C). In this case, the expression of GluR2 occurs in both 
climbing fiber- and parallel fiber-Purkinje cell synapses (Morando et al., 2001) suggesting 
that climbing fiber activity normally prevents GluR2 targeting to proximal dendrites in the 
mature Purkinje cells. In support of this hypothesis, the blockade of the electrical activity of 
climbing fibers induced the expression of GluR2 at the proximal spines which are 
reinnervated by parallel fibers in the absence of climbing fiber innervation (Fig. 12C) (Cesa et 
al., 2003). The reinnervation of these spines by climbing fibers after restoring electrical 
activity was accompanied by the disappearance of GluR2. These data demonstrate that 
GluR2 is downregulated by mature climbing fiber activity. 
 
3.6 The Lurcher mutation kills Purkinje cells 
The Lurcher mutation was first described as a spontaneous mutation in mouse by Phillips 
(1960) and is attributed to a semi-dominant gain-of-function mutation in the SYTANLAAF 
motif of the TM3 domain of the Grid2 gene (Zuo et al., 1997). The perinatal death of the 
homozygous GluR2Lc/Lc mutant mice can be explained by the loss of large trigeminal motor 
neurons involved in suckling (Cheng and Heintz, 1997).  
The heterozygous GluR2Lc/+ mutant mice display specific ataxia due to postnatal 
Purkinje cell degeneration which results in an almost total loss of the Purkinje cell population 
and target death-related loss of granule cells (Swisher and Wilson, 1977; Wetts and Herrup, 
1982).  
 
3.6.1 The Lurcher mutation and glutamate receptors 
The implication of the mutated SYTANLAAF motif in the constitutive activation of 
GluR2Lc has been validated by inducing this mutation in AMPA and kainate receptors which 
then display similar activity without ligand binding, slower deactivation and desensitization in 
the presence of an agonist (Kohda et al., 2000; Schwarz et al., 2001). This indicates that the 
Lurcher mutation affects receptor affinity and that this conserved SYTANLAAF motif plays a 
major role in the ionic channel properties of ionotropic glutamate receptors. This motif seems 
to play an important role in the gating properties of AMPA and NMDA GluR channels too, 
because these properties are also altered when the Lurcher mutation is introduced in these 
receptors (Ikeno et al., 2001). The introduction of the Lurcher mutation in GluR1 increased 
the affinity of GluR1
Lc
 for glutamate and reduced the desensitization of GluR1
Lc
 channel at 
low receptor occupancy. This explains the small and sustained current observed in these 
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GluR1
Lc
 channels (Klein and Howe, 2004). GluR1
Lc
 and GluR6
Lc
 mutant receptors expressed 
in HEK cells can form functional heteromeric channels with GluR2Lc, which permit 
glutamate-induced
 
currents. In contrast, the formation of heteromeric wild-type 
GluR2/iGluR channels modifies glutamate signaling by forming non-functional channels, 
leading to the reduction of glutamate-induced currents (Kohda et al., 2003). The pore of 
GluR2Lc shows functional similarities to Ca²+-permeable AMPA/kainate receptors and is 
able to form ion channels that are potentiated by extracellular Ca²
+ 
at physiological 
concentrations (Wollmuth et al., 2000). This Ca²
+
 influx or Ca²
+
-dependent potentiation may 
contribute to the role of GluR2 in cerebellar LTD.  
 
3.6.2 The molecular basis of Purkinje cell death in the Lurcher mouse 
The massive neurodegeneration observed in the cerebellar cortex of the GluR2Lc/+ mouse 
has been shown to involve apoptosis (Phillips, 1960; Norman et al., 1995; Wullner et al., 
1995; Selimi et al., 2000c). Purkinje cell death is believed to result from excitotoxic effects of 
the Lurcher mutation in the GluR2 receptor (Zuo et al., 1997) even in the absence of any 
ligand binding (Kohda et al., 2000).  
Investigation of the apoptotic mechanisms leading to Purkinje cell death in the Lurcher 
mouse revealed increased BAX and BCL-XL expression by Purkinje cells (Wullner et al., 
1998). Nevertheless, overexpressing Bcl-2 (Zanjani et al., 1998a) and knocking-out Bax only 
delayed Purkinje cell death (Doughty et al., 2000; Selimi et al., 2000c). Overexpressing Bcl-2 
prevented target-related cell death of inferior olivary neurons (Zanjani et al., 1998b), whereas 
inactivation of Bax rescued granule cells from target-related apoptotic cell death (Selimi et al., 
2000c). The involvement of mitochondrial apoptotic factors in Lurcher-induced cell death is 
supported by the translocation of cytochrome c from mitochondria to the Apaf1 complex 
during the period of maximal neuronal death in the cerebellum of the GluR2Lc/+ mouse 
(Frischmuth et al., 2006). The effector protein caspase-3, but not the apoptotic factor p53, was 
shown to be involved in apoptosis of GluR2Lc/+ Purkinje cells and granule cells (Doughty et 
al., 2000; Selimi et al., 2000a; 2000b). As both Bax inactivation and Bcl-2 overexpression 
only delayed GluR2Lc/+ Purkinje cell death, Bcl-2 family members seem to contribute to 
Purkinje cell apoptosis, but additional extracellular apoptotic signaling cannot be ruled out. 
Indeed, the elimination of tissue plasminogen activator, a serine protease known to activate 
caspase-8 also delayed GluR2Lc/+ Purkinje cell and granule cell apoptosis (Lu and Tsirka, 
2002). Caspase-3 was not detected in many cerebellar neurons stained with fluoro-Jade B, a 
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specific marker for dying neurons (Baurle et al., 2006). These data suggest that more than one 
neuronal death mechanism operates in the GluR2Lc/+ Purkinje cells. Further investigations 
should help to elucidate complex neuronal responses elicited by excitotoxicity in the Lurcher 
Purkinje cells. 
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4. The Nagasaki prion protein-deficient mice 
Prion diseases or transmissible spongiform encephalopathies (TSEs) are infectious, fatal 
neurodegenerative diseases that affect humans and various animals. These include Creutzfeld 
Jacob disease, scrapie and BSE (appendix N°2). In humans, prion diseases manifest as rapid 
progressive dementias with clinical visual or cerebellar signs and akinetic mutism.  
The agents that cause TSEs are known as prions (Prusiner, 1982). One hypothesis 
postulates that prions are PrP
res 
(prion protein resistant to proteinase K) (Bolton et al., 1982; 
Prusiner et al., 1984) a conformational isoform of the host cellular prion protein, PrP
C
 
(Caughey and Raymond, 1991). Although many different functions have been attributed to 
PrP
C
, its physiological function remains unclear.  
 
4.1 The prion protein family 
The prion gene family consists in three known members: the prion protein gene Prnp, the 
Doppel gene Prnd and the Shadoo gene Sprn. 
 
4.1.1  The prion protein gene Prnp 
The prion protein gene Prnp is located on chromosome 2 in mice (Horiuchi et al., 1998) 
and encodes PrP
C
 (Oesch et al., 1985; Basler et al., 1986). PrP
C
 is the cardinal protein 
involved in prion diseases (Bueler et al., 1993) including the genetic forms of TSEs caused by 
mutations in Prnp. These are hereditary Creutzfeld-Jacob disease, fatal familial insomnia and 
Gertsmann-Straüssler-Scheinker syndrome. 
 
4.1.2  The Doppel gene Prnd 
The Doppel gene Prnd is located 16kB downstream of the murine Prnp locus and 
encodes a 179 amino acid-long prion protein-like Doppel (Dpl) (Moore et al., 1999; Li et al., 
2000a) which shares 25% identity with PrP
C
. Detailed analysis of the toxicity of abnormal 
overexpression of Dpl in central neurons in some Prnp
0/0
 mouse lines is one of the research 
axis of my thesis (see below). 
 
4.1.3  The Shadoo gene Sprn 
Shadoo, a short protein homologous for the central hydrophobic region of PrP
C
 was 
discovered while looking for nucleotide sequences homologous to the Prnp sequence. The 
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Shadoo coding gene Sprn is located on chromosome 7 in mouse and its expression is 
restricted to the brain (Premzl et al., 2003).  
 
4.1.4 The prion proteins 
4.1.4.1 The cellular prion protein 
The cellular prion protein is a glycosyl phosphatidyl inositol (GPI)-anchored glycoprotein 
that contains a long, flexible N-terminal tail, three α-helices, and a two-stranded antiparallel 
β-sheet that flanks the first α-helix. PrPC displays a single disulfide bond which links helices 2 
and 3 thereby stabilizing the C-terminus (Fig. 13). The N-terminus contains two specific 
regions, a copper-binding N-terminal octapeptide regions and a hydrophobic core (Fig. 13) 
(Locht et al., 1986; Riek et al., 1997). Mutations within this hydrophobic region favor the 
formation of C- and N-terminal 
ctm
PrP and 
Ntm
PrP transmembrane topological variants of 
PrP
C
. The
 Ctm
PrP causes neurodegeneration (Hegde et al., 1998). Although it does not appear 
to be infectious when inoculated in reporter
 
mice, transgenic mice expressing 
Ctm
PrP develop 
neurological
 
illness and neuronal death that resembles certain prion diseases (Stewart et al., 
2005). 
 
4.1.4.2 Doppel 
Dpl, like PrP
C
, is an -helical protein with a C-terminal GPI anchor (Fig. 13) (Silverman 
et al., 2000). Nevertheless Dpl resembles a truncated form of PrP
C
 with approximately 25% 
sequence identity and an additional outer disulfide bond (Lu et al., 2000). Disruption of the 
helix B separates it into B and B′ regions, and the two β-strands have opposing orientations 
(Fig. 13). Interestingly, no evidence of disease association with Dpl could be disclosed (Mead 
et al., 2000) and Dpl does not have any scrapie isoform (Settanni et al., 2002; Peoc'h et al., 
2003). 
 
4.1.4.3 Shadoo 
Murine Shadoo is a protein with N- and C-terminal signal sequences similar to PrP
C
 and 
Doppel (Fig. 13) (Premzl et al., 2003). Shadoo shares homology to the PrP
C
 N-terminal 
domain with a series of N-terminal charged tetrarepeats. As mentioned, the bulk of the 
homology between Shadoo and PrP
C
 is found within the hydrophobic tract. Additionally, 
Shadoo is devoid of cysteine residues, preventing the formation of stabilizing disulfide bonds. 
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Shadoo has recently been shown to counteract neurotoxic activity of Dpl in a PrP
C
-like 
neuroprotective activity (Watts et al., 2007) 
 
4.2 The cellular prion protein PrPC 
4.2.1 Expression of PrPC in the central nervous system 
Prion protein gene expression is detected as early as E13.5  in the developing mouse brain 
(Manson et al., 1992). It further increases in a region-specific manner during the postnatal 
period (Mobley et al., 1988). In addition, glial cells express prion protein mRNAs throughout  
postnatal development in rodent brain (Moser et al., 1995). In the adult, high levels of PrP
C
 
are found in brain and spinal cord neurons (Manson et al., 1992; Harris et al., 1993), as well 
as in neurons and Schwann cells of the peripheral nervous system (Ford et al., 2002). In the 
brain, PrP
C
 has been detected in neurons of the olfactory bulb, the neocortex, the amygdala, 
the putamen, the hippocampus, the brainstem and the cerebellum (Fournier et al., 1995; Sales 
et al., 1998; Haeberle et al., 2000; Laine et al., 2001; Mironov et al., 2003; Bailly et al., 2004; 
Galvan et al., 2005). PrP
C
 is a neuronal cell surface protein (Caughey and Raymond, 1991) 
distributed in patches on the surface of the cerebellar Purkinje cells, granule cells and deep 
cerebellar neurons (Bailly et al., 2004). The preferential synaptic distribution of PrP
C
 has been 
described at pre- and post-synaptic elements of excitatory synapses on Purkinje cells 
(Haeberle et al., 2000; Bailly et al., 2004), as in other central synapses (Fournier et al., 1995; 
Bailly et al., 2004). Taking into account the synaptic localization of PrP
C
 and 
electrophysiological studies on hippocampal slices devoid of PrP
C
 strongly suggest that PrP
C 
has important synaptic functions (Collinge et al., 1994; Fournier et al., 1995; Herms et al., 
1999). Indeed, in these hippocampal slices, long term potentiation is impaired (Collinge et al., 
1994) and the expression level of PrP
C
 is correlated with glutamatergic synaptic transmission 
(Carleton et al., 2001). Moreover, Ca²
+
-activated K
+
 currents are decreased in Purkinje cells 
from Prnp-ablated mice (Herms et al., 2001) and the whole cell current of granule cells 
incubated with a recombinant PrP is reduced (Korte et al., 2003). This and the fact that 
hippocampal neurons depleted in cholesterol have an abnormal cell membrane expression of 
PrP
C
 (Galvan et al., 2005) suggest an important role for PrP
C
 in the regulation of synaptic 
transmission. 
In cultured fetal hippocampal neurons, expression  of a recombinant form of PrP results in 
the elaboration of axons and dendrites and increases the number of synaptic contacts (Kanaani 
et al., 2005). Neuritogenesis decreases when neurons or astrocytes do not express PrP
C
 in 
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neuron-astrocyte cocultures (Lima et al., 2007) and it has been demonstrated in vivo that PrP
C
 
also plays an important role in cellular differentiation during neural development (Steele et 
al., 2006). Taken together, these data indicate that PrP
C
 can function as a growth factor 
involved in neurogenesis and the development of neuronal polarity. 
 
4.2.2 Cell trafficking of PrPC 
PrP
C
 biosynthesis is achieved by translocation to the ER due to the presence of an N-
terminal signal peptide. This signal peptide is then cleaved in the ER lumen and the C-
terminal GPI anchor is added (Caughey et al., 1989). The secreted PrP
C
 form is then 
transported to the cell surface where it is expressed for 1 hour before undergoing endocytosis 
in early endosomes (Fig. 14). The important intracellular amount of PrP
C
 (35 to 50%) 
indicates that integral PrP
C
 is continuously cycled between the cell surface and the endosomes 
(Fig. 14) (Shyng et al., 1993). In this way, endocytosis of raft-associated PrP
C
 is likely to 
involve a clathrin-dependent mechanism. The copper-binding N-terminal region of PrP
C
 is 
implicated in this mechanism since deletions within the N-terminal region of PrP
C
 reduces 
internalization of the protein (Shyng et al., 1994; 1995). Furthermore, when copper ions bind 
to the N-terminal octapeptide repeats, PrP
C
 is liberated from lipid rafts prior to its 
internalization by clathrin-mediated endocytosis (Fig. 14) (Taylor et al., 2005). In addition, 
this mechanism of endocytosis depends on the intervention of the low-density-lipid receptor 1 
(Taylor and Hooper, 2007). 
Inhibition of the proteasome induces a cytosolic accumulation of PrP
C
 indicating that PrP
C
 
can be catabolized through the ER-associated degradation (ERAD) pathway (Fig. 14) 
(Yedidia et al., 2001). 
 
4.2.3 Neuronal effects of PrPC deficiency 
Less than a decade after the discovery of PrP
C
, mice homozygous for disrupted Prnp were 
generated in order to characterize its physiological functions. Two Prnp knock-out (Prnp
0/0
) 
mutant mouse lines Zurich I (Bueler et al., 1992) and Edinburgh (Manson et al., 1994) were 
generated and developed normally. Only subtle deficiencies related to neuronal functions 
were detected. Alteration of sleep rhythms characterized by enhanced sleep fragmentation 
including short waking episodes was observed in these Prnp-deficient mice (Tobler et al., 
1996; 1997). In addition, several alterations were observed including impairment of long-term 
potentiation, weakened GABA receptor-mediated inhibition (Collinge et al., 1994) and 
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disruption of K+ currents (Colling et al., 1996) in hippocampal slices of these Prnp-deficient 
mice. Interestingly, these neurophysiological phenotypes were rescued by the introduction of 
a high number of transgenic copies of Prnp confirming that this phenotype is a consequence 
of the loss of PrP
C
 (Whittington et al., 1995). Moreover, loss of PrP
C
 alters both the 
intracellular calcium homeostasis of cultured cerebellar granule cells (Herms et al., 2000) and 
the maximal increase of intracellular calcium concentration provoked by depolarization in 
Purkinje cells. These data provide strong evidence that Ca2+-activated K+ currents in mice 
are reduced due to an altered intracellular calcium homeostasis. Furthermore, a profound but 
transient impairment of synaptic excitation and plasticity has been evidenced in granule cells 
of 3 week-old Prnp
0/0 
mice suggesting that PrP
C
 plays an important role in granule cell 
development (Prestori et al., 2008). 
In addition, PrP
C
 deficiency also impairs the anti-apoptotic PI3-kinase/Akt pathway, 
leading to apoptotic caspase-3 activation (Weise et al., 2006) (see below).  
 
4.2.4  Molecular partners of PrPC 
Identification of molecular partners of PrP
C
 is one way to elucidate its potential 
physiological functions. The trafficking of PrP
C
 implies that it is exposed to a large number of 
molecular partners in various cell compartments, including the extracellular matrix, plasma 
membrane and vesicular compartments. The N-terminal domain of PrP
C
 has been shown to be 
critical for the internalization of the protein (Gauczynski et al., 2001) and several molecules 
bind PrP
C
 in vitro although the physiological relevance of these interactions remains to be 
determined.  
High concentrations of PrP
C
 have been purified with caveolae-like domains (Vey et al., 
1996) supporting an interaction with caveolin, a transmembrane adaptor of caveolae-like 
domains (Harmey et al., 1995). Such a direct interaction might explain the functional coupling 
of PrP
C
 that has been demonstrated with Fyn (Mouillet-Richard et al., 2000; Toni et al., 
2006), a tyrosine kinase involved in mediating semaphorin function (reviewed in Ahmed and 
Eickholt, 2007). A number of intracellular proteins involved in neuronal signaling processes 
are able to bind PrP
C
. They include synapsin Ib, Grb2, and prion interactor protein Pint-1 
(Spielhaupter and Schatzl, 2001) although the significance of their interaction with PrP
C
 
remains obscure. 
At the cell surface, N-CAM (Schmitt-Ulms et al., 2001), glycosaminoglycans (Pan et al., 
2002) and clathrin (Shyng et al., 1994; 1995) are plasmalemma-bound molecular partners of 
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PrP
C
. Glycosaminoglycans could intervene in the pathogenic conversion of PrP
C
 (Pan et al., 
2002) and clathrin is involved in the endocytosis of PrP
C
 (see above) (Shyng et al., 1994; 
1995). Interaction of N-CAM with PrP
C
 permits the recruitment of N-CAM to lipid rafts and 
activation of Fyn (Santuccione et al., 2005).  
Prior to its endocytosis, PrP
C
 can also bind the 37/67 kDa laminin receptor (Rieger et al., 
1997; Gauczynski et al., 2001; Hundt et al., 2001). A binding site in both PrP
C
 and laminin 
receptor may provide direct interaction, and a second one depends on heparan sulfate 
proteoglycan (HSPG)-mediated interaction
 
(Rieger et al., 1997; Gauczynski et al., 2001; 
Hundt et al., 2001). In turn, laminin receptor binds both
 
PrP
C
 and laminin (Rieger et al., 1999)  
and PrP
C
 binds laminin
 
itself (Graner et al., 2000; Coitinho et al., 2006). These 
interactions
 
may have important consequences during neuritogenesis (Graner et al., 2000) and 
memory processing (Coitinho et al., 2006).  
The stress inducible protein 1 (STI1) was discovered as an additional PrP
C
-associated 
membrane protein (Zanata et al., 2002). STI1 is a co-chaperone protein organizing Heat 
Shock proteins 70 and 90 complexes. STI1 binds to the hydrophobic core of PrP
C
 to induce 
neuroprotection by preventing protein kinase A-dependent cell death (Lopes et al., 2005). 
Binding of ST1 to PrP
C
 is also able to induce neuritogenesis (Lopes et al., 2005). This 
mechanism requires endocytosis of STI1-bound PrP
C
 (Caetano et al., 2008). In addition, 
interaction between STI1 and PrP
C
 also affects short- and long-term memory  (Coitinho et al., 
2007).  
 Na
+
/K
+
 ATPase, -actin, -spectrin and creatine kinase-have been identified as 
potential molecular partners of PrP
C
 in PrP/affinity chromatography fractions (Petrakis and 
Sklaviadis, 2006). PrP
C
, in association with Na
+
/K
+
-ATPase and cytoskeletal proteins may 
cluster and stabilize receptors in the cell membrane, while creatine kinase- might regulate 
vesicle transport and neurotransmitter release. 
 
4.2.5 Copper-binding and anti-oxidative properties of PrPC 
The well-established copper-binding and anti-oxidant properties of PrP
C
 are thought to be 
important in the regulation of synaptic copper concentration and its anti-apoptotic functions.  
Copper is an essential cofactor of many cellular redox reactions and it is now widely 
accepted that PrP
C
 is a copper-binding protein (Brown et al., 1997a). Binding of a copper ion 
to PrP
C
 is achieved by two of the N-terminus octapeptide repeats (Fig. 13) (Stockel et al., 
1998; Garnett and Viles, 2003) and by two histidines close to the hydrophobic core (Jones et 
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al., 2004). The octapeptide repeats specifically bind up to 4 Cu
2+
 ions copper in a pH-
dependent and negatively cooperative manner (Walter et al., 2006). Indeed, at physiological 
pH, Cu
2+ 
initially binds to PrP
C
 at the two histidines with a high affinity. Subsequently Cu
2+ 
ions bind to single histidine residues within the octarepeat region with a lower affinity (Wells 
et al., 2006a; Wells et al., 2006b; Klewpatinond et al., 2008). In addition, there is evidence 
that Cu²
+
 can facilitate PrP
C
 self association (Wells et al., 2006a; Wells et al., 2006b) and that 
zinc significantly alters the distribution of copper among the available binding modes (Walter 
et al., 2007). 
Copper binding alters PrP
C
 biochemical and biological properties by switching the -
helical tertiary structure into a -sheet configuration that is different from the -sheet-rich 
pathological PrP
res
 (Qin et al., 2000; Quaglio et al., 2001; Leclerc et al., 2006). Copper-bound 
PrP
C
 has increased protease resistance (Quaglio et al., 2001). PrP-deficient mice are hyper 
sensitive to copper toxicity and oxidative stress (Brown et al., 1998) which can be explained 
by the reduction in the activity of Cu/Zn superoxide dismutase (Brown et al., 1997b; Brown et 
al., 2002) and glutathione reductase (White et al., 1999) in neurons. Thus, PrP
C
 is proposed to 
have a proper superoxide dismutase activity (Brown et al., 1999) which directly detoxifies 
reactive oxygen species (ROS), responsible for oxidative stress-induced apoptosis (Brown et 
al., 2002). Alternatively, but not exclusively, PrP
C
 may indirectly up-regulate distinct Cu/Zn 
superoxide dismutases depending on the level of its copper charge (Fig. 15) (Brown et al., 
2001; Sakudo et al., 2005a).  
 
4.2.6 Anti-apoptotic activity of PrPC 
Neuronal apoptosis occurs in the brain infected by scrapie (Lucassen et al., 1995) and in 
fatal familial insomnia (Dorandeu et al., 1998) suggesting that either prions are pro-apoptotic 
agents or PrP
C
 has an anti-apoptotic cytoprotective function that is absent in prion-infected 
brains due to its conversion in pathological PrP
res
. This important question remains to be 
answered. 
Using a yeast two-hybrid system, Kurschner and Morgan (1995; 1996) demonstrated that 
PrP
C
 binds Bcl-2 family members through a common BH domain. This suggests that PrP
C
 
could have BCL-2-like properties. In PrP-deficient neurons, serum-free culture conditions 
induced apoptosis that was abrogated by either PrP
C
 or BCL-2 (Kuwahara et al., 1999). This 
suggests that PrP
C
 is an anti-apoptotic BCL-2-like protein. This is supported by the 
suppression of BAX-dependent apoptosis in human neurons by PrP
C
. This anti-BAX effect 
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has been shown to be specific for the octapeptide repeat domain of PrP
C
 (Bounhar et al., 
2001). Furthermore, BAX-mediated neuronal death is counteracted by overproduction of 
cytosolic PrP
C
 induced by ERAD reverse translocation (Roucou et al., 2003). The anti-
apoptotic properties of PrP
C
 have been challenged because induction of PrP
C
 expression in 
HEK cells provokes p53-mediated caspase-3 activation (Paitel et al., 2002; 2003; 2004). 
However, this was subsequently shown to be a cell line-specific effect since PrP
C
 
upregulation has no neurotoxic effect on N2A cells. Moreover, antibody-induced down-
regulation of PrP
C
 increased BAX expression, caspase-3 induction and apoptosis (Zhang et 
al., 2006). Also, PrP-deficient neuronal cell lines underwent down-regulation of BAX, 
caspase-3 and cytochrome c after PrP
C
 expression was restored (Kim et al., 2004). Recently, 
PrP
C
 anti-apoptotic activity was shown to be independent of BCL-2 in yeast (Bounhar et al., 
2006). In addition, the anti-BAX properties of PrP
C
 have been confirmed in vivo as PrP
C
 
rescued neurons from ethanol-induced BAX-mediated apoptosis (Gains et al., 2006). On the 
other hand, PrP
C
 does not prevent BAK- , BID- and staurosporine-induced apoptosis 
indicating that anti-apoptotic properties of PrP
C
 are BAX-specific. Indeed, PrP
C
 prevents the 
initial conformational change of BAX necessary for its pro-apoptotic activation (Roucou et 
al., 2005). 
 
4.3 The prion protein paralogue Doppel 
Research efforts to determine the functions of PrP
C
 in knock-out mutant mice (Fig. 16) 
have revealed that large deletions in Prnp result in the ectopic neuronal expression of Dpl. 
Such disruptions of Prnp extend into the upstream region of intron 2 resulting in cis-
activation of Prnd. This allows an abnormal intergenic splicing between the Prnp promoter 
and the Prnd ORF (Moore et al., 1999) and prevents cleavage of Prnp pre-mRNA which is 
elongated up to the last exon of Prnd. The production of chimerical mRNAs made up of Prnp 
exons 1 and 2 and Prnd coding exons results in abnormal regulation of Prnd under the control 
of the Prnp promoter (Fig.17) (Moore et al., 1999; Li et al., 2000a; 2000b; Yoshikawa et al., 
2007). The resulting ectopic Dpl neuronal expression in Prnp
0/0
 mouse lines (Fig. 16) such as 
Ngsk (Sakaguchi et al., 1995; 1996), Rcm0 (Moore et al., 1999), ZrchII (Rossi et al., 2001) 
and Rikn (Kuwahara et al., 1999) leads to late onset Purkinje cell degeneration and ataxia. 
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4.3.1 Somatic and germinal expression of Dpl 
Dpl is highly expressed in Sertoli cells and spermatozoa of the testis (Peoc'h et al., 2002) 
(Tranulis et al., 2001) during adulthood. During embryogenesis, Dpl is transiently expressed 
under the control of Brn-3a and Brn-3b transcription factors in dorsal root ganglia and spinal 
cord neurons as early as E13.5 (Calissano et al., 2004). Lower levels of Dpl mRNA are 
detected in spleen, heart, bone marrow, skeletal muscles and neocortex of the neonatal 
hamster, but not in kidney, liver and lung (Li et al., 2008). Significant levels of Dpl 
expression have never been detected in the brain of any adult mammalian species.  
 
4.3.2 Physiological functions of Dpl 
The only obvious phenotypic feature of Dpl-deficient Prnd
0/0
 mice is male, but not female 
sterility. Prnd
0/0 
spermatid numbers are strongly reduced and spermatozoid heads are 
misoriented (Behrens et al., 2002). This deficit impairs the capacity of the spermatozoid to 
cross the zona pellucida of the egg (Behrens et al., 2002). The important oxidative DNA 
damages resulting from Dpl deficiency in male gametes suggests that Dpl is involved in 
spermatogenesis through its anti-oxidant protective functions (Paisley et al., 2004). In 
addition, the subcellular localization of Dpl appears to evolve with the different stages of 
male gametogenesis with a strong early nuclear localization before concentrating in the  
cytoplasm (Kocer et al., 2007). 
The structural homology between PrP
C
 and Dpl (Fig. 13) suggests a subcellular 
colocalization. Indeed, the immunohistochemical distribution of Dpl in the brain of NP
0/0 
 
mouse and of PrP
C
 in the brain of wild-type mouse are similar (Al Bersaoui et al., 2005). In 
neuroblastoma cell cultures, Dpl and PrP
C
 get internalized together from patches on the 
plasma membrane (Massimino et al., 2004). In addition, like PrP
C
 (Zidar et al., 2008), Dpl is a 
copper-binding protein (Qin et al., 2003). Since copper-binding is a prerequisite for PrP
C
 
through interaction with the precursor of laminin receptor, the binding of Dpl to this precursor 
suggests that PrP
C
 and Dpl are internalized together (Yin et al., 2004). Nevertheless, Dpl does 
not interact with all the molecular partners of PrP
C
. It does not interact with Grb2 (Azzalin et 
al., 2005), but interacts with RACK1 (Azzalin et al., 2006), an intracellular adaptor protein 
involved in the regulation of intracellular calcium (Sklan et al., 2006). Whereas PrP
C
 
increases the concentration of subplasmalemmal calcium pools in CHO cells, Dpl has a 
depleting effect which can be abolished by PrP
C
. This is consistent with a functional interplay 
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and an antagonistic role of the two proteins, whereby PrP
C
 protects and Doppel sensitizes 
cells toward stress conditions (Brini et al., 2005). 
 
4.3.3 The neurodegenerative phenotype of the Nagasaki mouse 
When the first NP
0/0 
mouse line overexpressing Dpl was observed to display premature 
Purkinje cell loss (Sakaguchi et al., 1996), it was postulated that PrP
C 
was needed to ensure 
Purkinje cell survival during aging (Nishida et al., 1999). In other words, the resistance to 
prion disease conferred by PrP
C
 deficiency should result in late onset ataxia. Several 
neuropathological signs have been reported in the brain of the Dpl-overexpressing mice, 
including necrosis of pyramidal cells in the hippocampus (Moore et al., 2001), torpedo-like 
varicosities of Purkinje cell axons projecting into the granular layer, abnormal myelinisation 
in the spinal cord and peripheral nervous system (Nishida et al., 1999), and abnormal 
astrocytic and microglial activation in the forebrain and cerebellum (Atarashi et al., 2001). 
Subsequently, Dpl was shown to be expressed in NP
0/0 
Purkinje cells and hippocampal 
pyramidal cells and to be responsible for Purkinje cell neurodegeneration (Li et al., 2000a; 
2000b). Furthermore, overexpression of Dpl in the non-ataxic ZrchI Prnp
0/0
 mice induced 
severe granule and Purkinje cell loss in the cerebellum (Moore et al., 2001). Conversely, 
Purkinje cell neurodegeneration did not occur when Dpl overexpression was suppressed by 
knocking-out Prnd
 
in ZrchII Prnp
0/0
 mutant mice. These data confirm that Dpl is responsible 
for Purkinje cell death in the Dpl-overexpressing Prnp
0/0 
mutant mouse lines (Genoud et al., 
2004). Furthermore, decreased Dpl expression in ZrchI Prnp
0/0
; NP
0/0
 and ZrchI Prnp
0/0
; 
ZrchII Prnp
0/0
 double mutant mice displayed a delayed neurological effect of Dpl in 
proportions suggesting that the onset of ataxia and Purkinje cell loss is Dpl gene dose-
dependent (Moore et al., 2001; Rossi et al., 2001; Valenti et al., 2001).  
 
4.3.4 Neurotoxicity of Doppel 
4.3.4.1 Doppel can be considered as a terminal truncated PrP (PrP) 
To identify regions of the PrP
C 
sequence involved in prion disease, ZrchI mice expressing 
N-terminal truncated PrP
C
 have been generated. Among these transgenic mouse lines, the 
PrP (lacking aa32-134) transgenic mouse display severe granule cell loss and severe ataxia 
that is rescued by re-expression of a full-length PrP (Shmerling et al., 1998). When targeted to 
Purkinje cells, the PrP transgene induces Purkinje cell loss and ataxia, as observed in Dpl-
overexpressing mouse lines, suggesting that Dpl and PrP cause Purkinje cell death by the 
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same mechanism (Flechsig et al., 2003). Indeed, Dpl fused with the N-terminal segment 
lacking in PrP has anti-apoptotic activity in vitro (Lee et al., 2006). 
 
4.3.4.2 Pro-apoptotic properties of Doppel 
Pro-apoptotic properties of Dpl were suggested by TUNEL-identification of apoptotic 
granule cells in the cerebellar cortex of ZrchI mice transgenically expressing Dpl (Moore et 
al., 2001). Indeed, oxidative stress was observed in Dpl overexpressing central neurons of 
Rcm0 mice with increased activity of heme oxygenase 1, as well as neuronal and inducible 
nitric oxide synthase (Wong et al., 2001). Furthermore, abnormal activation of nitric oxide 
synthase by exogenous Dpl peptide was antagonized by exogenous PrP
C
 in cultured cerebellar 
cells (Cui et al., 2003). Removing serum from culture medium of Dpl-overexpressing Rikn 
hippocampal neurons (Kuwahara et al., 1999) induced apoptosis which could be abolished by 
reexpression of PrP
C
, suggesting that PrP
C
-Dpl interaction can regulate cell survival (Sakudo 
et al., 2005b). Dpl-induced apoptosis involves a caspase-dependent apoptotic pathway since 
N2A cells transfected with a plasmid coding for Dpl display activation of the apoptotic 
effector caspase-3, DNA fragmentation and apoptosis (Qin et al., 2006). In addition, 
overexpression of BCL-2 in PrP mice reduced caspase-3 activation (Nicolas et al., 2007). 
 
4.3.4.3 Doppel and PrPC antagonism 
Two hypothetical mechanisms have been proposed to explain the interaction between 
PrP
C
 and Dpl: the competition mechanism and the sensitization mechanism (Fig. 18). 
 
1.1.1.1.1 The competition model 
In the competition model (Fig. 18A), PrP
C
 and a still unknown low affinity molecule 
called compete to bind an unidentified  ligand LPrP to elicit an anti-apoptotic activity 
(Shmerling et al., 1998; Kuwahara et al., 1999). Dpl as well as PrP are able to bind LPrP in 
the absence of PrP
C
 and, this would hijack its cell survival-promoting properties into 
apoptosis (Shmerling et al., 1998; Flechsig et al., 2003; Lee et al., 2006). Along this line, the 
laminin receptor precursor protein has been proposed to be a potential LPrP because it binds 
both PrP
C
 and Dpl (Gauczynski et al., 2001; Hundt et al., 2001; Yin et al., 2004).  
1.1.1.1.2 The sensitization model 
Serum withdrawal increases apoptosis of Prnp-deficient neurons (Kuwahara et al., 1999), 
suggesting that PrP
C
 has a neuroprotective role itself (Fig. 18B). Indeed, PrP
C 
SOD activity 
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(Brown et al., 1999) can antagonize Dpl-induced oxidative stress (Wong et al., 2001; Cui et 
al., 2003) and N-terminal truncated PrP
C
 abrogates its capacity to rescue neurons from Dpl 
toxicity (Atarashi et al., 2003). In the sensitization hypothesis, the apoptogenic oxidative 
damage caused by Dpl would not be detoxified in neurons because lacking PrP
C
. 
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Results 
1. Purkinje cell death mechanisms induced by mutations of the 
glutamatergic GluR2 receptor in mouse 
 
1.1  Publication 1. Lurcher GRID2-induced death and depolarization can be 
dissociated in cerebellar Purkinje cells. Selimi F, Lohof AM, Heitz S, Lalouette A, 
Jarvis CI, Bailly Y, Mariani J. Neuron (2003) 37:813-9. 
Based on data showing that the C-terminus region of GluR2Lc activates the autophagic 
promoter Beclin1 (Liang et al., 1998) via nPIST (Yue et al., 2002), the first research theme of 
my thesis was focused on the mechanisms controlling the onset of Purkinje cell death induced 
by GluR2Lc. I contributed to a first study in which heteroallelic mutant mice expressing only 
one copy of the Lurcher allele and no copy of the wild-type allele were generated. In these 
mice, Purkinje cell death occurred already at P5, when the cerebellum is not yet obviously 
affected and preceded chronic depolarization in GluR2Lc/+ mutant mice. In the GluR2ho/Lc 
Purkinje cells, autophagic profiles occurred in correlation with massive Purkinje cell death, 
when GluR2Lc could not induce depolarization of Purkinje cells. These results suggest that 
GluR2Lc receptors activate a neuronal death pathway independent of depolarization. 
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1.2 GluR2Lc-induced excitotoxicity kills Purkinje cells 
Although the Lurcher mutation has been known to be responsible for excitotoxic 
apoptotic Purkinje cell death for a long time, clear evidence for autophagy has only been 
recently obtained showing autophagosomes accumulation in axonal swellings as well as in 
somato-dendritic compartments of the Lurcher Purkinje cells (Wang et al., 2006). The 
increased density of mitochondria and oxidative stress in the GluR2Lc/+ Purkinje cells 
suggests that an apoptotic pathway is activated in these neurons (McFarland et al., 2007). 
Nevertheless, autophagic profiles appear in GluR2Lc/+ Purkinje cells before ion flux-
mediated excitotoxicity induces neuronal death suggesting the early activation of a non-
ionotropic cell death mechanism. The putative dissociation between non-ionotropic (reflected 
by autophagy) and ionotropic neurotoxic cascade may be achieved by experimentally 
blocking GluR2Lc-mediated ion flux. For this reason, I treated GluR2Lc/+ organotypic 
cerebellar cultures with 1-Naphtyl-acetyl-spermine (NASP), an open channel blocker known 
to considerably reduce Ca²
+
 entry (Koike et al., 1997) and GluR2Lc/+-mediated currents 
(Kohda et al., 2000). If autophagy is independent from GluR2Lc/+-induced excitotoxicity, 
NASP-blockade of excitotoxic ion flux is predicted to not affect autophagy in the treated 
GluR2Lc/+ Purkinje cells.  
 
1.2.1 Blockade of ion flux excitotoxicity rescues GluR2Lc/+ Purkinje cells 
Organotypic cerebellar cultures obtained from P0 GluR2Lc/+ and wild-type cerebellum 
were maintained for 6 and 12 days in vitro (DIV) (Fig. 19A). NASP treatment during the 12 
day-long culture period restored GluR2Lc/+ Purkinje cell numbers to wild-type levels (P = 
0.97) while this treatment had no effect on wild-type Purkinje cells (P = 0.97) (Fig. 19B). 
When the culture period was restricted to 6 days, equivalent Purkinje cell populations survive 
in GluR2Lc/+ and wild-type cultures whereas 6 day-long NASP treatment had no effect on 
either culture (P = 0.95) (Fig. 19B). In addition, GluR2Lc/+ Purkinje cells did not survive 
when NASP treatment was applied during the 6 first days of the 12 DIV period (P = 1.00). On 
the contrary, when these 12 DIV GluR2Lc/+ cerebellar organotypic cultures were treated with 
NASP for either the 4 or the 2 last days, there was an increased Purkinje cell survival (P < 
0.05 and P < 0001) (Fig. 19B). GluR2Lc/+ Purkinje cell numbers were restored to wild-type 
level when NASP treatment was applied for the last 6 days of the 12 DIV period (P = 0.29) 
(Fig. 19B). This indicates that Purkinje cells of 12 DIV cerebellar organotypic cultures from 
P0 GluR2Lc/+ mice have a differential sensitivity to GluR2Lc toxicity after 6 DIV. 
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1.2.2 Blockade of ionotropic excitotoxicity suppresses autophagy and rescues dendritic 
development of GluR2Lc/+ Purkinje cells.  
Immunofluorescent staining for the autophagic marker LC3B disclosed autophagic 
corpuscles in the soma of CaBP-positive GluR2Lc/+ Purkinje cells which display severe 
dendritic atrophy after 12 DIV in organotypic cultures (Fig. 20 A-C). Blocking the 
excitotoxicity of GluR2Lc/+ by NASP treatment for 12 DIV suppressed LC3B 
immunoreactivity (Fig. 20 E, F)of  GluR2Lc/+ Purkinje cells (Fig. 20 D, F) and rescued wild-
type-like morphology of the dendritic arborisation (Fig. 20 G-I).  
NASP treatment during the 12 day-long culture period (Fig. 21A) restored GluR2Lc/+ 
Purkinje cell dendritic area and maximum dendritic length to the same extent as wild-type (P 
= 0.87 and P = 0.91) while this treatment had no effect on wild-type Purkinje cells (P = 0.91 
and P = 1.00) (Fig. 21B). The dendritic area and maximum dendritic length of GluR2Lc/+ 
Purkinje cells were not restored by a NASP treatment applied during the 6 first days of the 12 
DIV period (P = 0.57 and P = 0.76) (Fig. 21B). On the contrary, in these 12 DIV GluR2Lc/+ 
cerebellar organotypic cultures, NASP treatment during the last 4 days induced a significant 
increase in the maximum dendritic length of Purkinje cells (P < 0.05) (Fig. 21B). GluR2Lc/+ 
Purkinje cell dendritic area and maximum dendritic length were restored to the same extent as 
wild-type Purkinje cells when NASP treatment was applied for the last 6 days of the 12 DIV 
period (P = 1.00 and P = 0.77) (Fig. 21B). As observed for Purkinje cell survival, this 
indicates that growth of Purkinje cells in cerebellar organotypic cultures during 12 DIV from 
P0 GluR2Lc/+ mice is only sensitive to GluR2Lc toxicity after 6 DIV. 
 
1.3  Impaired survival and dendritic development of hotfoot Purkinje cells ex vivo.  
The effect of a GluR2-deficiency on Purkinje cell survival and growth was investigated 
in cerebellar organotypic slice cultures derived from natural Grid2 knock-out hotfoot mice 
(Table 1). The GluR2ho/ho Purkinje cell population was significantly decreased compared to 
the wild-type Purkinje cell population (T = 2.89, P < 0.05) (Fig. 22A). No significant 
differences between the two genotypes were evident by a quantitative measurement of 
dendritic tree area (W = 16.0, P = 1.00) and maximum dendritic length (W = 10.0, P = 0.058). 
Nevertheless, estimation of branching points disclosed a significant difference between 
GluR2ho/ho and wild-type secondary (P < 0.01) and tertiary (P < 0.0001) dendritic 
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ramifications whereas the GluR2ho/ho and wild-type proximal dendrites did not differ (P = 
0.97) (Fig. 22B, C). 
 
1.4 Delayed climbing fiber translocation in the developing hotfoot cerebellar cortex 
During the normal postnatal period, pruning of multiple climbing fiber innervation of 
Purkinje cells establishes the mono-innervation of each Purkinje cell by a single climbing 
fiber (Lohof et al., 1996). This regressive phenomenon is contemporaneous of climbing fiber 
somato-dendritic translocation (Chedotal and Sotelo, 1992). Whereas in the adult GluR2ho/ho 
cerebellar cortex, immature multiple climbing fiber innervation of Purkinje cells is 
abnormally maintained and the climbing projection domain on Purkinje cells is aberrantly 
extended (Ichikawa et al., 2002), little is known about the developmental sequence of 
climbing fiber-Purkinje cell relationships during the postnatal period. Using specific 
immunolabelling of climbing fibers by VGlut2, the somato-dendritic translocation of the 
climbing fibers was found to be delayed in the GluR2ho/ho cerebellar cortex as soon as the 
end of the pericellular nest stage at P10 (Fig. 23).  
 
2. Doppel-induced cell death mechanism(s) in prion protein-
deficient Purkinje cells of the Nagasaki mutant mouse 
In PrP-deficient mice of the Nagasaki strain (NP
0/0
), ectopic expression of PrP-like 
protein Doppel (Dpl) in central neurons induces significant Purkinje cell death resulting in 
late-onset ataxia. In an initial set of experiments, I have found that NP
0/0
 Purkinje cell death 
can be partly prevented by either knocking-out the apoptotic factor BAX or overexpressing 
the anti-apoptotic factor BCL-2 suggesting that apoptosis may be involved in Dpl-induced 
death of Purkinje cells. In the next set of experiments using Western blotting and 
immunohistofluorescence, I showed that before (3-4 months) and during significant PC loss 
(6-8 months), the NP
0/0 
Purkinje cells displayed increased expression of the scrapie responsive 
gene 1 (Scrg1) potentially associated with autophagy and of the autophagic markers LC3B 
and p62. At the ultrastructural level, autophagic-like profiles accumulated in somato-dendritic 
and axonal compartments of the NP
0/0
, but not in those of the wild-type Purkinje cells. 
Interestingly, the most robust autophagy was observed in NP
0/0
 Purkinje cell axon 
compartments in the deep cerebellar nuclei suggesting that autophagy is initiated in the axons. 
Taken together, these results indicate that Dpl may trigger both autophagic and apoptotic 
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processes in NP
0/0
 Purkinje cells. The increased autophagic features observed in the Purkinje 
cells of the NP
0/0
 mice may result from either an upregulation of autophagy or an extensive 
accumulation of autophagosomes due to progressive dysfunctioning of autophagy as observed 
in amyloid neurodegenerative diseases. In this latter case, impaired autophagic proteolysis 
may trigger apoptotic cascades. 
 
2.1 Publication 2. Bax contributes to Doppel-induced apoptosis of prion protein-
deficient Purkinje cells. Heitz S, Zanjani H, Lutz Y, Gautheron V, Bombarde G, 
Richard F, Fuchs JP, Vogel M, Mariani J, Bailly Y.  Dev Neurobiol, (2007) 
67:670-686. 
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2.2 Publication 3. BCL-2 counteracts Dpl-induced apoptosis of prion protein-
deficient Purkinje cells in the Ngsk Prnp
0/0
 mouse. Heitz S, Gautheron V, Lutz Y,
 
Rodeau J-L, Zanjani HS, Sugihara I, Bombarde G, Richard F, Fuchs J-P, Vogel 
MW, Mariani J, Bailly Y. Dev Neurobiol, (2008) 68:332-348 
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2.3 Publication 4. Autophagy and cell death of Purkinje cells overexpressing Doppel 
in Ngsk Prnp-deficient mice. Heitz S, Leschiera R, Haeberlé A-M, Demais V, 
Grant N, Bombarde G, Bailly Y. Brain Pathol, in review. 
 
. 
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Discussion  
I will briefly summarize the main results of my thesis and discuss them in the specific 
context of the Lurcher and the Nagasaki mutant mice and other murine models of 
neurodegeneration. The importance of apoptotic and autophagic processes in the degeneration 
of Purkinje cells in Lurcher and Nagasaki mice will be then compared in light of the 
mechanisms provoking neuronal death in the two models. Finally, future experimental 
research axes will be described that could further improve our knowledge of neuronal death 
mechanisms in the central nervous system.  
 
1. Excitotoxicity and autophagy are related during Lurcher 
Purkinje cell death  
Young postnatal GluR2Lc/+ Purkinje cells have been reported to display autophagy before 
they undergo excitotoxic apoptotic cell death (Yue et al., 2002). This autophagy has been 
suggested to occur independently from GluR2Lc-induced ionotropic excitotoxicity since I 
contributed to show that Purkinje cell death and autophagy occur in the heteroallelic 
GluR2Lc/ho double mutant mouse well before ionotropic excitotoxic cell death could operate 
in GluR2Lc/+ Purkinje cells (Selimi et al., 2003: publication 1). In most cases, autophagy is 
believed to constitute a major neuroprotective response to cellular stress and metabolic 
deficiencies, but autophagy may also be a response to an early, GluR2Lc-mediated injury 
distinct from ionotropic excitotoxicity. 
A clue for the mechanism underlying Purkinje cell death in this model comes from my recent 
experiments on organotypic cerebellar cultures of GluR2Lc/+ mice. The massive death of 
GluR2Lc/+ Purkinje cells which occurs in this model was rescued by treatment with NASP, a 
cationic open channel blocker. This indicates that excitotoxicity is the main cause of 
GluR2Lc-induced Purkinje cell death. Furthermore, NASP treatment downregulated the 
Discussion 
 
139 
 
expression of the autophagic marker LC3B-II in the GluR2Lc/+ Purkinje cells as shown by 
immunocytofluorescence of organotypic cerebellar cultures. This suggested that autophagy 
depends on the excitotoxic mechanism induced by the aberrant functioning of mutated 
GluR2Lc. One open question is whether this excitotoxicity-related autophagy is a 
neuroprotective response or a true cell death pathway activated by excitotoxic stress in 
parallel with apoptosis. The possible rescue of some GluR2Lc/+ Purkinje cells when 
autophagy is inhibited with 3-methyl-adenine (3-MA) in Lurcher organotypic cerebellar 
cultures may support the latter hypothesis. 
In addition, NASP treatment alone was sufficient to completely restore arborisation of the 
GluR2Lc/+ Purkinje cell dendritic tree to the same extent as the wild-type suggesting that 
GluR2Lc also mediates dendritic atrophy of the GluR2Lc/+ Purkinje cells. Indeed, dendritic 
growth seems to proceed normally until 6 DIV in organotypic culture and until P6 in vivo 
(Bailly et al., 1996). The remaining question is whether GluR2Lc-mediated autophagy is 
involved in Purkinje cell dendritic atrophy. Insight into this question will come from 
determining the effect of the autophagy inhibitor 3-MA on the dendritic growth of the 
GluR2Lc/+ Purkinje cells in organotypic cerebellar cultures.  
My investigations indicate that Purkinje cell death also occurs in the absence of GluR2 in 
the deficient hotfoot mutant mice, even though Purkinje cell loss could not be evidenced in 
vivo (Kurihara et al., 1997), suggesting that firstly, GluR2ho/ho Purkinje cells are more 
sensitive to cell death conditions and secondly, that these conditions may be counteracted in 
situ, but exacerbated in organotypic cerebellar cultures. In addition, the Purkinje cell dendritic 
tree of GluR2ho/ho mutant mice is not as developed as the wild-type mice in organotypic 
culture indicating that GluR2ho/ho Purkinje cell growth is impaired in organotypic cultures. 
On the other hand, the extent of the Purkinje cell dendritic tree is similar in wild-type and 
GluR2ho/ho mice in situ (Ichikawa et al., 2002). My data in organotypic cerebellar cultures 
confirm that GluR2 plays an essential role in the survival and dendritic development of 
Purkinje cells in this model. Restoring GluR2 expression in GluR2ho/ho and GluR2-/- 
mutant mice re-establishes the normal synaptic configuration of parallel fiber- and climbing 
fiber-Purkinje cell innervation (Kohda et al., 2007). The numerous naked spines on 
GluR2ho/ho Purkinje cell dendrites are reinnervated by homologous afferences. This is 
unlikely to occur in organotypic cultures of GluR2ho/ho Purkinje cells since both sources of 
homologous afferents are lacking. In such conditions, restoring GluR2 expression in these 
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neurons in the presence or absence of 3-MA might provide insight into the potential role of 
this receptor in the autophagic recycling of naked spines lacking afferent inputs. Furthermore, 
treating GluR2ho/ho Purkinje cells in organotypic cerebellar cultures with the autophagic 
activator rapamycin should indicate whether the naked spines of the GluR2ho/ho Purkinje 
cells can be recycled by autophagy.  
 Since Purkinje cell dendritic growth has not yet been investigated in the postnatal 
cerebellum of the hotfoot mouse, retardation in postnatal dendritic development as a potential 
factor of synaptogenesis impairment cannot be ruled out. This is in line with the deficiency in 
climbing fiber translocation observed in the cerebellar cortex of the 10 to 15 day-old postnatal 
GluR2ho/ho mutant mice. At this age, GluR2 is expressed at the climbing fiber-Purkinje cell 
synapses in the wild-type cerebellum (Zhao et al., 1997). Thus, the receptor is likely to 
promote climbing fiber translocation since this process is delayed when GluR2 is lacking in 
the GluR2ho/ho Purkinje cells. An important role in Purkinje cell excitatory synaptogenesis 
has been assigned to GluR2 based on its expression in climbing fiber-Purkinje cell synapses 
during translocation and pruning periods, impaired synaptogenesis in GluR2-lacking 
Purkinje cells, and the observed shift in the partition of Purkinje cell projection domain 
between parallel and climbing fibers. Whether expression of GluR2 is altered in the 
abnormal development of parallel and climbing fiber synapses in other experimental and 
mutant models of impaired Purkinje cell excitatory synaptogenesis is an interesting, but still 
unanswered question. In addition, the involvement of autophagy in the climbing fiber 
synaptogenesis needs to be examined during the main elimination period of climbing fiber 
synapse using immunocytochemistry for autophagic markers at the electron microscopy scale. 
More than one single mechanism probably accounts for the death of Purkinje cells in 
GluR2Lc/+ mutants. The deletion of Bax expression alters the pattern of caspase-3 activation, 
but only delays GluR2Lc/+ Purkinje cell death (Selimi et al., 2000c) implying that BAX is 
involved in the caspase-3-dependent death mechanism (Selimi et al., 2000b). Also delayed 
death of Purkinje cells in GluR2Lc/+ mutant mice overexpressing Bcl-2 supports the 
involvement of pro-apoptotic members of the Bcl-2 family in GluR2Lc/+ Purkinje cell 
apoptosis (Zanjani et al., 1998a; 1998b). On the other hand, autophagy has been demonstrated 
in GluR2Lc/+ Purkinje cells by LC3 immuncytochemistry and by ultrastructural analysis 
suggesting that autophagy also plays a central role in GluR2Lc-induced Purkinje cell death. 
In addition, GluR2Lc promotes activation of the major autophagic factor Beclin1 in 
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GluR2Lc/+ Purkinje cells (Yue et al., 2002). The participation of multiple cell death pathways 
is further evidenced in GluR2Lc/+ Purkinje cells by caspase-3 immunohistochemistry and 
FluoroJade-B labelling which indicates that the cellular overload produced by the initial 
Grid2 defect in Lurcher mutants apparently activates a variety of apoptotic and non-apoptotic 
pathways in the Purkinje cell population (Baurle et al., 2006). In addition, nitric oxide-
induced oxidative stress occurs in dying GluR2Lc/+ Purkinje cells (McFarland et al., 2007) 
and the resulting production of ROS is known to induce autophagy (Djavaheri-Mergny et al., 
2006) as well as apoptosis (reviewed in Orrenius, 2007). Nevertheless, treating GluR2Lc/+ 
organotypic cerebellar Purkinje cells with NASP, believed to block excitotoxicity, not only 
significantly reduces Purkinje cell death and dendritic atrophy, but also abrogates the 
induction of autophagy. This supposes that the induction of autophagy in GluR2Lc/+ Purkinje 
cells is not uniquely mediated by the property of GluR2Lc channels to promote Beclin1 
activity, but is also a cellular response to metabolic stress. Taking into account the 
downregulation of autophagy and the rescue of GluR2Lc/+ Purkinje cells by NASP, GluR2Lc 
is likely to induce autophagy in Purkinje cells by a ROS-mediated pathway rather than 
through its nPIST-mediated interaction with Beclin1. Altogether, these data suggest that the 
functional significance of autophagy in GluR2Lc/+ Purkinje cells is likely to be related to a 
neuroprotective mechanism in response to excitotoxic insult.  
 
2. Multiple death mechanisms induced by Dpl in Nagasaki 
Purkinje cells 
Activation of the neurotoxic mechanism triggered by Dpl in prion-protein deficient NP
0/0 
Purkinje cells had previously been shown to provoke the premature death of these neurons (Li 
et al., 2000b). Our analysis of the impact of Bax knock-out as well as of overexpression of 
Bcl-2 on Dpl-induced Purkinje cell death revealed a contribution of Bcl-2 family members to 
Dpl-mediated apoptosis. Although the Purkinje cell population is partially rescued in the 
NP
0/0
:Bax
-/-
 and NP
0/0
-Hu-bcl-2 double mutant mice indicating that BAX is involved in Dpl-
induced apoptosis, numerous Purkinje cells died by a BAX-independent mechanism in the 
double mutants (Heitz et al., 2007; 2008: publications 2 and 3). Such a mechanism may be 
either apoptotic or non-apoptotic. This question has led my further investigations to determine 
a possible role of autophagy in Dpl-induced Purkinje cell death (Dron et al., 2005; Heitz et al., 
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in review: publication 4). Robust autophagy was observed in NP
0/0 
Purkinje cells well before 
significant neuronal loss. Ultrastructural examination showed an abnormal accumulation of 
autophagic vacuoles and autophagolysosomes in NP
0/0 
Purkinje cells which, in addition to the 
upregulation of the autophagic markers LC3B-II and p62 in these neurons, suggested that 
autophagic flux was either upregulated or impaired. At the current state of my research, the 
most plausible hypothesis is that abnormal upregulation of autophagy occurs in Purkinje cells 
at a maximal rate that reaches a plateau as early as 3 months and continues until 8 months as 
indicated by the persistence of p62 and LC3B-II upregulation. In this case, autophagy is likely 
to be a neuroprotective response to Dpl-induced stress, but ultimately is insufficient to prevent 
neuronal death. Another possibility could be that autophagy precedes and is causally linked to 
the subsequent onset of programmed Purkinje cell death (Canu et al., 2005; Djavaheri-
Mergny et al., 2006; 2007). Alternatively, robust accumulation of autophagic organelles and 
p62 upregulation could reflect an impairment of the autophagic flux in Dpl-diseased Purkinje 
cells as it has been proposed in Alzheimer-diseased neurons. Indeed, the accumulation of 
autophagosomes, late autophagic vacuoles, lysosomes and autophagolysosomes in dystrophic 
neurites has also been reported in Alzheimer-diseased brain (Nixon et al., 2005; Yu et al., 
2005) and other neurodegenerative pathologies such as prion diseases (Liberski et al., 2008). 
A deficiency in the autophagic process has also been proposed to occur in Huntington disease 
to explain the abnormal accumulation of p62-positive aggregates (Filimonenko et al., 2007) 
that are normally degraded through autophagy (Ravikumar et al., 2004). In this case, 
autophagic stress would be induced by the incapacity of the diseased neurons to clear p62-
bound misfolded protein aggregates (Chu, 2006). The robust accumulation of autophagic 
organelles and the upregulation of p62 argue in favor of the impairment of autophagy in NP
0/0 
Purkinje cells. 
The contribution of autophagy to Dpl-induced Purkinje cell death needs to be further 
analyzed in vitro using autophagy antagonist 3-MA and agonist rapamycin in NP
0/0
 
organotypic cerebellar cultures. If autophagy contributes directly to Dpl-induced Purkinje cell 
death, neuronal death should be increased by rapamycin and decreased by 3-MA. On the other 
hand, if autophagy is a neuroprotective reaction to Dpl toxicity, rapamycin should rescue 
Purkinje cells and 3-MA should increase Purkinje cell death. Furthermore, investigating 
autophagy in the NP
0/0
:Bax
-/-
 and NP
0/0
-Hu-bcl-2 double mutant mice will provide novel 
insights into the relationships between intrinsic pathway of apoptosis and autophagy in the 
mechanism of Dpl-induced Purkinje cell death. Indeed, it is important to determine the 
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mechanism by which NP
0/0
:Bax
-/-
 and NP
0/0
-Hu-bcl-2 Purkinje cells die. This mechanism 
could be autophagic independently of Bcl-2 family-related apoptosis or non-autophagic by an 
extrinsic apoptotic pathway (Fig. 24). 
 
3. Differential combination of apoptosis and autophagy in 
Nagasaki and Lurcher cerebellar Purkinje cells 
In light of previous reports in the literature, my results support the concept that both 
apoptosis and autophagy occur in Nagasaki and Lurcher cerebellar Purkinje cells (Table 2) 
(Selimi et al., 2003: publication 1; Heitz et al., 2007, 2008, in review: publications 2, 3 and 4). 
Although several apoptotic pathways including intrinsic and extrinsic pathways  are likely to 
contribute to Lurcher Purkinje cell death (Selimi et al., 2000a; Lu and Tsirka, 2002; Selimi et 
al., 2003: publication 1), much less is known about the apoptotic mechanism triggered by Dpl 
in NP
0/0
 Purkinje cells. Certainly, the BAX-dependent intrinsic pathway is responsible for part 
of the NP
0/0
 Purkinje cell loss (Heitz et al., 2007, 2008: publications 2 and 3) but the results 
reported above argue for a second still unknown and likely extrinsic pathway. On the other 
hand, autophagy has recently been reported to mediate GluR2Lc–induced Purkinje cell 
degeneration (Yue et al., 2002; Selimi et al., 2003: publication 1). These data show that LC3-
positive autophagy occurs abundantly before Purkinje cell death without any signs of 
autophagic flux impairment such as autophagosome accumulation and p62 upregulation 
(Wang et al., 2006). The axonal origin of autophagosomes in GluR2Lc/+ Purkinje cells was 
clearly evidenced and the incidence of autophagosomes is much less within the cell bodies 
and dendrites of GluR2Lc/+ Purkinje cells (Wang et al., 2006). Such a limited autophagy 
probably cannot rescue GluR2Lc/+ Purkinje cells from death, but might activate or enhance 
apoptotic pathways triggered by the massive Ca²
+
 entry through the constitutively activated 
GluR2Lc channels (McFarland et al., 2007). Very interestingly, the autophagic features 
displayed by the NP
0/0
 Purkinje cells are strikingly different. Most of the autophagic 
organelles accumulate within Purkinje cell axon terminals and dystrophic swellings 
suggesting the axonal initiation of autophagy, but also autophagic flux impairment. This 
deficiency is supported by the upregulation of p62 in the NP
0/0
 Purkinje cells (Heitz et al., in 
review: publication 4). These differences indicate that Dpl and Grid2 trigger specific cascades 
of programmed cell death in the same type of central neuron, the cerebellar Purkinje cell. 
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Autophagic deficiency has been reported in several neurodegenerative diseases including 
Alzheimer and prion diseases (Nixon, 2006; Liberski et al., 2008) where it is believed to 
contribute to neurodegeneration. Thus, the NP
0/0
 Purkinje cell provides an attractive model to 
the cellular and molecular mechanisms of neuronal death in these pathologies in perspective 
of designing new therapeutic approaches. 
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Material and Methods 
1. Animals and genotyping 
1.1 Animals  
1.1.1 The Grid2Lc/+(Lurcher) and the Grid2ho/ho (hotfoot) mice 
Grid2
Lc/+
 mice (gift from J. Mariani) were intercrossed to obtain Grid2
Lc/Lc
, Grid
+/+
, 
Grid2
Lc/+
 mice in the same litter. Grid2
ho/ho
 mice (gift from J. Mariani) were crossed with 
Grid2
+/+
 mice to get Grid2
ho/+
 mice. Littermates were intercrossed to obtain Grid2
ho/ho
, 
Grid2
ho/+
 and Grid2
+/+
 mice in the same litter. The generation of Grid2
ho/Lc
 mice is described 
in Selimi et al., 2003 (Publication 1).  
Grid2
Lc
, Grid2
+
 and Grid2
ho
 alleles were identified using the further mentioned probes 
and primer sets. 
 
1.1.2 The NP0/0, the  NP0/0:Bax-/- and the NP0/0-Hu-bcl-2 mice 
Bax
-/-
 mice were generated by deleting exons 2 to 5 (Knudson et al., 1995) and Hu-bcl-2 
mice from the NSE73a strain were generated by injecting embryos with the EB-2 construct in 
the cloning vector pSK+ containing the human BCL-2 coding region (Tsujimoto and Croce, 
1986; Martinou et al., 1994). Further breeding strategies were designed taking into account 
that Bax
-/-
 males and Hu-bcl-2 females are sterile. NP
0/0
 mice were generated by deleting the 
entire open reading frame (ORF) of the Prnp gene, located in exon 3, as well as 5’ and 3’ non-
coding flanking regions (Sakaguchi et al., 1995) and the deleted sequence was replaced by a 
Neo cassette. For this study, founding mice have been first backcrossed with C57BL/6 mice 
for at least 10 generations.  
For the generation of the NP
0/0
:Bax
-/-
 double mutant mouse line, NP
0/0
 males and females 
(gift from S. Katamine) were then crossed with Bax
+/- 
males and females (gift from S. 
Korsmeyer) and offspring were identified by PCR genotyping using the further mentioned 
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primer sets. NP
+/0
:Bax
+/-
 mice were further intercrossed, generating NP
0/0
:Bax
-/-
, NP
0/0
:Bax
+/-
, 
NP
0/0
:Bax
+/+
, NP
+/0
:Bax
-/-
, NP
+/0
:Bax
+/-
, NP
+/0
:Bax
+/+
, NP
+/+
:Bax
+/+
, NP
+/+
:Bax
+/-
 and 
NP
+/+
:Bax
-/-
 genotypes. The NP
0/0
:Bax
-/-
 double mutants were obtained by crossing 
NP
0/0
:Bax
+/-
 males with NP
0/0
:Bax
-/-
 or NP
0/0
:Bax
+/-
 females.  
NP
0/0
 females were crossed with Hu-bcl-2
 
males in order to generate the NP
0/0
-Hu-bcl-2 
double mutant mouse line, and offspring were identified using the further mentioned probes 
and primer sets. NP
+/0
-Hu-bcl-2 males were further crossed with NP
0/0
 females to generate 
NP
0/0
-Hu-bcl-2 offspring. Strict littermates of the different genotypes have been used 
throughout the study.  
Mice were bred at the animal facilities of Anatomisches Institut in Basel and of 
Neurosciences IFR37 in Strasbourg. They were maintained and submitted to experiments 
according to the NIH guidelines (NIH Publication 80-23, revised 1996), the European 
Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the 
Swiss authorities. A minimal number of animals was used and handled with maximum care to 
minimize their suffering. 
 
1.2 Genotyping 
1.2.1 DNA extraction 
Tail samples from weanling pups were used to extract DNA. Tails were transferred in a 
mix of 615µl Tris-SDS-EDTA buffer (TSE, Tris 25mM pH8, SDS 1%, EDTA 25mM pH8, 
NaCl 75mM) and 15µl Proteinase K diluted 10mg/ml (Sigma Aldrich) for 4 hours at 55°C 
before centrifugation at 13000 rotations per minute (rpm) for 4 min. Supernatant was 
collected in 500µl isopropanol and centrifuged as previously described. The pellet was 
washed in 500µl ethanol 100% and centrifuged. Ethanol was removed and 100µl water was 
added to the pellet. 
 
1.2.2 Genotyping 
Genotyping for Grid2
Lc
 and Grid2
ho
 alleles was performed by PCR followed by single-
strand conformation polymorphism (SSCP) using the Grid2 forward 
5’TAAAAGCATATTGATGTTGTTG3’ and reverse 
5’CAGCATTTGTCAGGTTTGGTGAC3’ primers. Cycling parameters for PCR were 5 min 
at 94°C for one cycle, and 1 min at 94°C , 1 min at 60°C and 1 min at 72°C for a total of 35 
cycles before 7 min at 72°C for one last cycle. A solution of 10µl of blue bromophenol 
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(0.05%), xylene cyanol (0.05%) and 20mM EDTA pH8 in formamide was added to 10µl of 
each sample before electrophoresis on a 15% acrylamide gel (Biorad) over-night at 4°C using 
a DCode Universal Mutation Detection System (Biorad). The gel was further stained with the 
Silver Staining kit (Amersham) and the Lurcher and wild-type alleles were detected by 2 
different bands and the hotfoot allele by the absence of any band. 
Genotyping for Bax was performed by PCR by using a set of three primers: Bax exon 5 
forward primer (5’GAGCTGATCAGAACCATCATG3’), Bax intron 5 reverse primer 
5’GTTGACCAGAGTGGCGTAGG3’) and Neo reverse primer (5’CCGCTTCCATTGCT-
CAGCGG3’). Cycling parameters were 2 min at 94°C for one cycle, and 45 sec at 94°C , 45 
sec at 55°C and 1.5 min at 72°C for a total of 40 cycles before 7 min at 72°C for one last 
cycle. Four µl of DNA loading buffer (Sigma-Aldrich) was added to 8µl of each sample 
before an electrophoresis on a 2% agarose gel (Sigma-Aldrich) at 130V for 10 min. Bands 
were revealed using the UV Appligene equipment (Oncor). The Bax
-
 allele was determined by 
a band of 507 base pairs (Bp) and the Bax
+
 allele by a band of 304 Bp. 
Genotyping for Hu-bcl-2 was performed by PCR by using a set of two primers: Hu-bcl-2 
transgenic forward 5’GAA-GAC-TCT-GCT-CAG-TTT-GG3’ and reverse 5’ATG-AGC-
CTT-GGG-ACT-GTG-AA3’. Cycling, electrophoresis and identification of bands parameters 
were the same as for Bax genotyping. The presence of the Hu-bcl-2 transgene was determined 
by a band of 496 Bp. 
Genotyping for Dpl was performed by PCR. The Prnp ORF was identified using the 
following primers: forward 5'CCGCTACCCTAACCAAGTGT3' and reverse 
5'CCTAGACCACGAGAATGCGA3', both located within the Prnp ORF; NP
0/0
 mutants were 
identified using the following primers: forward 5'TGCCGCACTTCTTTGTGAAT3' and 
reverse 5'CGGTGGATGTGGAATGTGT3' (within Neo cassette). Cycling parameters were 5 
min at 94 °C for one cycle, and 45 sec at 94 °C, 30 sec at 53 °C and 1.5 min at 72 °C for a 
total of 30 cycles before 10 min at 72 °C for one last cycle. Electrophoresis and identification 
of bands parameters were the same as for Bax genotyping. The Prnp
+
 allele was determined 
by a band of 347 Bp and the Prnp
0
 allele by a band of 228 Bp. 
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2. Methods 
2.1 Organotypic cerebellar culture 
Organotypic cerebellar cultures were realized using the static culture method. This 
method, first described by Yamamoto et al (1989) and further developed by Stoppini et al 
(1991), allows maintaining postnatal 350µm-thick cerebellar slices in culture. Due to the 
sagittal orientation of the Purkinje cell in the cerebellar folia, it is possible to preserve almost 
the complete Purkinje cell within a slice. New-born (P0) Grid
+/+
, Grid2
Lc/+
 mice and P8 
Grid2
ho/ho
, Grid2
ho/+
 and Grid2
+/+
 mice were decapitated and their brain aseptically removed 
and placed into ice-cold preparation medium made of minimal essential medium (MEM, 
Gibco) and 2mM glutamax I (Gibco) pH 7.3. The cerebellum was dissected, the meninges 
removed and 350 µm-thick sagittal sections were cut using a McIllwain tissue cutter under 
aseptic conditions. Tissue slices were separated and transferred onto permeable membranes 
(Millicell, Millipore) and incubated on a layer of serum-containing culture medium (25% 
Basal Eagle’s medium, 25% horse serum, 2mM glutamax I, 3.6mM glucose in MEM, Gibco) 
in a humidified atmosphere with 5% CO2 at 37°C. The medium was changed every 2-3 days 
for a total of 12 days. 1-Naphtyl-acetyl-spermine NASP (Sigma-Aldrich) was added at a 
concentration of 50µM at medium changes.  
 
2.2 Histology 
Mice were anaesthetized with sodium pentobarbital (0.15 mL per 100g i.p.; Sanofi) after 
which brain was dissected and immersed overnight in Carnoy’s fixative (60% ethanol, 30% 
chloroform, 10% acetic acid). After washes in iso-butanol (Carlo Erba), the brain was 
embedded in paraffin and sectioned 10 µm-thick in the sagittal plane. Sections were 
deparaffinised and rehydrated in decreasing concentrations of ethanol. They were then 
immersed in a solution of cresyl violet-thionine (25mg each in 100 ml of water) for 7 minutes, 
submitted to differentiation in 95% acidic ethanol and mounted in Eukitt before examination 
with a light microscope (Axioskop-II, Zeiss, Jena, Germany).  
 
2.3 Immunohistochemitry 
2.3.1 Tissue sections 
Mice were anaesthetized with a mixture of 5% ketamine and 5% xylazine (0.1 mL of the 
mix per 30g i.p.) and transcardiacally perfused with 4% paraformaldehyde in 0.1M phosphate 
Material and Methods 
 
149 
 
buffer (PB) pH 7.3. Brains were then immersed for 4 hours in the same fixative at 4°C before 
either cryoprotection in 0.44M sucrose in PB at 4°C over-night and freezing in liquid nitrogen 
(wild-type, NP
0/0
, NP
0/0
:Bax
-/-
 and NP
0/0
-Hu-bcl-2 mice) or immersion in iso-butanol for 4 
days before embedding in paraffin (wild-type, NP
0/0
, NP
0/0
:Bax
-/-
 and NP
0/0
-Hu-bcl-2 mice). 
Frozen sections were cut (10µm-thick) in the cerebellum with a cryostat (Leica) and paraffin 
sections were cut (10µm-thick) with a microtome (Leica). Paraformaldehyde-fixed brains of 
wild-type and Grid2
ho/ho
 mice was dissected and sagittal and transversal cerebellar sections 
(50µm-thick) were obtained with a vibratome (Leica). 
 
2.3.2 Immunohistochemistry  
Frozen sections and vibratome floating sections were rinsed in 0.1M phosphate buffer 
saline (PBS) pH 7.3. Paraffin sections were deparaffinised in toluene and rehydrated in 
decreasing concentrations of alcohol. All sections were pre-incubation for 45 min in a 
blocking solution at room temperature. This was made of PBS containing 3% normal goat 
serum (NGS) and 0.5% Triton X-100 for immunohistofluorescence on frozen and paraffin 
sections, 2% normal horse serum (NHS) and 0.05% Triton X-100 for immunoperoxidase on 
paraffin sections and, 0.02% gelatin (D
r
 Oetker), 0.25% Triton-X 100 and 0.1M lysine for 
immunohistofluorescence on vibratome sections. The sections were then incubated overnight 
at 4°C in the blocking solution containing specific primary antibodies (Table 3). 
Then, sections were rinsed in PBS (2x10 min) and incubated with secondary antibodies 
(Table 3) in blocking solution. Immunoperoxidase detection was achieved using the avidin 
biotin complex (ABC) method with 3,3’-diamino-benzidine tetra-hydrochloride (Fast-DAB, 
Sigma Aldrich). After rinsing in PBS, the fluorescent sections were mounted in Mowiol and 
the immunoperoxidase sections were mounted in Eukitt. The frozen and the paraffin sections 
were examined with a light microscope equipped with fluorescence and differential 
interference contrast illumination (Axioskop-II, Zeiss, Jena, Germany). The vibratome 
fluorescent sections were analyzed with a Zeiss confocal microscope LSM 510. 
 
2.3.3 Immunohistofluorescence in organotypic cerebellar cultures 
Cultures were fixed in a 4% paraformaldehyde in PB overnight at 4°C before rinsing in 
PB. The cultures were pre-incubated for 45 min in blocking solution made of 3% NGS and 
0.1% Triton X-100 in PB (PBT). The sections were then incubated overnight at 4°C with 
either rabbit polyclonal antibodies against CaBP (Swant and gift from Dr Thomasset) diluted 
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1/1000 and mouse monoclonal antibody against LC3B (Nanotools) diluted 1/20 in PBT 
containing 0.3% NGS.  
Sections were then rinsed in PB (2x10 min) and incubated with fluorescent secondary 
antibodies (table 3). After rinsing in PB, the cultures were mounted in Mowiol before 
examination with a fluorescence microscope (Axioskop-II, Zeiss, Jena, Germany). 
 
2.4 Transmission electron microscopy 
Mice were anaesthetized as described above (§2.2) and transcardially perfused with 
fixative in PB (Table 4). Vibratome sections (60µm-thick) were submitted to Scrg1- and 
GABA-immunocytochemistry using respectively pre-embedding and post-embedding 
immunogold as previously described (Heitz et al., in review: publication 4). The samples from 
cerebellar sections destined to ultrastructural analysis were prepared according to a classical 
protocol for transmission electron microscopy (Selimi et al., 2003: publication 1). The 
ultrathin sections were examined with a Hitachi 7500 transmission electron microscope 
equipped with an AMT Hamamatsu digital camera. 
 
2.5 Western blotting 
Western blotting was performed to evaluate the expression of LC3B-I and –II, p62 and 
Lamp1 in wild-type and NP
0/0
 cerebella according to the protocol described in Heitz et al., in 
review (publication 4).  
 
2.6 Quantitative analysis 
In all Purkinje cell quantitative analysis performed in these studies, Purkinje cell counts 
were performed by me with the genetic identity of the animal masked. 
 
2.6.1 Morphometric analysis of Purkinje cell dendritic tree in organotypic cerebellar 
cultures 
The size and the ramification degree of the Purkinje cell dendritic tree were evaluated by 
measuring the following morphometric features: the dendritic area, the distance between the 
tip of the longest dendrite and the center of the soma (maximum dendritic length) and the 
number of dendrite branching points per Purkinje cell.  
At least 15 Purkinje cells were selected in each mouse studied. These neurons displayed 
well visible axon and dendrites because isolated from the surroundings. These cells were 
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photographed with a CoolSnap Pro digital camera (Photometrics) and Image Pro plus 
software (Media Cybernetics) was used to measure the dendritic area and the maximum 
dendritic length. The dendrite branching points were counted visually. All morphometric data 
were submitted to statistical analysis. The non-parametric test of Mann-Witnney was used to 
compare wild-type and hotfoot Purkinje cell dendritic extent and the non-parametric test of 
Kruskall-Wallis followed, when justified, by post-hoc tests for multiple comparisons was used 
to compare the effects of NASP treatments on wild-type and Lurcher Purkinje cell dendritic 
extent. The significance threshold was set at P = 0.05.   
 
2.6.2 Quantitative analysis of Purkinje cells in organotypic cerebellar cultures 
Only CaBP-immunopositive Purkinje cells with neurites were counted in 4 organoypic 
cultures obtained from each mouse in these studies. 
Comparison of Purkinje cell numbers between untreated and NASP-treated wild-type and 
Lurcher organotypic cerebellar cultures was submitted to two-way analysis of variance (factor 
genotype, factor treatment) followed, when justified, by post hoc Tukey test for multiple 
comparisons.  
Student test was performed to compare wild-type and hotfoot Purkinje cell numbers in 
organotypic cerebellar cultures. The significance threshold was set at P = 0.05. 
 
2.6.3 Size of the cerebellar vermis 
The size of the cerebellar vermis was estimated by measuring the mean area of seven 
sagittal cresyl-violet-stained sections (Image J) separated from each other by 400µm.  
 
2.6.4 Quantitative analysis of Purkinje cells in tissue sections 
The Purkinje cell population was quantified and statistically evaluated as previously 
described (Heitz et al., 2007; 2008: publications 2 and 3) by a profile-based sampling method 
(Guillery and Herrup, 1997) using the Hendry correction factor (Hendry, 1976). 
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Appendix 
1. Models of Purkinje cell degeneration 
Purkinje cell death manifests itself by ataxia and tremor. In addition to the Grid2 mutant 
mice and Nagasaki mutant mice, several other mutant mice are featured by Purkinje cell 
death. 
 
1.1 Purkinje cell death and murine mutations 
1.1.1 The nervous mutant mouse 
In the cerebellum of nervous mutant mice, some Purkinje cells initially develop an 
alteration of their mitochondria at P9 and further degenerate by P19 when most of their 
cytoplasmic organelles lyses and the cytoplasmic matrix abruptly condenses followed by cell 
death (Landis, 1973). The observation of dying Purkinje cells in 12 month-old nervous mice 
suggests a continuous progression of Purkinje cell death process (Sotelo and Triller, 1979) 
throughout lifespan. Interestingly, Purkinje cell death is not random with 60% of Purkinje 
cells dying in the vermis and 90% in the hemispheres (Wassef et al., 1987). Purkinje cell 
death was more important in the anterior lobe than in the posterior one, with zebrin-positive 
cells exhibiting an enhanced sensitivity to the nervous mutation. Although the molecular 
target of this mutation remains unknown, the selective alteration of the mitochondria seems to 
indicate that oxidative stress may be at the origin of the Purkinje cell death in this mutant. The 
late cell death process is probably necrosis since ultrastructural features characterizing 
apoptosis have not been described (Landis, 1973). 
 
1.1.2 The toppler mutant mouse 
This autosomal mutation is characterized by a specific gait alteration (Duchala et al., 
2004) and a severe loss of Purkinje cells between P14 and P30. The degenerating Purkinje 
cells have nuclear DNA double-strand breaks and are TUNEL-positive, suggesting that they 
die by apoptosis.  
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1.1.3 The Purkinje cell degeneration (pcd) mutant mouse 
Mice homozygous for this mutation lose their Purkinje cells during the third and fourth 
postnatal weeks. In 4 month-old pcd/pcd cerebellum, some Purkinje cells survive, only in the 
lobule X (Wassef et al., 1986). Degenerating Purkinje cells show nuclear condensation and 
shrinkage of the cytoplasm suggesting apoptotic cell death (Landis and Mullen, 1978). 
Characterization of the pcd mutant alleles revealed mutations in the Nna1 gene. Nna1 encodes 
a putative nuclear protein containing a zinc carboxypeptidase domain initially identified by its 
induction in spinal motor neurons during axonal regeneration (Fernandez-Gonzalez et al., 
2002). As degenerating Purkinje cells are TUNEL-positive and have a decreased expression 
of BCL-2, Purkinje cell death in this mutant occurs essentially by apoptosis (Gillardon et al., 
1995a; 1995b). 
 
1.1.4 The woozy mutant mouse 
The woozy mutation affects Sil1 a protein of the HSP70 family which is present in the 
lumen of the ER. It is characterized by a late Purkinje cell death which starts after 10 weeks of 
age and continues until 18 months (Zhao et al., 2005). This progressive death process affects 
essentially the anterior lobe. Dying Purkinje cells are TUNEL- and caspase-3-positive 
suggesting that apoptosis is the death mechanism involved. Nevertheless, electron microscope 
analysis has also disclosed the occurrence of autophagy (Zhao et al., 2005). The abnormal 
accumulation of proteins resulting from the inactivation of Sil1 may provoke ER stress with 
subsequent alteration of calcium homeostasis and thus may also contribute to the death of 
Purkinje cells (Zhao et al., 2005). 
 
1.1.5 The Niemann Pick disease type C  
Niemann-Pick disease type C (NPC) is an early onset autosomal recessive disorder 
characterized by accumulation of cholesterol and other lipids in late endosomes/lysosomes 
(Loftus et al., 1997). About 95% of the cases are caused by mutations in the NPC1 gene, 
whereas the remaining 5% are due to mutations in the NPC2 gene. The Purkinje cells are 
preferentially affected with less than 10% neurons remaining in 2 month-old npc1 mutant 
mice, but surprisingly glia in the corpus callosum is affected earlier (German et al., 2001). 
Investigations of the basis of neurodegeneration in these mice have shown that dying Purkinje 
cells have features of autophagic cell death (Ko et al., 2005) with increased levels of LC3-II 
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(Bi and Liao, 2007). Furthermore, increases in autophagic activity are closely associated with 
alterations in lysosomal function and protein ubiquitination (Bi and Liao, 2007).  
 
1.1.6 The leaner mutant mouse 
The leaner mutant (tg
la
) mouse is severely ataxic due to cerebellar atrophy, resulting from 
gradual degeneration of granule, Purkinje, and Golgi cells (Herrup and Wilczynski, 1982; 
Frank et al., 2003). Pycnotic granule cells are numerous in the internal granular layer as early 
as P10 but significant Purkinje cell loss is not observed until the end of the first postnatal 
month and continues at a low rate throughout the life of the animal (Herrup and Wilczynski, 
1982). Molecular analysis has shown a mutation in the gene coding for the Cav2.1 voltage-
gated calcium channel which is highly expressed in the cerebellum (Volsen et al., 1995) and 
hippocampus (Day et al., 1996). The tg
la
 mutation results in alteration of calcium homeostasis 
of cerebellar Purkinje cells which can be attributed to reduced uptake by the
 
ER (Dove et al., 
2000). In addition, an apoptotic process kills cerebellar granule cells with a peak at P20 (Lau 
et al., 2004). This is accompanied by decreased expression of nNOS (Frank-Cannon et al., 
2007). Altogether, these data suggest that a major dysfunction of calcium homeostasis is 
responsible for granule and Purkinje cell death in this mutant.  
 
1.1.7 The hyperspiny mouse 
The hyperspiny Purkinje cell mutant mice show cerebellar symptoms from P10. The 
cerebellum is slightly hypoplastic and histological examination reveals that Purkinje cells 
have reduced dendritic arbors. As the name of the mutant implies, the proximal dendrites and 
soma of the Purkinje cells are studded with spines (Guenet et al., 1983). Focal axonal 
swellings are also found in nearly all axons (Sotelo, 1990b). Axonal pathology leads to a 
retrograde degeneration resulting in a 15% Purkinje cell loss (Guenet et al., 1983; Sotelo, 
1990b; 1990a).  
 
1.1.8 The tambaleante mouse 
The tambaleante spontaneous mutation particularly affects Purkinje cells, because these 
neurons suffer from a late, slow and progressive degenerative process starting at about 2 
months of age (Wassef et al., 1987). In one year-old mice, the degeneration is almost 
complete with less that 1% surviving neurons (Wassef et al., 1987; Rossi et al., 1995). 
Pathological signs are characterized by moderate thickening of the main axonal stems. The 
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recurrent axon collaterals and varicose axonal enlargements or torpedoes commonly 
accompany these alterations (Rossi et al., 1995). Dense somatic material, autophagic vacuoles 
and autophagolysosomes are observed in the soma and dendrites of these Purkinje cells 
(Dusart et al., 2006) suggesting that Purkinje cells undergo autophagic degeneration. 
Nevertheless, some Purkinje cells exhibit apoptotic-like condensation of the nucleus, and 
dendritic debris of the dying Purkinje cells can be seen in the molecular layer of 6 to 12 
month old tambaleante cerebella. Therefore, it is likely that after an initial intense autophagic 
phase, the affected Purkinje cells follow a different death pathway, probably involving 
apoptosis (Dusart et al., 2006).  
 
1.1.9 The weaver mutant mouse 
The autosomal recessive weaver mutation is a single amino acid exchange in a G-protein 
coupled, inwardly rectifying K
+
 channel (GIRK2) (Patil et al., 1995)  and generates chronic 
depolarization of the affected neurons (Patil et al., 1995; Liss et al., 1999). This leads to 
massive death of granule cells (80%) during the 2 first postnatal weeks (Smeyne and 
Goldowitz, 1989). Dying granule cells display typical apoptotic morphology, DNA 
fragmentation (Smeyne and Goldowitz, 1989; Gillardon et al., 1995a), increased Bax 
expression (Wullner et al., 1995) and successive activation of caspase-9 and caspase-3 (Peng 
et al., 2002). In addition, about 40% of Purkinje cells and 25% of the deep cerebellar neurons 
also die postnatally (Maricich et al., 1997). 
 
1.1.10 The staggerer mutant mouse 
The autosomal recessive staggerer (Rora
sg
) mutation causes a deletion of the Rora gene 
(Hamilton et al., 1996) which encodes a retinoid-like nuclear receptor involved in neuronal 
differentiation and maturation, with high expression in Purkinje cells (Hamilton et al., 1996; 
Ino, 2004). In homozygotes, Purkinje cells declined in number before P5 and, at the end of the 
first postnatal month, only 25% of them remained (Herrup and Mullen, 1979). The remaining 
Rora
sg
 Purkinje cells are reduced in size, lack tertiary dendritic spines receiving synaptic 
contacts from parallel fibers (Sotelo, 1975) and are multiply innervated by climbing fibers, a 
sign of developmental arrest (Mariani, 1982).  
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1.1.11 The reeler mutant mouse 
The autosomal recessive reeler mutation disrupts the Reln gene (D'Arcangelo et al., 1995) 
which encodes reelin, an extracellular matrix protein involved in neural adhesion and 
migration at critical stages of development (D'Arcangelo et al., 1995; Hack et al., 2002). 
Reeler mutants display essentially architectonic disorganization in the cerebellum (Mariani et 
al., 1977) and the inferior olive (Goffinet, 1983). In the reeler cerebellum 90% of granule 
cells (Caviness and Rakic, 1978), 50% loss of Purkinje cells (Heckroth et al., 1989) and 20% 
of inferior olivary neurons (Blatt and Eisenman, 1985) are loss. In addition, adult reeler 
Purkinje cells are innervated by more than one climbing fiber (Mariani et al., 1977; Mariani, 
1982).  
 
1.2 Purkinje cell death in neurological disorders 
1.2.1 Brain ischemia  
Brain ischemia induces increases in glutamate, intracellular calcium, and release of free 
radicals leading to neuronal death (Lipton, 1999; Welsh et al., 2002). A massive excitotoxic 
loss of Purkinje cells is correlated with ataxia in patients recovering from global ischemic 
stroke (Sarna and Hawkes, 2003). The origin of this excitotoxic neuronal death is complex, 
probably, resulting from the intensive innervation of Purkinje cells by glutamatergic 
climbing/parallel fibers (Sarna and Hawkes, 2003), deficiency of glutamate reuptake (Welsh 
et al., 2002; Yamashita et al., 2006) and persistent activation of AMPA receptors (Hamann et 
al., 2005).  
 
1.2.2 Alzheimer disease 
Purkinje cell loss was originally demonstrated in brains of patients deceased from familial 
and sporadic Alzheimer diseases (Fukutani et al., 1996). Significant cerebellar atrophy was 
related to a 35% loss of Purkinje cells (Wegiel et al., 1999). This loss was accompanied by a 
loss of inferior olivary neurons and a massive cerebellar gliosis (Sjobeck and Englund, 2001). 
This is manifested by some of the symptoms and signs observed in Alzheimer disease such as 
spatial disorientation.  
 
1.2.3 Huntington disease 
In the Huntington disease, Purkinje cell loss has been reported (Rodda, 1981), but the 
death mechanisms causing neuronal death is unknown. Dying Purkinje cells characteristically 
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exhibit neuronal intranuclear inclusions, condensation of both cytoplasm and nucleus, and 
ruffling of the plasma membrane while maintaining ultrastructure of cellular organelles 
(Turmaine et al., 2000). These cells do not develop any sign of nuclear or cytoplasmic 
blebbing, apoptotic bodies, or DNA fragmentation (Turmaine et al., 2000) and this suggests 
that Purkinje cell death mechanism is neither apoptosis nor necrosis.  
 
1.2.4 Prion diseases 
Creutzfeld-Jacob disease induces a virtually complete disappearance of parallel fibers 
(Berciano et al., 1990) caused by massive loss of granule cells which is total in the cerebellar 
vermis (Hauw et al., 1981; Tiller-Borcich and Urich, 1986; Berciano et al., 1990; Kovacs et 
al., 2001). This is accompanied by hypertrophy of primary and secondary Purkinje cell 
dendrites (Tiller-Borcich and Urich, 1986) which express PrP
C 
(Lemaire-Vieille et al., 2000). 
Interestingly, Fas, Fas-L, and Bax expression are increased and caspase-3 immunoreactivity is 
enhanced in the cytoplasm of surviving Purkinje cells in CJD (Puig and Ferrer, 2001) 
suggesting either impairment of apoptosis or non-apoptotic roles for these proteins. In 
addition, the heat shock protein Hsp72 accumulates in TUNEL-negative Purkinje cells and is 
absent from TUNEL-positive granule cells suggesting that this protein helps to rescue 
Purkinje cells from the TSE (Kovacs et al., 2001). This suggests that accumulation of the 
inducible Hsp-72 in Purkinje cells may be part of a cytoprotective mechanism in prion-
diseased cerebellum. 
 
2. Prion diseases 
Prion diseases are
 
infectious,
 
genetic, or sporadic TSEs, characterized by prion protein 
aggregation and neurodegeneration. These diseases include kuru and CJD in humans, scrapie 
in sheep and BSE in animals. These diseases are incurable,
 
with a variety of motor or 
cognitive symptoms and fatal issue (Knight and Will, 2004).
 
 
Current
 
understanding of TSEs have evolved from the concept of the "prion"
 
that is a 
proteinaceous, nucleic acid-free, infectious particle (Prusiner, 1998).
 
The pathogenesis of 
prion diseases is attributed to major changes
 
in the metabolism of PrP
C 
 (Aguzzi et al., 2008). 
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2.1 The Prion Concept: a protein-only hypothesis of infection 
The infectious agent responsible for the transmission of the disease is probably not 
constituted of nucleic acids since this agent is resistant to doses of radiation that inactivate
 
viruses and bacteria (Alper, 1985). Also, its sensitivity
 
profile to various chemicals differs 
from viruses and viroids (Behrens and Aguzzi, 2002).
 
 
A protein unusually resistant
 
to proteolysis has been evidenced and is required for 
infectivity without the intervention of any other component (Prusiner et al., 1984).
 
Therefore, 
a single protease-resistant
 
protein (PrP
res
), component of the infectious agent (Prusiner, 1998), 
may be responsible for the transmission of TSEs. The infectious particle shares an identical 
amino acid sequence with PrP
C 
(Oesch et al., 1985; Basler et al., 1986) suggesting that PrP
res
 
is an abnomal
 
conformer of PrP
C 
with distinctive properties (Prusiner et al., 1984).  
Several hypotheses postulate the nature of the infectious particle. In the virino hypothesis, 
(Kimberlin and Wilesmith, 1994) the infectious agent consists of an essential scrapie-specific 
nucleic acid associated with PrP
C
. Nevertheless, no evidence for TSE-specific nucleic acids 
has yet been obtained (Safar et al., 2005). The protein-only hypothesis (Griffith, 1967; 
Weissmann, 1991; Prusiner, 1998) is currently the most widely accepted. In this hypothesis, 
posttranslational modifications of the -helical structure of PrPC into a β-sheet structure 
results in the production of PrP
res 
from host PrP
C
 (Baldwin et al., 1994). This explains the 
capacity of PrP
res 
to form protease-resistant aggregates which
 
in turn accumulate within the 
brain (Ross and Poirier, 2004). Prnp knockout mice, devoid of prion protein, are resistant 
(Sailer et al., 1994) to infection
 
with pathogenic PrP
res
 and reintroduction of Prnp restores 
infectibility and prion pathogenesis in these mice (Aguzzi and Polymenidou, 2004). This 
suggests that the presence of endogenous PrP
C
 is essential for the development of the disease.  
The mechanism of infection and propagation might involve a catalytic cascade where 
infection with PrP
res
 or conversion of PrP
C 
into PrP
res
 leads to further conversion of PrP
C
 into 
PrP
res
. The newly formed PrP
res
 will in turn convert a new PrP
C
 molecule into a proteinase K-
resistant entity.  
 
2.2 Molecular and cellular basis of neurodegeneration in prion diseases 
2.2.1 Apoptosis  
Hypothalamic cell lines infected by scrapie prions develop features of apoptosis such as  
DNA fragmentation and activation of caspases (Schatzl et al., 1997; Unterberger et al., 2005). 
In addition, activation of the JNK pathway has been demonstrated (Carimalo et al., 2005), 
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suggesting that this pathway may be involved in prion-induced neuronal death. In addition, 
the expression
 
of Fas-L, Bcl-2, BAX, and active caspase-3 are modified in Purkinje cells of 
human CJD
 
cerebellum (Puig and Ferrer, 2001). An immunohistochemical
 
study shows 
overexpression
 
of BAX, but not caspase-3 in scrapie-infected sheep (Lyahyai et al., 2006). 
This suggests that although apoptosis
 
is a relevant cell death pathway in prion disease, it is 
probably not the exclusive
 
pathway. 
 
2.2.2 Autophagy 
The accumulation autophagic vacuoles in TSEs has been described (Liberski et al., 2004; 
2008) and may result from intraneuronal accumulation of PrP
res
. This suggests that 
accumulation of PrP
res
 may lead to localized sequestration and phagocytosis of neuronal 
cytoplasm and ultimately to neuronal loss (Jeffrey et al., 1992).  
 
2.2.3 Synaptic and dendritic pathology 
A progressive loss of dendritic spines has been reported in addition to dendritic atrophy in 
CJD brains (Fraser, 2002). Notch-1, an inhibitor of dendritic growth and maturation, is 
increased and correlates with regressive dendritic changes, suggesting that Notch-1 could be a 
mediator of this process (Ishikura et al., 2005).  The resulting loss of synapses and dendritic 
spines may isolate neurons from electrical stimuli and trophic factors, which could trigger 
self-destructive mechanisms (Fraser, 2002; Unterberger et al., 2005) and is probably BAX-
independent (Chiesa et al., 2005). This loss of dendritic spines starts with the emergence of 
dendritic varicosities at sites where spines protrude from the dendrite (Fuhrmann et al., 2007). 
(Inouye and Oda, 1980; Shyng et al., 1993; Altman and Bayer, 1997; Weissmann and Aguzzi, 1999; White et al., 1999; Rossi et al., 2001; 
Medina et al., 2002; Brini et al., 2005; Hashimoto and Kano, 2005; Chowdhury et al., 2006; Papa et al., 2006; Djavaheri-Mergny et al., 2007; 
Sillitoe and Joyner, 2007; Watts and Westaway, 2007; Mandolesi et al., 2008) 
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Figure 1.  Cell death pathways. (Modified from Chowdhury et al., 2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 2. The intrinsic apoptotic pathway. 
A death signal (1) will either activate p53 or induce the cleavage of the BH3-only pro-
apoptotic factor Bid, resulting in the inhibition of BCL-2. The inhibitor effect of BCL-2 on 
BAX or BAK (3) will be suppressed, allowing BAX and BAK to form heterodimers and a 
pore in the mitochondrial outer membrane, resulting in the massive liberation of cytochrome c 
(4). Cytochrome c-bound Apaf1 will cleave the procaspase-9 into an active initiator caspase-9 
(5) which in turn will cleave the effector procaspase-3 (6) into active caspase-3. (7) Active 
caspase-3 will induce DNA damages, dismantling of the cellular architecture and cell death. 
  
 
 
Figure 3. ROS induces ER stress and a caspases-dependent apoptotis. 
Nitric oxide activates the mitochondrial respiratory complex (1) and the production of 
ROS. ROS-mediated MOMP will induce cytochrome c efflux to the cytoplasm (2) resulting in 
the massive liberation of Ca²
+
 from the ER (3). This Ca²
+
 liberation is regulated by BCL-2 and 
BAX. The massive liberation of Ca²
+
 will potentiate the MOMP resulting in a massive 
liberation of mitochondrial cytochrome c (4) and in caspase-3 dependent apoptosis (5). 
Activated BAX in the ER membrane can itself induce the caspase 12 activation (4’) and 
subsequent caspase 3 activation (5’). 
 
  
 
 
 
Figure 4. The apoptotic extrinsic pathways. 
Death receptors TNF-R1, TRAIL-R and Fas are activated by their ligands and activate 
TRADD or FADD (1) via their death domain. TRADD and FADD will activate caspase-8 (2). 
The activate caspase-8 will directly activate caspase-3 (3). Caspase-8 can also cleave Bid into 
truncated Bid (3’), which inhibits BCL-2. This activates the intrinsic pathway and ultimately 
to caspase-3-dependent apoptosis (4). Potentiation of the apoptosis can also result from BCL-
2 inhibition by TRADD-activated JUNK (5). 
  
 
 
Figure 5. Induction and completion of the autophagic cascade. 
(1) In the absence of nutrients and under Beclin1-dependent inhibition, TOR cannot 
maintain ATG13 phosphorylation. The dephosphorylated ATG13 will form an ATG 1-13 
complex (2) which activates the ATG 5-12 and the ATG8 conjugation systems (3). ATG 5-12 
will recruit an isolation membrane (5) while LC3-I is cleaved by ATG4 into its LC3-II form 
(4) in the ATG8 conjugation system. A phosphatidylethanolamine (PE) will be bound to LC3-
II by ATG3 and 7. This allows the sequestration of cytoplasm in a double-membraned 
autophagic vacuole or autophagosome (6) The autophagosome resulting from the isolation 
membrane elongation will fuse with a lysosome to form an autophagolysosome. The 
lysosomal cathepsins will finally degrade the autophagic body. 
  
 
 
 
Figure 6. ATG5 mediates interplay between autophagic and intrinsic apoptotic pathways. 
Truncated tATG5 resulting from the cleavage of ATG5 by calpains is able to dissociate 
the BCL-2/BAX complex. This allows tATG5 to bind BCL-2 via a BH3-like domain and 
BAX to exert pro-apoptotic activity. 
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Figure 7. Anatomical organization of the cerebellar cortex.  
A. Foliation of the C57Bl6 mouse cerebellum. The cerebellum is divided into anterior and 
posterior lobes by the fissura principalis (fp). Supplemental fissures further subdivide the 
anterior and posterior lobes into transversally oriented lobules I to X (Modified from Inouye 
and Oda, 1980). 
B. Neuronal composition of the cerebellar cortex. ml, molecular layer. pcl, Purkinje cell 
layer. igl, internal granular layer. wm, white matter (Modified from Sillitoe and Joyner, 2007). 
  
 
 
 
 
 
Figure 8. Schematic diagram of the cerebellar circuit with marked excitatory (+) and 
inhibitory (-) innervation (Modified from Medina et al., 2002) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Climbing fiber differentiation during postnatal development. (Modified from 
Hashimoto and Kano, 2005) 
At the “creeper stage” (P3), most Purkinje cells are innervated by 3 or more climbing 
fibers. Around P5, the peak of the nest stage  corresponds to the peak of multiple innervation 
of Purkinje cells by climbing fibers. During the “capuchon stage” (P7-P10), the climbing fiber 
somato-dendritic translocation correlates with an abrupt decline of the multiple innervation. 
Then, the adult numerical relationship of one climbing fiber per one Purkinje cell is finally 
established. 
  
 
 
 
Figure 10. Schematic diagram outlining the major efferent pathways of the deep 
cerebellar nuclei. (Modified from Altman and Bayer, 1997) 
Within the lower closed loop (blue), there are also projections from the red nucleus to the 
deep cerebellar nuclei (direct) or via the precerebellar nuclei to the deep cerebellar nuclei 
(indirect). The upper closed loop (red) predominantly involves the thalamus, cerebral cortex 
and pontine grey nuclei.  
CO=cerebral cortex, BG=basal ganglia, TH=Thalamus, VL=ventrolateral thalamus, 
CS=superior colliculus, RN=red nucleus, PG=pontine grey nucleus, IO=inferior olive, 
DCN=deep cerebellar nuclei, LR=lateral reticular nucleus, EC=external cuneate nucleus.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Structure of GluR2 and C-terminal partners. (Modified from Mandolesi et al., 
2008) 
A. The N-terminus region of GluR2 contains a LIVBP-like domain, a LAOBP-like 
domain which is divided in two parts by transmembrane domains (TM) 1 to 3 and a TM4. 
TM2 forms the ion-channel re-entrant loop segment.  
B. The intracellular C-terminus of GluR2 interacts with PICK-1, AP-4, spectrin and 
PDZ domain-containing proteins PSD93, PTP-MEG, delphilin, S-SCAM, nPIST and Shank. 
  
 
Figure 12. Parallel fiber and climbing fiber projection domains on Purkinje cell dendrites 
of the wild-type and GluR2ho/ho Purkinje cells (Modified from Ichikawa et al., 2002). 
A. In the adult wild-type (GluR2+/+) mouse, climbing fibers  innervate proximal primary 
and secondary dendrites (blue) while parallel fibers innervate tertiary branchlet spines (green). 
GluR2 receptors are expressed at the parallel fiber synapses. 
B. In the adult GluR2-deficient hotfoot (GluR2ho/ho) mouse, climbing fibers emit 
collaterals distally extending to abnormally innervate tertiary branchlets. Numerous Purkinje 
cell dendritic spines remain devoid of innervation. Climbing fibers often jump to form 
synapses on spiny branchlets of adjacent Purkinje cells.  
C. blocking the electrical activity afferent to wild-type Purkinje cells allows the parallel 
fibers to extend their territory to the proximal dendrite. This leads to the climbing fiber 
atrophy and restoration of GluR2 expression in the adult climbing fiber synapses. 
  
 
 
Figure 13: Structure of PrP
C
, Dpl, PrP and Shadoo. (Modified from Watts and 
Westaway, 2007). 
PrP
C
, Dpl and PrP have a structured C-terminal domain including 3 -helices and 2 -
sheets which are absent in Shadoo. Dpl has two disulfide bonds (S-S) when only one is 
present in PrP
C
 and PrP. Hydrophobic tract and repetitive regions are conserved in PrPC 
(octarepeats) and Shadoo (tetrarepeats). 
 
 
 
 
  
 
 
Figure 14: Intracellular and plasma membrane trafficking of PrP
C
. (Modified from Shyng et 
al., 1993) 
After ER synthesis, PrP
C
 is post-translationally modified in the ER and the Golgi 
apparatus before trafficked to the cell surface in a lipid raft microdomain (green). Copper-
binding makes PrP
C
 to exit the lipid raft to be internalized by clathrin-mediated endocytosis 
and submitted to constitutive cycling. A part of the internalized molecules are cleaved within 
endosomes and either externalized via exosomes or degraded by lysosomes.  
  
  
 
 
Figure 15: Schematic representation of Cu/ZnSOD and glutathione anti-oxidant pathways 
and putative interaction with PrP
C
-Cu
2+
. (Modified from White et al., 1999) 
PrP
C 
might facilitate the reduction of glutathione by the glutathione reductase which 
ultimately reduces reactive oxygen species. In the absence of PrP
C
, the reduction of oxidative 
species is impaired leading to a less efficient protection against oxidative stress.  
  
 
 
 
 
Figure 16: Various strategies used to disrupt the locus of the Prnp gene to generate 
different strains of Prnp knockout mice. (Modified from Rossi et al., 2001) 
Prnp ORF is in grey and non-coding sequences are in blue. The dotted line indicates the 
deleted Prnp sequence and the brace indicates an inserted neomycine phosphotransferase 
(Neo) or a hypoxanthine phosphoribosyltransferase (HPRT). LoxP is a 34 Kb recombination 
site from phage 1.  
  
 
 
 
 
Figure 17: Prnd expression depends on Prnp promoter in Nagasaki Prnp
0/0
 (NP
0/0
) mouse. 
(Modified from Weissmann and Aguzzi, 1999) 
When deletion of Prnp coding region and flanking regions includes the splice acceptor of 
intron 2, the resulting chimerical mRNAs comprising Prnp exons 1 and 2 are spliced to the 
Dpl-coding Prnd exon.  
 
  
 
 
Figure 18: Dpl-PrP
C
 interaction models. (Modified from Watts and Westaway, 2007) 
A. The competition model.  In wild-type mouse, PrP
C
 binds to a hypothetical ligand LPrP 
and elicits a survival signal. In Prnp
0/0
 mouse such as ZrchI, a hypothetical PrP
C
-like protein 
 binds to LPrP with a lower affinity and induces the same survival signal. When Dpl or PrP 
bind to LPrP, an improper signal leading to cell death is initiated. It is counteracted by 
reintroduction of PrP
C
. 
B. The sensitization model. PrP
C
 favors cell survival in wild-type mouse and its absence 
in ZrchI mouse has no specific effect. In NP
0/0
 mice, Dpl like PrP initiates a cell death signal 
which is directly abrogated by PrP
C
. 
 
  
 
A  
 
Group Treatment schedule Mean number of NASP 
treated PCs 
Mean number of 
untreated PCs 
WT 
1 
12 days treatment 429.4 ± 90.8 423 ± 60.7 
 
GluR2Lc/+ 
2 
12 days treatment 446.7 ± 36.7 258.24 ± 22.9 
 
WT 
3 
6 days treatment 512 ± 62.2 453 ± 43.1 
 
GluR2Lc/+ 
4 
6 days treatment 530.7 ± 163 494 ± 58 
 
GluR2Lc/+ 
5 
10 days feeding and  
2 days treatment 
324.3 ± 35 
258.24 ± 29.9 
GluR2Lc/+ 
6 
8 days feeding and  
4 days treatment 
388.6 ± 49.14 
GluR2Lc/+ 
7 
6 days feeding and  
6 days treatment 
401 ± 41 
GluR2Lc/+ 
8 
6 days treatment and  
6 days feeding 
252 ± 24 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19.  
A. Mean numbers of GluR2Lc/+ and wild-type Purkinje cells submitted to different NASP 
treatment schedules ± SD.  
B. Blockade of GluR2Lc/+-induced excitotoxicity by NASP treatment is efficient to 
significantly rescue GluR2Lc/+ Purkinje cells after at least 6 DIV in organotypic cerebellar 
cultures from P0 cerebellum. 1 to 8 are groups of wild-type and GluR2Lc/+ mice indicated in 
A.  
 
  
 
 
 
Figure 20. Somatic dots of LC3-immunofluorescent labeling (B, C) reveal autophagy in 
the CaBP-immunofluorescent GluR2Lc/+ Purkinje cells (A, C) displaying dendritic atrophy in 
12 DIV organotypic cerebellar cultures. Autophagy could not be detected (E, F) in GluR2Lc/+ 
Purkinje cells treated with NASP for 12 DIV (D, F). This treatment also restored the dendritic 
tree of GluR2Lc/+ Purkinje cells to its wild-type dimension but had no effect on wild-type 
Purkinje cells (G-L). Bar = 20µm for A-L. 
  
 
A  
Group Treatment 
schedule 
Mean dendritic 
area of treated 
PCs 
Mean dendritic 
area of untreated 
PCs 
Mean maximum 
dendritic length of 
treated PCs 
Mean maximum 
dendritic length 
of untreated PCs 
WT 
1 
12 days treatment 
1584.6 ± 142.8 1516.5 ± 191.5 23.9 ± 1.3 24.1 ± 1.2 
GluR2Lc/+ 
2 
12 days treatment 
1483.4 ± 117 
933.32 ± 127.05 
23.5 ± 1.27 
18.23 ± 1.18 
GluR2Lc/+ 
5 
10 days feeding and 
2 days treatment 
1068.18 ± 116 20.77 ± 2.3 
GluR2Lc/+ 
6 
8 days feeding and 
4 days treatment 
1085.4 ± 
120.85 
22.55 ± 2.1 
GluR2Lc/+ 
7 
6 days feeding and 
6 days treatment 
1451.7 ± 116.9 23.54 ± 1.09 
GluR2Lc/+ 
8 
6 days treatment 
and  
6 days feeding 
878.13 ± 36.32 15.69 ± 0.85 
 
B             
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. A. Mean area (µm²) and maximum dendritic length (µm) ± SD of GluR2Lc/+ 
and wild-type Purkinje cells submitted to different NASP treatment schedules in 12 DIV 
organotypic cerebellar cultures. 
B. Blockade of GluR2Lc/+-induced excitotoxicity by NASP treatment is efficient to 
significantly restore GluR2Lc/+ Purkinje cell dendritic growth after at least 6 DIV in 
organotypic cerebellar cultures from P0 cerebellum. 1 to 8 are groups of wild-type and 
GluR2Lc/+ mice indicated in A.  
 
  
 
 
Genotype Mean 
number of 
Purkinje cells 
Mean 
dendritic 
area 
Mean 
maximum 
dendritic 
length 
Mean 
numbers of 
primary 
dendrites 
Mean 
numbers of 
secondary 
dendrites 
Mean 
numbers of 
tertiary 
dendrites 
WT 998 ± 116 3138 ± 272 98 ± 1 1.58 ± 0.7 4.87 ± 1.59 53.2 ± 11 
GluR2ho/ho  681 ± 173 3037 ± 819 83 ± 5 1.61 ± 0.8 3.95 ± 1.4 18.13 ± 4.7 
 
Table 1. Mean number of Purkinje cells, mean area and maximum length of Purkinje cell 
dendritic tree and mean numbers of primary, secondary and tertiary dendrites of GluR2ho/ho 
and wild-type Purkinje cells ± SD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. A and B. Significant Purkinje cell loss and atrophy of secondary and tertiary 
Purkinje cell dendrites in GluR2ho/ho cerebellar cultures. C. Representative CaBP-
immunofluorescent Purkinje cells in GluR2ho/ho and wild-type organotypic cerebellar 
cultures. Bar = 50 µm. 
  
 
  
Figure 23. Climbing fiber (arrows) translocation along the soma and dendrites of the 
Purkinje cells (arrowheads) is impaired in GluR2ho/ho mice. 
A-H. At P10, VGlut 2-immunofluorescent (red) climbing fibers (A-D) innervate the soma 
but not the dendrites of the CaBP-immunofluorescent (green) GluR2ho/ho Purkinje cells (B, 
D) whereas climbing fiber somato-dendritic translocation (E-H) has already occurred on the 
proximal dendrite of the wild-type Purkinje cells (F, H). Fifteen day-old GluR2ho/ho Purkinje 
cells (J, L) exhibit somatic and limited dendritic climbing fiber innervation (I-L) while 
climbing fiber translocation to the primary and secondary dendrites is completed on the wild-
type Purkinje cells (M-P). Bar = 50µm for A-P. 
  
 
  
 
 
Figure 24. Hypothesis for a Dpl-induced neurotoxic mechanism. 
(1) Extracellular Dpl, bound to cell membrane, can activate TNF-R1, leading to the 
production of ROS (2) by an unidentified mechanism (Papa et al., 2006). (3) In parallel, 
cytosolic Dpl can induce production of ROS by a possible calcium-dependent pathway (Brini 
et al., 2005). The produced ROS will either induce autophagy (4) (Djavaheri-Mergny et al., 
2007) or activate JNK (5) (Papa et al., 2006) leading to the activation of caspase-8-dependent 
apoptosis and BAX-dependent apoptosis. 
  
 
 
Primary 
antibody 
Company Dilution 
Secondary 
antibody 
Company Dilution Experiment 
Mouse anti-
CaBP  
Sigma 
Aldrich 
1/1000 Alexa 546 
goat anti-mouse 
Molecular 
Probes 
1/1000 Immuno-
fluorescence  
Mouse anti-
CaBP  
Sigma 
Aldrich 
1/1000 - Alexa 488 goat 
anti-mouse 
Molecular 
Probes 
1/1000 Immuno-
fluorescence 
Rabbit anti-
CaBP 
From Mrs 
Thomasset 
1/1000 Alexa 546 goat 
anti-rabbit 
Molecular 
Probes 
1/1000 Immuno-
fluorescence 
Guinea pig 
anti-VGlut2 
Chemicon 1/3000 Alexa 546 goat 
anti-Guinea pig 
Molecular 
Probes 
1/1000 Immuno-
fluorescence 
Mouse anti-
GFAP 
Sigma 
Aldrich 
1/500 Byotinilated 
horse anti-mouse 
Vector Labs 1/200 Immuno- 
peroxidase 
Mouse anti-
GFAP 
Sigma 
Aldrich 
1/500 Alexa 546 goat 
anti-mouse 
Molecular 
Probes 
1/1000 Immuno-
fluorescence  
Rabbit anti-
GFAP 
Dako 1/500 Alexa 488 goat 
anti-rabbit 
Molecular 
Probes 
1/1000 Immuno-
fluorescence  
Rabbit anti-
aldolase C 
From Dr 
Sugihara 
160ng/mL Byotinilated 
horse anti-rabbit 
Vector Labs 1/200 Immuno- 
peroxidase 
Rabbit anti-
aldolase C 
From Dr 
Sugihara 
160ng/mL Alexa 488 goat 
anti-rabbit 
Molecular 
Probes 
1/1000 Immuno-
fluorescence  
Mouse 
anti-Hu-bcl-2 
BD 
Biosciences 
1/50 Byotinilate
d horse anti-
mouse 
Vector 
Labs 
1/200 Immuno- 
peroxidase 
Rabbit anti-
Scrg1 
From Dr Dron 1/60 Alexa 488 goat 
anti-rabbit 
Molecular 
Probes 
1/1000 Immuno-
fluorescence  
Mouse anti-
LC3B 
Nanotools 1/10 - Alexa 488 goat 
anti-mouse 
Molecular 
Probes 
1/1000 Immuno-
fluorescence 
Mouse anti-
p62 
BD 
Transduction 
Labs 
1/100 - Alexa 488 goat 
anti-mouse 
Molecular 
Probes 
1/1000 Immuno-
fluorescence 
 
Table 3. Antibodies used for immunohistochemical staining experiments. 
  
 
 
Method Fixative 
Transmission electron microscopy for 
ultrastructural analysis 
4% paraformaldehyde –  
2% glutaraldehyde in PB 
Scrapie responsive gene 1 (Scrg1) pre-
embedding immunogold 
1% paraformaldehyde in PB 
amino butyric acid (GABA) post-
embedding immunogold 
2% paraformaldehyde  - 2% 
glutaraldehyde in PB 
 
Table 4. Fixative used for transmission electron microscopy and immunocytochemistry. 
  
 
 
 
GluR2Lc/+ mouse NP0/0 mouse 
 
Refer
ence 
 
Refer
ence 
Apopt
osis 
Increased Bax IR in GluR2Lc/+ Purkinje cells 523 
DNA fragmentation in Dpl-overexpressing hippocampal 
neurons 
237 
TUNEL labeling of GluR2Lc/+  Purkinje cells 
522, 
338 
TUNEL labelling of Dpl overexpressing granule cells 324 
Caspase-3 IF in GluR2Lc/+ Purkinje cells 427 
ROS producing enzymes upregulation in Dpl-
overexpressing neurons 
94, 
521 
Delayed death of Bax-/-:GluR2Lc/+ Purkinje cell  428 
Activation of caspases 3 and 10 by Dpl in N2A and 
astrocytes 
376 
Inactivation of extrinsic pathway delays tPA-/-
:GluR2Lc/+ Purkinje cell death 
279 
Bcl-2 overexpression delays caspase-3 activation in the 
cerebellum of PrP transgenic mouse 
333 
ROS are induced in GluR2Lc/+ Purkinje cells 307 
Bcl-2 overexpression and Bax-/- partly rescue NP0/0 Purkinje 
cells 
171, 
172 
Autop
hagy 
GluR2 is linked to Beclin1 via nPIST  in cerebellar 
extracts and HEK cells 
541 
Scrg1 IR of NP0/0 Purkinje cells 
111, 
173 LC3 IR of GluR2Lc/+ Purkinje cells in vivo and in 
vitro 
499 
GluR2Lc induces autophagy in vitro in HEK cells 
and in vivo in Lurcher Purkinje cells 
541 
Early autophagy in NP0/0 Purkinje cells 173 
Autophagy is induced by GluR2Lc  in GluR2Lc/ho 
Purkinje cells 
429 
Induction of axonal autophagy in GluR2Lc/+ Purkinje 
cell 
499 
Upregulation of p62 in NP0/0 Purkinje cells 173 
Absence of p62 upregulation in GluR2Lc/+ Purkinje 
cells 
499 
  
 
 
Table 2. Experimental evidences for apoptosis and autophagy in Grid2 mutant mice and in Nagasaki Prnp-deficient mice overexpressing Dpl.
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Lurcher GRID2-Induced Death and Depolarization
Can Be Dissociated in Cerebellar Purkinje Cells
channel (Zuo et al., 1997), thus supporting a role as a
gated ion channel. In Lurcher heterozygous mice, the
expression of the Grid2Lc allele in cerebellar Purkinje
Fekrije Selimi,1 Ann M. Lohof,1 Ste´phane Heitz,2
Alexis Lalouette,1 Christopher I. Jarvis,1
Yannick Bailly,2 and Jean Mariani1,*
1Laboratoire De´veloppement et cells (PCs) leads to the permanent depolarization of
these neurons (Zuo et al., 1997) and their degenerationVieillissement du Syste`me Nerveux
CNRS-UMR 7102 from the second postnatal week onward (Caddy and
Biscoe, 1979). The permanent depolarization of Grid2Lc/Universite´ Pierre et Marie Curie
75005 Paris Grid2 PCs has been proposed to be the primary cause
of their death through an excitotoxic-like process (Zuo2 UPR 2356
CNRS et al., 1997). Only a small number of PCs are still present
in neonatal Lurcher homozygotes (Cheng and Heintz,IFR37 des Neurosciences
67084 Strasbourg 1997; Resibois et al., 1997); death of PCs thus takes
place at least 2 weeks earlier than in heterozygotes,France
suggesting a gene dosage effect of the Lurcher allele.
GRID2 is expressed as early as E15 in developing PCs
(Takayama et al., 1996), and GRID2Lc channels induceSummary
depolarization when expressed in heterologous cells
(Kohda et al., 2000; Zuo et al., 1997), raising the questionThe Lurcher mutation transforms the GRID2 receptor
into a constitutively opened channel. In Lurcher het- of what controls the onset of PC death and, in particular,
whether it is simply depolarization.erozygous mice, cerebellar Purkinje cells are perma-
nently depolarized, a characteristic that has been We generated and analyzed heteroallelic mutant mice
expressing only one copy of the Lurcher allele and nothought to be the primary cause of their death, which
occurs from the second postnatal week onward. The wild-type allele. Hotfoot (Grid2ho/Grid2ho) mice are “natu-
ral” Grid2 knock-out mice (Lalouette et al., 1998). Themore dramatic phenotype of Lurcher homozygotes is
thought to be due to a simple gene dosage effect of hotfoot-Nancy strain has a deletion of 948 bp in the
coding sequence of Grid2. These mice do not expressthe mutant allele. We have analyzed the phenotype
of Lurcher/hotfoot heteroallelic mutants bearing only the GRID2 protein and have a behavioral and morpho-
logical phenotype similar to the Grid2 targeted knock-one copy of the Lurcher allele and no wild-type Grid2.
Our results show that the absence of wild-type GRID2 out mouse (Lalouette et al., 2001). We crossed Grid2Lc/
Grid2 mice with Grid2ho/Grid2ho mice in order to obtainreceptors in these heteroallelic mutants induces an
early and massive Purkinje cell death that is correlated Grid2Lc/Grid2ho mice, which have only one copy of the
Lurcher allele and no wild-type allele. Our data providewith early signs of autophagy. This neuronal death is
independent of depolarization and can be explained in vivo evidence that the Lurcher GRID2 receptors can
induce neuronal death and activate autophagy indepen-by the direct activation of autophagy by Lurcher GRID2
receptors through the recently discovered signaling dently of their depolarization effect.
pathway formed by GRID2, n-PIST, and Beclin1.
Results
Introduction
Early Onset of Neurodegeneration
Glutamate receptor overactivation leads to neuronal in the Grid2Lc/Grid2ho Cerebellum
death through a process known as excitotoxicity and Grid2Lc/Grid2ho animals were viable but ataxic, sug-
contributes to numerous acute pathologies such as gesting a cerebellar defect. At P21, the cerebellum of
ischemia (Lee et al., 1999) and chronic ones such as Grid2Lc/Grid2ho animals was clearly atrophic when com-
amyotrophic lateral sclerosis (Lancelot and Beal, 1998). pared to the cerebella of Grid2/Grid2ho and Grid2/
The depolarization and the perturbed ion homeostasis, Grid2 control mice (Figure 1). This atrophy is much
in particular increased calcium concentration, that result more severe than that of the Grid2Lc/Grid2 cerebellum
from glutamate receptor overactivation have been given at the same age. While numerous PCs are still detected
a central role in the molecular events inducing neuronal by calbindin immunostaining in Grid2Lc/Grid2 cere-
death during excitotoxicity (Reynolds, 1998). bella, almost none are found in Grid2Lc/Grid2ho cerebella
Glutamate ionotropic receptors can be divided into (only 66  39 per hemicerebellum).
four subfamilies: the AMPA, NMDA, kainate, and  To determine whether the more severe loss of PCs in
(GRID1 and GRID2) receptors. GRID receptors were P21 Grid2Lc/Grid2ho cerebella was a consequence of an
cloned by sequence homology with other glutamate re- accelerated process or due to an earlier onset of degen-
ceptors, but no ligand has yet been found to activate eration, we counted the number of PCs in Grid2Lc/
these putative channels (Araki et al., 1993; Mayat et al., Grid2ho, Grid2Lc/Grid2, Grid2/Grid2ho, and Grid2/
1995). However, the Lurcher point mutation (Lc) trans- Grid2 cerebella of P5 and P10 animals in sections
forms the GRID2 receptor into a constitutively opened stained with an anti-calbindin antibody (specifically
staining PCs in the cerebellum) and with cresyl-violet
(Figures 1 and 2A). In Grid2Lc/Grid2 mice, the number*Correspondence: jean.mariani@snv.jussieu.fr
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Figure 1. Early Onset of Purkinje Cell Degen-
eration in Grid2Lc/Grid2ho Mice
At P21, almost no calbindin-immunopositive
Purkinje cells and very few granule cells are
still detected in the cerebellum of Grid2Lc/
Grid2ho mice (C), in contrast with the cerebel-
lum of Grid2/Grid2ho (A) and Grid2Lc/Grid2
mice (B). At P10, only a very few Purkinje cells
still survive in the cerebellum of the Grid2Lc/
Grid2ho double mutants (compare [F] with the
Grid2/Grid2ho [D] and Grid2Lc/Grid2 cere-
bella [E]). At P5, the cerebellum of the Grid2Lc/
Grid2ho mice (I) is smaller and less foliated
than the cerebellum of Grid2/Grid2ho (G) and
Grid2Lc/Grid2 (H) mice. Scale bars 500m.
of PCs per hemicerebellum decreased slightly from cantly less than in both Grid2/Grid2ho and Grid2Lc/
Grid2 cerebella (40.9  1.9 m and 42.5  1.5 m,52,923  2,381 at P5 to 52,509  4,479 at P10. The
number of PCs in Grid2Lc/Grid2 cerebellum was signifi- respectively; ANOVA followed by the Scheffe´’s post hoc
test, p  0.001). This shows that the early onset of PCcantly lower than that found in Grid2/Grid2 controls
at both ages (Tukey-Kramer test, p  0.05), but was degeneration leads to a deficit in the genesis of granule
cells, in addition to the target-related death of thesesignificantly lower compared to Grid2/Grid2ho cerebella
only at P10. Loss of one wild-type allele of Grid2 seems neurons (Wetts and Herrup, 1982). This is in accordance
with the known trophic support provided by PCs to theto delay PC development, as the number of PCs in
Grid2/Grid2ho cerebella is significantly reduced com- granule cell precursors (Feddersen et al., 1992; Smeyne
et al., 1995).pared to Grid2/Grid2 cerebella at P5, but reaches
control level at P10. Thus, a delay in PC development
probably also contributes to the reduced number of PCs Lurcher GRID2 Induces PC Death and Autophagy
Independent of Depolarizationin P5 Grid2Lc/Grid2 cerebella, suggesting that PC death
has barely begun in those mutants by that age. In con- PCs of Grid2Lc/Grid2 mice are chronically depolarized
due to a constitutively active inward current (Zuo et al.,trast, the cerebella of Grid2Lc/Grid2ho mice displayed a
striking atrophy by P5 and were less foliated than the 1997). We hypothesized that in the absence of the wild-
type Grid2 allele, this depolarization might be more se-cerebella of age-matched Grid2Lc/Grid2, Grid2/Grid2ho,
and Grid2/Grid2 animals (Figure 1). The number of PCs vere or show an earlier developmental onset, explaining
the accelerated PC death in Grid2Lc/Grid2ho mice. Wein Grid2Lc/Grid2hocerebella decreased from 20,455 
1,140 at P5 to 12,947  1,593 at P10, significantly re- therefore made patch-clamp recordings from PCs in
slices prepared from Grid2/Grid2, Grid2/Grid2ho,duced when compared to the numbers found in all other
genotypes at both ages (Figure 2A; Tukey-Kramer test, Grid2Lc/Grid2, or Grid2Lc/Grid2ho cerebella at P5–P6 and
P9–P12 (Figure 2B). As shown by Zuo et al. (1997),p  0.05).
These results show that PC death has already very Grid2Lc/Grid2 Purkinje cells at P9–P12 had very large
holding currents (1.670.11 nA), significantly differentsignificantly affected Grid2Lc/Grid2ho cerebella by P5, an
age at which Grid2Lc/Grid2 cerebella are not yet obvi- from Grid2/Grid2ho and Grid2/Grid2 values (Tukey-
Kramer test, p  0.05). Grid2Lc/Grid2ho PCs also hadously affected. Thus, the absence of the Grid2 wild-type
allele leads to an earlier onset of PC degeneration in higher holding currents than controls at P9–P12
(1.35  0.24 nA; p  0.05). The tendency was towardmice expressing one allele of Grid2Lc.
At P21, the internal granule cell layer is still well de- lower holding currents than in Grid2Lc/Grid2 Purkinje
cells, although this difference was not statistically signif-fined in Grid2Lc/Grid2 cerebella and contains numerous
granule cells, whereas it has almost completely disap- icant (p  0.05). At P5–P6, the Grid2Lc/Grid2 PCs had
larger holding currents (0.66  0.13 nA; p  0.05)peared in the cerebellum of Grid2Lc/Grid2ho animals (Fig-
ure 1). While the presence of an external granule cell than those of their control littermates, but were less
depolarized than Grid2Lc/Grid2 PCs at P9–P12. A strik-layer (EGL) containing granule cell precursors is clear
in the cerebellum of P10 Grid2Lc/Grid2 mice, this layer ing finding was that at P5–P6, PCs of Grid2Lc/Grid2ho
mice had holding currents equivalent to those of controlhas almost disappeared in P10 Grid2Lc/Grid2ho cerebella
(Figure 1). At P5, the thickness of the EGL in Grid2Lc/ animals (0.22  0.07 versus 0.24  0.03 nA for
Grid2/Grid2ho, 0.11  0.03 nA for Grid2/Grid2; p Grid2ho mice was only 26.0  0.9 m, which was signifi-
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still associated with signs of autophagy, we analyzed
by electron microscopy the cerebellar morphology of
our different mutants (Figure 3). Numerous autophagic
vesicles were detected in all the PCs analyzed from P5
Grid2Lc/Grid2ho cerebella. This was not the case for PCs
from age-matched Grid2/Grid2ho and Grid2Lc/Grid2
cerebella, which contained few or no autophagic pro-
files. This shows that the expression of GRID2Lc protein
can induce autophagy in correlation with PC death, even
in a situation where it is not able to induce depolarization
of these neurons.
Effects of Lurcher Allele Dosage
As Grid2Lc/Grid2Lc mice die perinatally (Cheng and
Heintz, 1997), the gene dosage effect of the Lurcher
allele was studied through the comparison of the cere-
bellar phenotype of our different mutants to that of
Grid2Lc/Grid2Lc mice at P0 (Figure 4). The Grid2Lc/Grid2Lc
cerebellum is clearly atrophic, in accordance with pre-
viously published results (Cheng and Heintz, 1997; Resi-
bois et al., 1997); folia are barely distinguishable, while
they are clearly visible in the cerebella of age-matched
Grid2ho/Grid2 controls and Grid2Lc/Grid2 mice. The
number of calbindin-positive PCs is also dramatically
reduced in the cerebella of Grid2Lc/Grid2Lc mice com-
pared to Grid2ho/Grid2 and Grid2Lc/Grid2 cerebella.
The morphology of Grid2Lc/Grid2ho cerebella at P0 differs
markedly from that of P0 Grid2Lc/Grid2Lc mice; folia are
clearly formed, and the number of PCs is superior to
Figure 2. Purkinje Cell Death Is Not Correlated with Depolarization that detected in Grid2Lc/Grid2Lc mice (compare Figures
in Grid2Lc/Grid2ho Cerebellum 4C and 4D). No neuronal death was apparent in the
(A) Purkinje cell number per hemicerebellum was assessed using brainstem of Grid2Lc/Grid2ho animals (data not shown) in
calbindin-immunostained sections (*p  0.05, significantly different contrast to what has been described for Grid2Lc/Grid2Lc
from Grid2/Grid2 values; **p  0.05, significantly different from
animals (Cheng and Heintz, 1997). These striking resultsGrid2Lc/Grid2 values, Tukey-Kramer test; n  3–5 animals per ge-
show that there is a gene dosage effect of the Lurchernotype).
allele leading to accelerated PC death in Grid2Lc/Grid2Lc(B) Holding currents are significantly larger at P9–P12 for Grid2Lc/
Grid2 and Grid2Lc/Grid2ho Purkinje cells (*p  0.05, Welch ANOVA cerebella compared to the PC death observed in Grid2Lc/
followed by Tukey-Kramer test) compared to the same genotypes Grid2ho cerebella.
at P5–P6 and compared to Grid2/Grid2ho and Grid2/Grid2 at
both ages. Grid2Lc/Grid2 holding currents at P5–P6 are significantly
Discussiondifferent from any other group (**p  0.05).
The expression of GRID2Lc in PCs causes a massive
degeneration of these neurons accompanied by target-0.05) and significantly lower than those of Grid2Lc/Grid2
mice. Thus the earlier PC death is not correlated with related death of PC afferents during the first postnatal
month in Grid2Lc/Grid2 mice (Caddy and Biscoe, 1979;an early depolarization.
To verify the expression of GRID2 in the Grid2Lc/ Dumesnil-Bousez and Sotelo, 1992). The observation
that Grid2Lc/Grid2 PCs are depolarized due to the con-Grid2ho PCs, we performed immunohistochemistry on
cerebellar sections of P5 mutants (see Supplemental stitutive inward current induced by the expression of
the mutant GRID2 receptors (Zuo et al., 1997) led to theData at http://www.neuron.org/cgi/content/full/37/5/
813/DC1). In Grid2ho/Grid2ho cerebella, no immunostain- hypothesis that this permanent depolarization causes
the death of PCs by an excitotoxic mechanism. Ouring was detected in PCs, supporting the results of La-
louette et al. (2001) and further confirming that hotfoot results show that the Lurcher GRID2 receptor can trigger
autophagy and PC death without inducing depolariza-mice can be considered a functional knock-out for
Grid2. In Grid2Lc/Grid2ho cerebella, GRID2 immunoreac- tion of these neurons and that, although gene dosage
partially determines the onset of PC degeneration, thetivity could be detected in PCs in a pattern similar to
that seen in Grid2/Grid2ho and Grid2Lc/Grid2 cerebella. loss of the wild-type Grid2 allele greatly increases the
vulnerability of PCs expressing Lurcher GRID2.Although Lurcher GRID2 is expressed in PCs of Grid2Lc/
Grid2ho mice at P5, depolarization of these neurons is Numerous studies have focused on the role of depo-
larization and the concomitant ionic flux in the processonly detected at P9. However PC death is already mas-
sive at P5 in Grid2Lc/Grid2ho mice. Recently, the presence leading to excitotoxicity (Iihara et al., 2001; Reynolds,
1998). However, it remains to be proven that massiveof autophagy has been revealed in PCs of Lurcher het-
erozygotes (Yue et al., 2002). In order to see whether depolarization and ionic flux are the only factors contrib-
uting to excitotoxicity in vivo. For example, the in-the early death of PCs in our heteroallelic mutants was
Neuron
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Figure 3. Activation of Autophagy in P5
Grid2Lc/Grid2ho Purkinje Cells
(A) Double-membrane vesicles (arrows) typi-
cal of autophagy have formed in the apical
cytoplasm of a Grid2Lc/Grid2ho Purkinje cell.
(B) Magnification of inset in (A).
(C–E) Examples of autophagosomes at differ-
ent stages in other Grid2Lc/Grid2ho Purkinje
cells.
(F) Representative view of the somatic cyto-
plasm of Grid2ho/Grid2 Purkinje cells. Go,
Golgi dictyosome; m, mitochodrion; n, nu-
cleus; rer, rough endoplasmic reticulum; tg,
trans-Golgi; Ly, lysosome; pf, parallel fibers.
Scale bars  500 nm.
creased calcium permeability of AMPA receptors in onward, this difference becomes highly significant, the
mean holding current for Grid2Lc/Grid2 PCs at this ageGluR2-deficient mice does not influence the vulnerability
being 1.67  0.11 nA, while control holding currentof their neurons to kainate in vivo (Iihara et al., 2001).
remains at 0.30  0.02 nA. This result is in agreementWhat triggers membrane depolarization and death in
with the results of Kohda et al. (2000), describing thatGrid2Lc/Grid2 PCs remains unknown. The expression
Grid2Lc/Grid2 PC depolarization is lower at P6–P7 thanof GRID2 is detected as early as E15 in cerebellar PCs
at P10. In Grid2Lc/Grid2 mice, PC loss is not obvious(Takayama et al., 1996). Expression of the Grid2Lc allele in
at P5, but is approximately 35% at P10. This temporalheterologous cells such as Xenopus oocytes or HEK293
correlation points toward a direct causality betweencells leads to a permanent depolarization of these cells
membrane depolarization and PC death in Grid2Lc/(Kohda et al., 2000; Zuo et al., 1997), raising the question
Grid2 mice, as had been proposed previously (Zuo etof why Grid2Lc/Grid2 PCs begin to die only after P5.
al., 1997). PC death occurs much earlier in Grid2Lc/Our electrophysiological study of PC membrane po-
Grid2ho cerebella than in Grid2Lc/Grid2 cerebella, whiletential shows that at P5, Grid2Lc/Grid2 PCs are slightly
the copy number of the Grid2Lc allele is the same in bothdepolarized when compared to control PCs. From P9
animals. In Grid2Lc/Grid2ho mutants, the number of PCs
is already reduced by approximately 66% at P5, 84%
at P10, and reaches almost 0 at P21. The phenotype of
our heteroallelic mutants could have been explained in
the context of depolarization if the absence of the wild-
type allele led to an earlier onset of depolarization. How-
ever, our study shows that at P5, the holding current
for Grid2Lc/Grid2ho PCs is equivalent to the control value
and lower than for Grid2Lc/Grid2 PCs. The loss of the
Grid2 wild-type allele does not affect the ability of
GRID2Lc channels to induce depolarization of PCs later
during development, as Grid2Lc/Grid2ho PCs become de-
polarized at P9–P12. In Grid2 knock-out mice, no PC
degeneration has been detected. This is also true for
hotfoot homozygotes, for which the number of PCs is not
different from the wild-type (H. Zanjani et al., personal
communication). Grid2 knock-out mice display fewer
parallel fiber/Purkinje cell synapses (Kashiwabuchi et
Figure 4. Comparison of Cerebellar Degeneration in P0 Mutants
al., 1995; Kurihara et al., 1997). This is unlikely to be a
The P0 Grid2Lc/Grid2ho cerebellum (C) is less developed than control
cause of the phenotype of the Grid2Lc/Grid2ho mice, asGrid2/Grid2ho (A) and Grid2Lc/Grid2 (B) cerebella, suggesting that
reduction of this input by X-irradiation does not altersome Purkinje cell death might already have occurred at this age.
the time course of PC death in Grid2Lc/Grid2 animalsThe P0 Grid2Lc/Grid2Lc cerebellum (D) shows a much more dramatic
loss of Purkinje cells than the other genotypes. (Doughty et al., 1999). Moreover, a significant part of
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PC death in Grid2Lc/Grid2ho mice occurs before the bulk through their channel function but also through direct
of synaptogenesis between granule cells and PCs (be- molecular signaling pathways.
tween P5 and P15). Thus, the earlier onset of PC degen-
Experimental Procedureseration in Grid2Lc/Grid2ho animals is not due to an in-
creased ability of Lurcher GRID2 to form leaky channels
Animals and Genotypingin the absence of the wild-type GRID2, nor to a reduced
Grid2Lc/Grid2 mice (B6CBA strain) were mated with Grid2ho/Grid2ho
number of synapses. In this case, membrane depolariza- homozygotes (C57Bl6 strain ho-Nancy allele described in Lalouette
tion is not correlated with the degenerative process. et al. [2001]). Grid2Lc/Grid2ho animals identified by their ataxic pheno-
type were then further mated to Grid2ho/Grid2 or Grid2Lc/Grid2Studies have revealed that glutamate ionotropic re-
animals to obtain Grid2Lc/Grid2ho, Grid2Lc/Grid2, Grid2ho/Grid2,ceptors are not only gated ion channels, but also plat-
and Grid2Lc/Grid2Lc animals in the same litter. Grid2/Grid2 controlsforms for signaling pathways (Grant and O’Dell, 2001;
were obtained by crossing B6CBA mice with C57Bl6 mice. LittersSheng and Pak, 2000). Recently, a direct link between
were sacrificed at different ages from postnatal day 0 (P0) to P21
GRID2 receptors and the process of autophagy has according to the guidelines from the NIH Guide for the Care and Use
been found through the interaction of GRID2 with Bec- of Laboratory Animals. Genotyping was performed by polymerase
lin1 via n-PIST (Yue et al., 2002). Autophagy overactiva- chain reaction (PCR) followed by analysis of single-strand conforma-
tion polymorphism (SSCP) as described previously (Selimi et al.,tion can lead to neuronal death and has been observed
2000b; Zuo et al., 1997). PCR was performed using 200–300 ng ofin various developmental and pathological paradigms
genomic DNA and the following primers: 5	-TAAAAGCATATTGAT(Anglade et al., 1997; Clarke, 1990). Although apoptotic
GTTGTTG-3	; 5	-CAGCATTTGTCAGGTTTGGTGAC-3	. At P0, mor-
characteristics have been detected in Lurcher PCs (Sel- phological analysis of the brainstem was performed to differentiate
imi et al., 2000a; Wullner et al., 1995), apoptosis inhibi- between Grid2Lc/Grid2ho and Grid2Lc/Grid2Lc animals.
tion by bax inactivation or BCL-2 overexpression only
delays PC death in the Lurcher heterozygous mutants, Histology and Neuronal Counts
10 m-thick brain sections were obtained and stained with an anti-suggesting that alternative death pathways are induced
calbindin antibody and cresyl violet as previously described (Selimiin Lurcher PCs (Doughty et al., 2000; Selimi et al., 2000b;
et al., 2000b). The number of PCs per hemicerebellum was deter-Zanjani et al., 1998). Expression of GRID2Lc in heterolo-
mined by counting the number of calbindin-immmunopositive PCs
gous cells induces autophagy, and morphological signs every 40th section at 1000
 magnification. The total number of PCs
of autophagy have been found in PCs from P10 Lurcher was obtained from a graph of the number of PCs in each counted
heterozygotes, suggesting that autophagy could be the section plotted against the distance of the section from the midline.
Corrections were made for double-counting PCs based on thealternative death pathway induced by GRID2Lc receptors
method of Hendry (1976). We chose to use this traditional correctionin PCs (Yue et al., 2002). We have shown here that
factor for our cell counts rather than more recently developed ste-GRID2Lc is able to induce autophagy and death in PCs
reological techniques so that our results would be directly compara-that are not depolarized. The concomitant expression
ble with previously published counts. The external granule cell layer
of the wild-type receptor delays the overactivation of (EGL) thickness was measured in at least eight regions of the primary
autophagy, as few signs of autophagy are detected in fissure in three vermal sections per cerebellum at 1000
magnifica-
P5 Lurcher heterozygotes. When the quantity of these tion using a CCD camera and the NIH Image software. These mea-
surements were made for three animals of each genotype to obtainproteins is low, as is the case before P10 (Zhao et al.,
the mean EGL thickness.1998), the coexpression of the wild-type GRID2 with the
Lurcher GRID2 seems to be sufficient to prevent cell
Immunohistochemistry and Electron Microscopydeath. However, when the quantity of these proteins is
GRID2 immunohistochemistry was performed based on the protocol
increased, the activation of autophagy might be too of Takayama et al. (1995). 20 m thick cryostat sections from P5
overwhelming to be inhibited by the presence of the litters of a Grid2Lc/Grid2ho 
 Grid2ho/Grid2 cross were processed
wild-type GRID2. Moreover, the depolarization and im- using an anti-GRID2 antibody (Chemicon, Temecula, CA) followed
by an FITC conjugated anti-rabbit IgG and were analyzed usingpaired ion homeostasis that starts after P5 in Grid2Lc/
confocal microscopy.Grid2 PCs might also contribute to an enhanced sensi-
Grid2Lc/Grid2ho (n  3), Grid2Lc/Grid2 (n  2), Grid2ho/Grid2 (n tivity to the death signal induced by the Lurcher GRID2
2), and Grid2ho/Grid2ho (n  2) mice were perfused with a mixture ofreceptor and/or induce parallel death pathways.
4% paraformaldehyde and 2% glutaraldehyde in sodium phosphate
Our results show that GRID2 receptors can modulate buffer. Vibratome sagittal sections were postfixed with 2% osmium
neuronal death through a pathway that does not require tetroxyde, then treated en bloc with uranyle acetate, and flat-
depolarization of the neurons and which might involve embedded in Araldite M (Fluka). 60 nm ultrathin sections were exam-
ined with a Hitachi 7500 transmission electron microscope operateddirect molecular signaling pathways. Our data taken to-
at 60kV.gether with those of Yue et al. (2002) give strong in
vivo evidence that this pathway is autophagy, whose
Electrophysiologyoveractivation can be directly induced by the interaction
250 m thick cerebellar slices were prepared from P5–P12 mice
of GRID2Lc with Beclin1 via n-PIST (Yue et al., 2002). It using standard procedures (Llano et al., 1991). The slice recording
is interesting in this regard to note that in ischemia, chamber was continuously superfused with buffer containing 125
direct inhibition of NMDA receptors or of calcium chan- mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 26 mM NaHCO3, 2 mM
nels has been proven unsuccessful as a therapeutic CaCl2, 1 mM MgCl2, and 25 mM glucose, continuously bubbled with
95% O2, 5% CO2. Whole-cell patch-clamp recordings were madestrategy (Lee et al., 1999). Very recently, it has been
from PCs using an Axopatch 200 amplifier (Axon Instruments, Fostershown that blocking the interaction between NMDA re-
City, CA). Patch pipettes were filled with a solution containing 6 mMceptors and the scaffolding protein PSD-95 reduces fo-
KCl, 140 mM K D-gluconate, 10 mM HEPES, 1 mM EGTA, 0.1 mM
cal ischemic brain damage in rats (Aarts et al., 2002). CaCl2, 5 mM MgCl2, 4 mM Na2ATP, 0.4 mM NaGTP (pH 7.3, 290–300
Altogether, these data highlight the possibility that in the mOsm). Purkinje cells were voltage clamped at 70mV while re-
different pathologies involving excitotoxicity, glutamate cording the holding current. In some cases, the superfusion buffer
was replaced by a solution in which NaCl was substituted by 136receptor activation might induce cell death not only
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mM N-methyl-D-glucamine (NMDG) chloride (Zuo et al., 1997). This rensen, S., Orser, B.A., Roder, J.C., and Tymianski, M. (2001). The
influence of glutamate receptor 2 expression on excitotoxicity inallowed confirmation that the leak current was indeed due to the
Lurcher mutation and not to poor clamp quality. In the majority of Glur2 null mutant mice. J. Neurosci. 21, 2224–2239.
recordings, 5 mg/ml biocytin was added to the pipette solution, Kashiwabuchi, N., Ikeda, K., Araki, K., Hirano, T., Shibuki, K., Taka-
and the slice was fixed (in 4% paraformaldehyde in PBS) to allow yama, C., Inoue, Y., Kutsuwada, T., Yagi, T., Kang, Y., et al. (1995).
confirmation of the PC morphology using the ABC reaction (Elite Impairment of motor coordination, Purkinje cell synapse formation,
ABC kit, Vectastain). and cerebellar long-term depression in GluR delta 2 mutant mice.
The number of animals and cells analyzed for each group was: Cell 81, 245–252.
at P5–P6, 9 Grid2/Grid2ho animals (45 cells), 4 Grid2Lc/Grid2 (16),
Kohda, K., Wang, Y., and Yuzaki, M. (2000). Mutation of a glutamate
4 Grid2Lc/Grid2ho (16), 4 Grid2/Grid2 (17); at P9–P12, 10 Grid2/
receptor motif reveals its role in gating and delta2 receptor channel
Grid2ho (23), 6 Grid2Lc/Grid2 (17), 9 Grid2Lc/Grid2ho (12), 3 Grid2/
properties. Nat. Neurosci. 3, 315–322.
Grid2 (25).
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ABSTRACT: Research efforts to deduce the function
of the prion protein (PrPc) in knock-out mouse mutants
have revealed that large deletions in the PrPc genome
result in the ectopic neuronal expression of the prion-like
protein Doppel (Dpl). In our analysis of one such line of
mutant mice, Ngsk Prnp0/0 (NP0/0), we demonstrate that
the ectopic expression of Dpl in brain neurons induces sig-
nificant levels of cerebellar Purkinje cell (PC) death as
early as six months after birth. To investigate the involve-
ment of the mitochondrial proapoptotic factor BAX in the
Dpl-induced apoptosis of PCs, we have analyzed the pro-
gression of PC death in aging NP0/0:Bax2/2 double knock-
out mutants. Quantitative analysis of cell numbers showed
that significantly more PCs survived in NP0/0:Bax2/2 dou-
ble mutants than in the NP0/0:Bax1/1 mutants. However,
PC numbers were not restored to wildtype levels or to the
increased number of PCs observed in Bax2/2 mutants.
The partial rescue of NP0/0 PCs suggests that the ectopic
expression of Dpl induces both BAX-dependent and BAX-
independent pathways of cell death. The activation of glial
cells that is shown to be associated topographically with
Dpl-induced PC death in theNP0/0:Bax1/1mutants is abol-
ished by the loss of Bax expression in the double mutant
mice, suggesting that chronic inflammation is an indirect
consequence of Dpl-induced PC death. ' 2007 Wiley Periodi-
cals, Inc. Develop Neurobiol 67: 670–686, 2007
Keywords: prion protein; Doppel; BAX; apoptosis;
Purkinje cell
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INTRODUCTION
Doppel (Dpl) is the first identified homolog of the cel-
lular prion protein, PrPc, implicated in the pathogene-
sis of transmissible spongiform encephalopathies
(TSE) (Prusiner, 1998). Dpl is an N-truncated form of
PrPc with common structural features as well as cellu-
lar trafficking pathways (Weissmann and Aguzzi,
1999; Silverman et al., 2000; Flechsig et al., 2003;
Qin et al., 2003; Massimino et al., 2004). Targeted
disruptions of the PrPc coding gene (Prnp) that
extend into the upstream region of intron 2 result in
cis-activation of the Dpl gene (Prnd). Ectopic Dpl
neuronal expression in Prnp0/0 mouse lines such as
Ngsk (Sakaguchi et al., 1996), Rcm0 (Moore et al.,
1995), ZH-II (Rossi et al., 2001), and Rikn
(Yokoyama et al., 2001) causes late onset Purkinje
cell (PC) degeneration and ataxia. Dpl shares 25%
identity to PrPc, but lacks its flexible N-terminal
sequence. Expression of the N-terminal truncated
form of PrP (DPrP) in Prnp-ablated mouse lines
(Flechsig et al., 2003) causes neurodegenerative
effects in PCs similar to the overexpression of Dpl
(Anderson et al., 2004; Yamaguchi et al., 2004), and
the neurotoxic effects of Dpl and DPrP are both
antagonized by PrPc (Nishida et al., 1999; Cui et al.,
2003; Flechsig et al., 2003; Anderson et al., 2004;
Yamaguchi et al., 2004). These results suggest that
Dpl and DPrP may cause cell death by the same
mechanism, perhaps by interfering with a cellular sig-
naling pathway essential for cell survival and nor-
mally controlled by full-length PrPc (Shmerling et al.,
1998; Anderson et al., 2004).
To date, only a few studies have investigated the
mechanism by which Dpl kills neurons. PrP-deficient
cells have been shown to undergo Dpl-induced apo-
ptosis in a dose-dependent, cell autonomous manner
(Sakudo et al., 2005). Furthermore, oxidative stress
and glial activation may play a role in the death of
neurons since NOS activity is induced by Dpl in vitro
and in vivo (Wong et al., 2001; Cui et al., 2003) and
ectopic expression of Dpl in Ngsk Prnp0/0 (NP0/0)
mice is associated with an activation of glial cells
(Atarashi et al., 2001). The normal prion protein,
PrPc, has a protective function since Dpl-induced ap-
optosis is inhibited by PrPc either expressed endoge-
nously or applied exogenously (Cui et al., 2003). The
neuroprotective functions of PrPc have been attrib-
uted to its BCL-2-like properties (Kuwahara et al.,
1999). PrPc binds to BCL-2 in the yeast two-hybrid
system (Kurschner and Morgan, 1995) and PrPc as
well as BCL-2 protect yeast (Li and Harris, 2005)
and neurons (Bounhar et al., 2001; Roucou et al.,
2003) from BAX-induced apoptosis. PrPc protects
against cell death by preventing the conformational
change of BAX that occurs during BAX activation
(Roucou et al., 2005). Thus, PrPc seems to have an
antagonistic function on mitochondrial apoptotic
pathways.
To investigate the involvement of BAX in the
mechanism of Dpl-induced apoptosis, we have
crossed NP0/0:Baxþ/þ mice with Bax2/2 mice to
obtain NP0/0:Bax2/2 double mutant mice. The sur-
vival of cerebellar PCs was analyzed in these mice at
a period of maximal PC death in NP0/0:Baxþ/þ mice
(i.e. 12–21 months). In addition, the distribution of
PCs and activated astrocytes was analyzed by immu-
nohistofluorescence in NP0/0:Baxþ/þ and double mu-
tant mice to investigate a causal link between PC loss
and gliosis in the cerebellar cortex and the eventual
effect of Bax inactivation in this process.
METHODS
Animals and Genotyping
As previously reported, Bax2/2 mice were generated by
deleting exons 2–5 (Knudson et al., 1995); further breeding
strategies were designed taking into account that Bax2/2
males are sterile. NP0/0:Baxþ/þ mice were generated by
deleting the entire open reading frame (ORF) of the Prnp
gene, located in exon 3, as well as 50 and 30 noncoding
flanking regions (Sakaguchi et al., 1995). In both cases the
deleted sequences were replaced by a Neo cassette. Geno-
types were determined by PCR. Bax mutants were identi-
fied as described earlier (Knudson et al., 1995). The Prnp
ORF was identified using the following primers: forward
50CCGCTACCCTAACCAAGTGT30 and reverse 50CCT-
AGACCACGAGAATGCGA30, both located within the
Prnp ORF. NP0/0:Baxþ/þ mutants were identified using the
following primers: forward 50TGCCGCACTTCTTTGT-
GAAT30 and reverse 50CGGTGGATGTGGAATGTGT30
(within Neo cassette).
For this study, founding mice have been first back-
crossed with C57BL/6 mice for at least 10 generations.
NP0/0:Baxþ/þ males or females (gift from S. Katamine)
were then crossed with Baxþ/2 males or females (gift from
S. Korsmeyer) and offspring were identified by PCR geno-
typing using the aforementioned primer sets. NPþ/0:Baxþ/2
mice were further intercrossed, generating NP0/0:Bax2/2,
NP0/0:Baxþ/2, NP0/0:Baxþ/þ, NPþ/0:Bax2/2, NPþ/0:Baxþ/2,
NPþ/0:Baxþ/þ, NPþ/þ:Baxþ/þ, NPþ:Baxþ/2, and NPþ/þ:
Bax2/2 genotypes. The NP0/0:Bax2/2 double mutants were
obtained by crossing NP0/0:Baxþ/2 males with NP0/0:Bax2/2
or NP0/0:Baxþ/2 females. Strict littermates of the different ge-
notypes have been used throughout the study. All mice were
submitted to footprint tests at 10, 12, 14, 16, and 18months.
Mice were bred at the animal facilities of the Neuro-
sciences IFR37 in Strasbourg and maintained according to
the NIH guidelines (NIH Publication 80–23, revised 1996)
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and the European Communities Council Directive of No-
vember 24, 1986 (86/609/EEC). A minimal number of ani-
mals were used (Table 1) and handled with maximum care
to minimize their suffering.
Histology
All mice (Table 1) were anesthetized with sodium pento-
barbital (0.15 mL per 100 g, i.p.; Sanofi), after which brains
were dissected and immersed overnight in Carnoy’s fixative
(60% ethanol, 30% chloroform, 10% acetic acid). Brains
were dehydrated, embedded in paraffin, and sectioned in
the sagittal plane at 10 lm.
In addition, 10- and 21-month-old NP0/0:Baxþ/þ mice
(n ¼ 3/age) were anesthetized as described earlier and per-
fused with 4% paraformaldehyde in 0.1 M phosphate buffer
(PB), pH 7.3. The brains were dissected and immersed for
4 h in the same fixative at 48C before cryoprotective treat-
ment by immersion in 0.44 M sucrose in PB at 48C over-
night. After freezing the brains in liquid nitrogen, transverse
sections were cut (10 lm thick) with a cryostat (Leica).
Size of the Cerebellar Vermis
The size of the cerebellar vermis was estimated by mea-
suring the mean area of seven sagittal cresyl-violet—
stained sections (ImageJ) separated from each other by 400
mm (total sampling distance, 2470 lm) in the 18- and 21-
month-old wildtype, NP0/0:Baxþ/þ, NP0/0:Baxþ/2, NP0/0:
Bax2/2, and Bax2/2 mice (n ¼ 3/genotype).
Cell Counts
The PC population was quantified in all mice aged from 4
to 21 months (Table 1). The cresyl-violet—stained PCs
were counted in 10-lm-thick paraffin sections using a 633
objective (final magnification, 6303) in every 40th sagittal
section (from a random start) through the entire cerebellum
as described previously (Wetts and Herrup, 1982; Herrup
and Sunter, 1986; Zanjani et al., 2004). In brief, the PC
nuclei profiles were counted along the entire length of the
PC layer in each section. PCs were identified as neurons in
the PC layer with a large soma and some portion of their
nuclei in the plane of the section [black arrowheads in Fig.
1(C,F,I,L,O)]. The total number of PCs was estimated by
graphing the number of visible PC nuclei per section as a
function of the distance of each section from the midline
and then integrating the area under the polygon to calculate
the raw total. The raw total was adjusted for double count-
ing errors using the Hendry correction (Hendry, 1976)
because it was specifically designed to account for experi-
mental changes in the size of the cells being counted (Zan-
jani et al., 2004). The Hendry correction factor is calculated
in each cerebellum from measurements of the nuclear pro-
file area and long diameter of over 300 PCs using ImageJ.
We chose to use this classical correction factor for our cell
counts instead of more recently developed stereological
Table 1 Age and Number of Mutants and Normal Mice, Mean Area and Long Diameter 6 SD of Purkinje Cell (PC)
Nuclei and Mean Numbers 6 SD of PC Counted in Groups of Age- and Genotype-Matched Mice
Genotype
Age
(month) No. of Mice
Mean Area
of PC Nuclei (lm2)
Mean Long Diameter
of PC Nuclei (lm) Mean no. of PC
Wildtype 12 3 93.526 7.41 12.93 6 0.73 135,5546 6760
16 3 Not done Not done 145,2716 6,657
18 3 96.266 6.24 13.08 6 0.47 147,884690,94
21 3 77.566 13.32 11.86 6 1.06 143,3036 8,905
Bax2/2 12 3 72.816 1.78 11.99 60.2 200,1976 11,871
16 3 Not done Not done 173,5186 13,761
18 3 88.356 21.08 12.47 6 1.55 138,083610,423
NP0/0:Baxþ/þ 4 3 85.926 8.82 12.94 6 0.07 145,0146 10,472
6 3 Not done Not done 112,9186 8,419
10 3 Not done Not done 79,8366 1,853
12 3 93.476 11.58 13.20 6 0.88 61,2366 671
16 3 Not done Not done 48,7886 763
18 3 100.696 5.32 13.75 6 0.21 40,9406 1,695
21 3 76.916 10.5 12.48 6 0.32 36,7576 3,464
NP0/0:Baxþ/2 12 3 83.426 9.13 12.35 6 0.30 73,1466 7,230
18 3 84.246 18.2 12.63 6 0.99 42,8536 4,377
21 3 80.276 13.82 12.55 6 0.47 42,3786 6,987
NP0/0:Bax2/2 12 3 82.546 12.2 12.44 6 0.81 89,7966 6,019
16 3 Not done Not done 90,4546 6,607
18 3 89.556 2.81 12.82 6 0.3 81,8216 2,208
21 3 81.326 12.09 12.19 6 0.56 72,4756 5,172
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Figure 1 Histology of the cerebellum of the 18-month-old wildtype (A,B,C), Bax2/2 (D,E,F), NP0/0:
Baxþ/þ (G,H,I), NP0/0:Baxþ/2 (J,K,L), and NP0/0:Bax2/2 (M,N,O) mice. Cresyl-violet staining
(A,C,D,F,G,I,J,L,M,O) and calcium-binding protein 28 kDa (CaBP) immunofluorescence (B,E,H,K,N)
in sagittal sections of the median vermis. The cerebellum appears smaller in the NP0/0:Baxþ/þ, NP0/0:
Baxþ/2, and the NP0/0:Bax2/2 than in the wildtype and Bax2/2 genotypes. The CaBP-immunofluores-
cent PCs (white arrowheads) form a dense monolayer between the molecular (ML) and the internal
granular (IGL) layers in the wildtype (B) and Bax2/2 (E) cerebellar cortex. PC loss is moderate in the
NP0/0:Bax2/2 cerebellar cortex (N) and almost complete in the NP0/0:Baxþ/þ (H) and NP0/0:Baxþ/2 (K)
cerebellar cortex. In the cerebellar cortex of all mice (C,F,I,L,O), PCs display a normal aspect and loca-
tion between ML and IGL. Black arrowheads point to the PC nuclei. White arrowheads point to nuclei
of presumptive astrocytes, the number of which is increased around PC soma in the cerebellar cortex of
the NP0/0:Baxþ/þ (I), NP0/0:Baxþ/2 (L), and NP0/0:Bax2/2 (O) mice. A,D,G,J,M, 317; bar ¼ 1 mm.
B,E,H,K,N, 3200; bar ¼ 50 lm. C,F,I,L,O, 3630; bar ¼ 20 lm. [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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techniques since the profile counting method provides data
on the transversal distribution of PCs. None of the nuclear
profile area and long diameter measurements varied signifi-
cantly between age-matched groups of different genotypes
and between groups of the same genotype at different ages
(Table 1).
The lateral distribution of PC loss and of PC rescue was
estimated in age-matched NP0/0:Baxþ/þmutants versus
wildtype and NP0/0:Bax2/2 double mutants by comparing
PC numbers between corresponding sagittal levels (2 lev-
els/hemisphere and 7 vermal levels). The rostrocaudal dis-
tribution of PC loss in age-matched NP0/0:Baxþ/þ versus
wildtype cerebellum and of PC rescue in age-matched NP0/0:
Bax2/2 versus NP0/0:Baxþ/þ cerebellum was estimated by
comparing the PC numbers ratios between the anterior cere-
bellum (lobules I to V) and the posterior cerebellum (lobules
VI to X) in the corresponding sagittal levels (2 levels/hemi-
sphere and 7 vermal levels).
All the PC counts were performed by the same person
(SH), with the genetic identity of the animals masked.
Statistics
Data are given as mean 6 standard deviation (SD). Statisti-
cal comparisons of group means (cerebellar size, PC num-
bers, PC numbers anterior/posterior ratio, PC nuclear area
and long diameter, n ¼ 3 mice per group) were performed
with Minitab 13.20. Depending on the context, either two-
way ANOVA (factor ‘‘genotype’’, factor ‘‘age’’ and within
factors ‘‘brain region’’ and ‘‘parasagittal level’’) or one-way
ANOVA (factor ‘‘genotype’’, factor ‘‘age’’) was used, fol-
lowed by post hoc Tukey test for multiple comparisons when
justified. The significance threshold was set at p ¼ 0.05.
Statistical significance of the difference in PC numbers
between 4-month-old NP0/0:Baxþ/þ and 12-month-old wild-
type as well as between astrogliotic and nonastrogliotic
areas of the 4-month-old NP0/0:Baxþ/þ cerebellar cortex
was determined by using Student’s test (p < 0.05). The
same test was applied to compare PC numbers between cer-
ebellar cortex areas with intense versus normal GFAP im-
munostaining in the 4-month-old NP0/0:Baxþ/þ mice.
Immunoperoxidase for Glial Fibrillary
Acidic Protein
Brain sections of wildtype (4 and 18 months), NP0/0:Baxþ/þ
(4, 10, and 18 months), NP0/0:Bax2/2 (10 and 18 months),
and Bax2/2 (18 months) mice were deparaffinized in tolu-
ene and rehydrated in decreasing concentrations of ethanol.
The sections were incubated in 1% H2O2 in 0.1 M phos-
phate-buffered saline (PBS) for 20 min. After rinsing in
PBS, the sections were preincubated for 45 min in blocking
solution made of 0.5% Triton X-100 and 3% normal horse
serum (NHS) in PBS (PBST). The sections were then incu-
bated overnight at 48C in PBST containing 0.3% NHS and
mouse monoclonal antibody against glial fibrillary acidic
protein (GFAP; Sigma) diluted 1/500. The sections were
then rinsed in PBS (2 3 10 min) and incubated with biotin-
ylated horse anti-mouse immunoglobulins (Vector Labs).
The GFAP-bound biotinylated horse anti-mouse immuno-
globulins were visualized using the ABC method (Hsu
et al., 1981) with 3,30-diamino-benzidine tetra-hydrochlor-
ide (Fast-DAB, Sigma) as the chromogen. Six sections sep-
arated from each other by 400 lm were selected in the cere-
bellar vermis of the three 4-month-old NP0/0:Baxþ/þ mice
to be immunostained for GFAP and counterstained with
cresyl violet. Stained sections were rinsed in PBS, dehy-
drated in graded ethanol and toluene, and mounted with
Eukitt. The sections were examined under a light micro-
scope equipped with differential interference contrast illu-
mination (Axioskop-II, Zeiss, Jena, Germany). In each sec-
tion, Purkinje cells (PCs) with a visible nucleus were
counted in 1–5 cortical areas delineated sharply by intense
GFAP immunostaining of activated astrocytes as well as in
equivalent areas of cerebellar cortex with normal intensity
of GFAP staining. Similar lengths of astrocytotic and
unreactive cerebellar cortex (1–2 mm) were analyzed in
each animal.
Immunofluorescence Staining for
Calcium-Binding Protein
Brain sections of 18-month-old wildtype, NP0/0:Baxþ/þ,
NP0/0:Bax2/2, NP0/0:Baxþ/2, and Bax2/2 mice were depar-
affinized in toluene and rehydrated in decreasing concentra-
tions of ethanol. After rinsing in PBS, the sections were
preincubated for 45 min in blocking solution made of 0.5%
Triton X-100 and 3% normal goat serum (NGS) in PBS
(PBST). The sections were then incubated overnight at 48C
in PBST containing 0.3% NGS and mouse monoclonal anti-
body against calcium-binding protein (CaBP; Sigma)
diluted 1/500. The sections were then rinsed in PBS (2
3 10 min) and incubated with green fluorescent Alexa 488
goat anti-mouse immunoglobulins (Molecular Probes)
diluted 1/500 in PBS containing 0.3% NGS.
Double Immunofluorescence Staining
for GFAP and CaBP
Frozen brain sections of paraformaldehyde-fixed 4–21-
month-old NP0/0:Baxþ/þ mice were rinsed in PBS and were
preincubated for 45 min in blocking solution made of 0.5%
Triton X-100 and NGS in PBS (PBST). The sections were
then incubated overnight at 48C in PBST containing 0.3%
NGS, rabbit polyclonal antibody against GFAP (Dako)
diluted 1/500, and mouse monoclonal antibody against
CaBP (Sigma) diluted 1/500. The next day, sections were
rinsed in PBS (2 3 10 min) and then incubated with second
antibodies: green fluorescent Alexa 488 goat anti-rabbit
immunoglobulins (Molecular Probes) and red fluorescent
Alexa 546 goat anti-mouse immunoglobulins (Molecular
Probes) diluted 1/500 in PBS containing 0.3% NGS.
After rinsing in PBS, single and double immunofluores-
cent sections were mounted in Mowiol before examination
under a fluorescence microscope (Axioskop-II, Zeiss, Jena,
Germany).
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Digital Images
Digital micrographs were stored using Zeiss Axiovision
software. Photoshop 7.0 was used for final adjustments of
contrast and brightness.
RESULTS
Bax Deletion Rescues NP0/0 PCs From
Doppel Neurotoxicity
Bax Deletion Has No Significant Effect on NP0/0
Ataxia and Cerebellar Atrophy. The abnormal cere-
bral expression of Dpl has been shown to be responsi-
ble for premature death of PCs in the PrP-deficient
mice of the Ngsk line (Moore et al., 2001; Anderson
et al., 2004). To determine whether the proapoptotic
BCL-2 family member BAX is required for NP0/0 PC
death, we have analyzed some features of the motor
behavior and cerebellar anatomy of NP0/0:Bax2/2
double mutants and controls through the period of
cerebellar degeneration in NP0/0:Baxþ/þ mutants. All
pups developed normally into the 12th postnatal
month when NP0/0:Baxþ/þ mutants and double
mutants began to exhibit motor impairment character-
istic of the NP0/0:Baxþ/þ condition, as shown by hind
footprints analysis (a trembling of the hindquarters on
initiation of movement and during walking; Sakagu-
chi et al., 1996). No difference was observed in the
timing of the onset of ataxia between NP0/0:Bax2/2,
NP0/0:Baxþ/þ, and NP0/0:Baxþ/2 mutants (data not
shown). The folial pattern and cytoarchitecture of the
cerebellum of the Bax2/2, NP0/0:Baxþ/þ, NP0/0:Baxþ/2,
and NP0/0:Bax2/2 mutants were normal when com-
pared with that of wildtype mice at all ages studied
(Fig. 1). There were no obvious differences between
the wildtype and Bax2/2 mice in the overall size of
the cerebella (Fig. 2) or in the histological aspect of the
molecular and internal granular layers [Fig. 1(B,E)].
However, the size of the cerebellar vermis was signifi-
cantly reduced in the 18- and 21-month-old NP0/0:
Baxþ/þ mice (Fig. 2). The size of the cerebellar vermis
of the 21-month-oldNP0/0:Bax2/2mice was intermedi-
ate between that of wildtype mice and NP0/0:Baxþ/þ
mutants (Fig. 2). PCs in the mutants were arrayed nor-
mally at the interface between the molecular and the
internal granular layers [Fig. 1(E-F,H-I,K-L,N-O)],
and they were indistinguishable from wildtype PCs
[Fig. 1(B,C)]. However, the PC monolayer appeared
to contain fewer neurons in the NP0/0:Baxþ/þ, the
Figure 2 The 18-month-old NP0/0:Baxþ/þ mice have a significantly smaller cerebellum (estimated
size by the mean area (mm2) of 7 sagittal sections in the vermis) than the wildtype and Bax2/2 mice
(F4,10 ¼ 8.07, p < 0.01) of the same age. At 21 months, the NP0/0:Bax2/2 mice have a significantly
larger cerebellum than do NP0/0:Baxþ/þ mice (F2,6 ¼ 76.27, p < 0.01).
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NP0/0:Bax2/2, and the NP0/00/0:Bax2/2 mice [Fig.
1(H,K,N)] than in the wildtype and Bax2/2 mice
[Fig. 1(B,E)].
PC Death Is Already Significant in the 6-Month-Old
NP0/0:Bax1/1 Cerebellum. The neurotoxic effect of
Dpl overexpression was evaluated by estimating PC
loss in the cerebellum of the NP0/0:Baxþ/þ mice from
4 to 21 months. PC loss induced by Dpl was previ-
ously detected at 20 months in the cerebellum of the
NP0/0:Baxþ/þ mice (Sakaguchi et al., 1996). An ear-
lier decrease in mRNA expression of the PC specific
IP3R1 was detected in the cerebellum of 8-month-old
NP0/0:Baxþ/þ mice (Atarashi et al., 2001). In this
study, the number of PCs remained stable in wildtype
mice from 12 to 21 months (F3,8 ¼ 1.46, p > 0.2, Ta-
ble 1, Fig. 3). In contrast, although PC numbers were
normal in the 4-month-old NP0/0:Baxþ/þ mutants, the
PC population declined thereafter until 21 months,
PC loss slowing between 12 and 21 months (F6,14
¼ 172.67, p < 0.001, Table 1, Fig. 3).
Bax Deletion Protects PCs from Dpl-Induced Apop-
tosis. The role of Bax expression in the apoptotic
mechanism triggered by Dpl in the PrP-deprived PCs
was investigated by comparing the total number of
PCs between NP0/0:Bax2/2, NP0/0:Baxþ/2, NP0/0:
Baxþ/þ, Bax2/2 and wildtype mice at 10, 12, 16, 18,
and 21 months of age (Table 1).
When comparing NP0/0:Bax2/2 and NP0/0:Baxþ/þ
at 10–21 months, two-way ANOVA showed a signifi-
cant effect of genotype (F1,20 ¼ 666.77, p < 0.001)
and age (F4,20 ¼ 120.33, p < 0.001) and of their
interaction (F4,20 ¼ 3.37, p < 0.05). The cerebellum
of the 12-month-old NP0/0:Bax2/2 double mutants
contained 47% more PCs than the cerebellum of the
NP0/0:Baxþ/þ mutants of the same age (Fig. 4). This
difference increased with age up to 97% at 21
months, suggesting that Bax deletion protects PCs
from Dpl-mediated toxicity. Although the number of
PCs did not change significantly between 10 and 18
months in the NP0/0:Bax2/2 double mutants, there is
a significant decrease between 12 and 21 months
(Fig. 4), indicating that some PC loss still occurs in
spite of Bax deletion.
The mean number of PCs was also higher in NP0/0:
Baxþ/2 mice than in NP0/0:Baxþ/þ mice (significant
effect of genotype: F1,12 ¼ 8.29, p ¼ 0.014, and of
age: F2,12 ¼ 61.7, p < 0.001). The interaction term
was not significant (F2,12 ¼ 1.68, p > 0.2, Fig. 4),
which means that this relative increase was similar at
12 (20%), 18 (5%), and 21 (3.5%) months (Table 1).
Spatial Extent of Dpl Neurotoxicity and Bax Knock-
Out Neuroprotection. Although significant PC loss
occurred at each parasagittal level in the NP0/0:Baxþ/þ
cerebellum at any age studied [Fig. 5(A)], normaliz-
ing values of PC numbers at the different parasagittal
levels counted in the cerebellar vermis and hemi-
spheres of the 12-, 16-, and 18 [Fig 5(B)]-month-old
NP0/0:Baxþ/þ and wildtype mice did not disclose sig-
nificant differences in PC loss along the transversal
dimension of the NP0/0:Baxþ/þ cerebellum.
Two-way repeated measures ANOVA with factors
‘‘genotype’’ and ‘‘brain region’’ (anterior/posterior,
within-subject) showed a significant rostrocaudal dif-
ference similar in wildtype, NP0/0:Baxþ/þ and NP0/0:
Bax2/2 mice at 12 (data not shown, factor genotype:
F2,6 ¼ 28.47, p < 0.001, factor region: F1,6 ¼ 101.09,
p < 0.001, interaction term: F2,6 ¼ 1.38, p ¼ 0.322)
Figure 3 Time course of PCs mean numbers in the cere-
bellum of wildtype and NP0/0:Baxþ/þ mutant mice during
adulthood and aging. PC numbers of 4-month-old NP0/0:
Baxþ/þ mutant mice were not significantly different from
those of wildtype mice at 12 months (t4 ¼ 1.29, p > 0.25).
Figure 4 Time course of PCs mean numbers in the cere-
bellum of wildtype and different mutant mice during aging.
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and 18 [Fig. 6(A); factor genotype: F2,6 ¼ 220.17,
p < 0.001, factor region: F1,6 ¼ 105.92, p < 0.001,
interaction term: F2,6 ¼ 1,75, p ¼ 0.253] months.
However, calculation of the anterior/posterior PC
numbers ratio for each mouse indicated a significantly
lower ratio (one-way ANOVA) in the 12 (F2,6 ¼
17.25, p < 0.01)- and 18 [Fig. 6(B); F2,6 ¼ 6.21,
p < 0.05]-month-old NP0/0:Baxþ/þ mice, revealing
that the anterior (I-V) cerebellar lobules have lost
relatively more PCs than the posterior (VI-X) ones.
Significant rescue of PCs occurred at each parasagit-
tal level in theNP0/0:Bax2/2 cerebellum at any age stud-
ied [Fig. 5(A)]. Normalizing values of PC numbers at
the different parasagittal levels counted in the cerebellar
vermis and hemispheres of the 12-, 16-, and 18
[Fig 5(B)]-month-old NP0/0:Baxþ/þ and NP0/0:Bax2/2
mice did not disclose significant differences in PC res-
cue along the transversal dimension of the NP0/0:Bax2/
2 cerebellum. The anterior/posterior PC numbers ratios
of NP0/0:Bax2/2 and NP0/0:Baxþ/þ were not signifi-
Figure 5 A. At any of the 11 parasagittal levels analyzed in the cerebellar vermis (V) and left
(LH) and right (RH) hemispheres PC numbers are significantly different in the 18-month-old wild-
type (blue), NP0/0:Bax2/2 (red) and NP0/0 :Baxþ/þ (orange) mice (two-way ANOVA with repeated
measures on parasagittal levels: effect of genotype: F2,60 ¼ 113.17, p < 0.001; effect of level:
F10,60 ¼ 20.79, p < 0.001; effect of interaction: F20,60 ¼ 2.23, p < 0.01). B. The same data are nor-
malized within each group to the mean value (n ¼ 3) of PC numbers at the sagittal level. Two-way
ANOVA (effect of genotype: F2,66 ¼ 12.19, p < 0.001; effect of parasagittal level: F10,66 ¼ 21.87,
p < 0.001; effect of interaction: F20,66 ¼ 1.72, p > 0.05) failed to disclose any significant difference
at any parasagittal level analyzed.
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cantly different at 12 months (data not shown; F2,6
¼ 17.25, p< 0.01; Tukey: p> 0.5) and 18 months [Fig.
6(B); F2,6¼ 6.21, p< 0.01; Tukey: p> 0.2], suggesting
that Bax knock-out rescued PCs evenly throughout the
rostrocaudal axis of the cerebellum.
Supernumerary PCs of the Bax2/2
Transgenic Mice Die During Aging and
Cannot Account for the Protective Effect
of Bax Deletion on the NP0/0:Bax1/1 PCs
Elimination of Bax expression in mice has been previ-
ously shown to increase cerebellar PC numbers by
more than 30%, which supports the hypothesis that
BAX plays a role in naturally occurring PC death (Fan
et al., 2001). Comparing Bax2/2 and wildtype mice at
12, 16, and 18 months, two-way ANOVA showed sig-
nificant effects of genotype (F1,12 ¼ 33.86, p < 0.001),
age (F2,12 ¼ 9.42, p < 0.005), and interaction (F2,12
¼ 20.39, p < 0.001). A 48% larger PC population was
indeed counted in our 12-month-old Bax2/2 mice
when compared with the wildtype mice (Fig. 4). How-
ever, the number of supernumerary Bax2/2 PCs de-
creased thereafter. By 16 months, Bax2/2 mutants con-
tain only 19%more PCs than the wildtype mice (Fig. 4).
The number of PCs in Bax2/2 mutants and wildtype
mice was not significantly different by 18 months
(Fig. 4). The decline in PC numbers in Bax2/2 mutants
between 12 and 18 months (Fig. 4) suggests that the loss
of Bax expression is no longer sufficient to maintain the
survival of the supernumerary PCs in the agingmice.
One possible explanation for the rescue of PCs in
the NP0/0:Bax2/2 double mutants is that it is simply
due to the presence of supernumerary Bax2/2 PCs res-
cued from developmental cell death. At 12 months the
NP0/0:Bax2/2 cerebellum contains 47% more PCs
than the NP0/0:Baxþ/þ cerebellum, which is similar to
the percent increase in PCs in the Bax2/2 mutant
when compared with wildtype mice (48%, Fig. 4).
Nevertheless, this explanation no longer holds at 16
months since the Bax2/2 cerebellum contains only
19% more PCs than the wildtype against 85% more
PCs in the NP0/0:Bax2/2 than in the NP0/0:Baxþ/þ mu-
tant ( Fig. 4). Finally, at 18 months, when the Bax2/2
cerebellum contains the same number of PCs as wild-
type mice, the NP0/0:Bax2/2 double mutant contains
almost twice as many PCs as in NP0/0:Baxþ/þ mutants
(Fig. 4), suggesting that the survival of these cells results
from a specific rescue effect ofBax deletion (effect of ge-
notype : F3,24 ¼ 452.21, p < 0.001; effect of age: F2,24
¼ 20.02, p < 0.001; effect of interaction: F6,24 ¼ 12.87,
p < 0.001; Tukey: p > 0.5 between 18-month-old wild-
type and Bax2/2 mice and p < 0.001 between 18-
month-oldNP0/0:Bax2/2 andNP0/0:Baxþ/þmice).
Bax Deletion Prevents Abnormal
Activation of NP0/0 Astrocytes
Activation of Astrocytes in the 4-Month-Old NP0/0:
Bax1/1 Cerebellar Cortex Correlates Topographi-
Figure 6 Purkinje cell numbers in the cortex of the ante-
rior (lobules I–V) and posterior (lobules VI–X) cerebellum
of the 18-month-old wildtype, NP0/0:Baxþ/þ and NP0/0:
Bax2/2 mice. Mean numbers from three mice per genotype
were estimated in sagittal cerebellar sections separated
from each other by 400 lm (2 sections in the right and in
the left hemispheres and 7 sections in the vermis). A. The
posterior (black) cerebellar cortex contains many more PCs
than the anterior (white) cerebellar cortex in all genotypes.
B. Significantly different wildtype and NP0/0:Baxþ/þ ante-
rior/posterior PC numbers ratios show a greater PC loss in
the anterior NP0/0:Baxþ/þ cerebellum (F2,6 ¼ 6.21, p
< 0.05, Tukey: p < 0.01). The anterior/posterior PC num-
bers ratios in the NP0/0:Baxþ/þ and NP0/0:Bax2/2 cerebella
are not significantly different (F2,6 ¼ 6.21, p < 0.05, Tukey:
p > 0.2), indicating that Bax knock-out rescues PC evenly
along the rostrocaudal dimension of the cerebellum. C. Sag-
ittal section through the median line in the cerebellar vermis
showing the 10 lobules and the fissura prima (fp) separating
the anterior cerebellum from the posterior cerebellum
between lobule V and lobule VI.
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Figure 7 A. Immunohistochemistry for the astrocyte marker GFAP discloses patches of gliosis
(between arrowheads) in the molecular layer (ML) of the 4- (A) month-old NP0/0:Bax+/+ cerebellar
cortex. C, E. Gliosis has propagated throughout the ML in the older 10- (E) and 18- (C) month-old
NP0/0:Bax+/+ mice. See also glial activation throughout the internal granular layer (IGL). B,D,F.
GFAP staining of radial Bergmann glia (arrowheads) and IGL astrocytes remains weak in the 4-
(B) and 18 (D)-month-old wildtype cerebellar cortex. GFAP immunoreactivity of the cerebellar
cortex of the 18-month-old Bax2/2 (F) and wildtype (B,D) mice (F) is similar at all ages studied.
G,H. Bax deletion has restored normal intensity of GFAP immunoreactivity in ML of the 10- (G)
and 18 (H)-month-old NP0/0:Bax2/2 cerebellar cortex, although astrogliosis still occurs in parts of
ML and throughout IGL at both ages. Arrow shows nonspecific GFAP staining of blood vessel
walls in all mice. Bar ¼ 50 lm,3200.
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cally with PC Loss. Glial cells (including astrocytes)
become activated in the cerebellar cortex of the NP0/0:
Baxþ/þ mutants as early as the third postnatal week as
shown by increased GFAP and lysozyme M (LM)
mRNA levels and by intense GFAP immunohisto-
chemical staining of astrocytes at the 20th month
(Atarashi et al., 2001). In the present GFAP immuno-
histochemical study, the cerebellar cortex of the 4-
month-old NP0/0:Baxþ/þ mice displayed activation of
astrocytes in restricted areas of the molecular and the
internal granular layers [Figs. 7(A,B) and 8(A)]. PC
counts showed that these areas contained fewer PCs
than in areas with normal GFAP immunoreactivity
(Fig. 8). In 10- [Fig. 7(E)] and 18 [Fig. 7(C,D)]-
month-old NP0/0:Baxþ/þ mice, astrogliosis extended
throughout the cerebellar cortex, suggesting that astro-
gliosis and PC death kinetics were correlated. More-
over, double GFAP and CaBP immunohistofluores-
cence studies showed that astrogliosis and PC loss to-
pography systematically overlapped in the cerebellar
cortex of the NP0/0:Baxþ/þ mice at all ages studied
(Fig. 9): indeed, GFAP labeling was the most intense
in regions devoid of PCs. This strongly suggests that
the gliosis relates to PC loss.
Activation of Astrocytes Is Moderated by Bax Dele-
tion in the NP0/0:Bax2/2 Cerebellar Cortex. Astro-
gliosis did not occur in the cerebellar cortex of the
Bax2/2 mice at any ages studied [Fig. 7(F)], indicat-
ing that Bax deletion itself has no effect on astrocytes.
In the cerebellar cortex of the 10- [Fig. 7(G)] and 18
[Fig. 7(H)]-month-old NP0/0:Bax2/2 double mutant
mice, GFAP immunohistochemistry revealed a much
less intense, patchy astrogliosis than in age-matched
NP0/0:Baxþ/þ mice [Fig. 7(C,E)]. This indicated that
Bax deletion could prevent the activation of astro-
cytes in the presence of ectopic Dpl in NP0/0:
Baxþ/þmutants.
DISCUSSION
To investigate whether the proapoptotic factor BAX
is necessary for the premature death of cerebellar PCs
in NP0/0 mice with overexpression of the PrPc paralog
Dpl (Moore et al., 1999; Weissmann and Aguzzi,
1999; Li et al., 2000), we crossed NP0/0 mutants with
Bax knock-out mutants and analyzed PC numbers
and glial activation. The results from our analysis of
Bax2/2 mutants and NP0/0:Bax2/2 double mutants
suggest three conclusions. First, the supernumerary
PCs rescued from developmental cell death in Bax2/2
mice eventually die during aging. Second, deletion of
Bax expression rescues many PCs from Dpl-induced
cell death in the NP0/0:Bax2/2 double mutant. Third,
deletion of Bax expression blocks the activation of
astrocytes induced by the NP0/0 deletion. These stud-
ies demonstrate an important role for BAX in Dpl-
mediated death of PrPc-deficient PCs.
Figure 8 A. Area of intensely GFAP immunoreactive radial Bergmann glia in the cerebellar mo-
lecular layer (ML) of a 4-month-old NP0/0:Baxþ/þ mouse. In this astrogliotic area, very few PCs
(white arrowhead) can be stained by cresyl violet than elsewhere (black arrowheads) in the cerebel-
lar cortex. IGL, internal granular layer, bar ¼ 50 lm. B. Areas of activated Bergmann glia (with
increased intensity of GFAP immunostaining, white bar) have lost significantly more PCs than
areas with normal Bergmann glia (with normal intensity of GFAP immunostaining, black bar) in
the 4-month-old NP0/0:Baxþ/þ mice (paired t-test, t4 ¼ 6.07, p < 0.03; n ¼ 3).
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Figure 9 Double immunofluorescence staining for GFAP (green in A–H) and CaBP (red in
A,C,E,G) in the cerebellar cortex of a 21-month-old NP0/0:Baxþ/þ mutant mouse (A–F) and a 12-
month-old wildtype mouse (G,H). A,B,G,H and C,D,E,F show cortical areas from respectively anterior
and posterior cerebellum. Asterisks indicate PCs location between the molecular (ML) and internal
granular (IGL) layers of the cerebellar cortex and white stars indicate intense GFAP immunostaining.
Black stars show a large pial blood vessel. wm, white matter. A,B,C,D,G,H,3200; E,F,3100; bar¼ 50
lm.
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Loss of Supernumerary PCs
in Bax2/2Mutants
Elimination of Bax increases PC numbers in adult
Bax2/2 mice (Fan et al., 2001), presumably by rescu-
ing PCs that are believed to die from BAX-mediated
naturally occurring cell death during development.
The present study shows that these supernumerary
PCs undergo BAX-independent cell death during
aging, thereby restoring the PC population to levels
in wildtype by 18 months in Bax2/2 mutants. Since
we did not have any Bax2/2 mice older than 18
months for this study, we did not estimate PC num-
bers in older mice. However, the number of PCs may
stabilize after 18 months. This is strongly suggested by
the similar phenomenon that occurs in the cerebellum
of transgenic mice that overexpress a human Bcl-2
transgene (Zanjani et al., 2004). In these mice, a signif-
icant number of PCs that are likely rescued from natu-
rally occurring cell death (Zanjani et al., 1996) has
been shown to decline from 6 to 12 months, to
approach wildtype levels by 18 months like in the
Bax2/2 mutants and stabilizing thereafter by 24
months (Zanjani et al., 2004). The failure to sustain the
survival of supernumerary PCs in Bax2/2 mutants
with aging suggests that PC survival may gradually
become independent of apoptotic mechanisms involv-
ing BCL-2 family members. The transition to alterna-
tive survival/death mechanisms may be correlated with
the decreased expression with age of survival factors
such as BCL-2, which normally antagonize BAX.
Indeed, BCL-2, a direct BAX antagonist that has been
shown to favor PC survival during the same period as
observed in Bax-deficient mice (Zanjani et al., 1996;
Fan et al., 2001), undergoes decreased expression by 5
months in wildtype mice (Merry et al., 1994; Zanjani
et al., 2004). Bax expression also has been shown to
decline with age in the CNS, although this decrease
has already occurred by 3 months (Vekrellis et al.,
1997).
Bax Deletion Rescues NP0/0 PCs from
Doppel Neurotoxicity
Previous studies have shown a loss of NP0/0 PCs by
20 months (Sakaguchi et al., 1996) whereas a
decrease of the PC marker IP3R1 mRNA was
detected in 8-month-old NP0/0:Baxþ/þ mice (Atarashi
et al., 2001). Our study extends the latter data by
demonstrating a significant reduction of PCs numbers
in NP0/0:Baxþ/þ cerebella by 6 months, i.e., much
sooner than previously believed. However, footprint
analyses only revealed motor impairments in NP0/0:
Baxþ/þ mutants by 12 months, suggesting either that
substantial numbers of PCs must be lost before ataxia
is apparent or that the development of the ataxic phe-
notype may also depend on neurodegeneration in
other parts of the brain. The NP0/0:Bax2/2 and NP0/0:
Baxþ/2 mice displayed ataxia at the same time as the
NP0/0:Baxþ/þ mice. This suggests that this phenotype
is not solely a function of the number of surviving
PCs since the NP0/0:Bax2/2 double mutants have
more PCs than NP0/0:Baxþ/þ mutants do at
12 months.
The participation of BAX in Dpl-mediated apopto-
sis in PCs was investigated by assessing PC numbers
through the lifespan of NP0/0:Bax2/2 double trans-
genic mice. The double transgenics contain many
more PCs than do the NP0/0:Baxþ/þ single mutants
during the period studied (12–21 months). While the
number of PCs in the Bax2/2 mutant declines from
12 to 18 months, the number of PCs in the NP0/0:
Bax2/2 mutant is stable during this period. Thus, the
rescue of PCs from developmental cell death by
deleting Bax expression cannot account for the long-
lasting effect of the loss of Bax expression on the
NP0/0 PC population. Thus the absence of BAX ena-
bles some PCs to resist Dpl neurotoxicity and indi-
cates that BAX plays a role in Dpl-mediated cell
death. There was a tendency for NP0/0:Baxþ/2 PCs to
resist Dpl-induced neurotoxicity, although this has
disappeared by 18 months. A Bax gene dose effect
might exist in the regulation of Dpl-mediated PC
death, although it was not observed in the regulation
of developmental PC death (Fan et al., 2001).
The graduate decline in the NP0/0:Bax2/2 PC pop-
ulation during the 9-month-long study indicated that
Bax deletion was not effective enough to oppose Dpl-
mediated apoptosis of all PCs. At all ages, the num-
ber of NP0/0:Bax2/2 PCs was significantly less than
in wildtype cerebella. This suggests that Bax-inde-
pendent death mechanisms can be activated by Dpl
specifically in the PrPc-deficient Ngsk PCs. Indeed,
PCs survive in Zu¨rich-1 (ZH-I) (Bu¨eler et al., 1993)
and Edbr (Manson et al., 1994) Prnp-knock-out mice
that do not overexpress Dpl, ruling out PrP-deficiency
as a cause of PC death in the NP0/0:Bax2/2 mice.
The ectopic expression of Dpl may induce BAX-
dependent and BAX-independent mechanisms in the
same PCs. Alternatively, the two pathways could be
mutually exclusive such that Dpl may selectively
stimulate one pathway or the other in different PCs.
Against this hypothesis, neither Dpl-induced PC loss
nor PC rescue induced by Bax deletion showed sig-
nificant variations along the lateral axis of the cere-
bellum in the NP0/0:Baxþ/þ and NP0/0:Bax2/2 mice,
suggesting that the neurotoxicity of Dpl, and in par-
ticular its BAX-mediated component, is evenly dis-
682 Heitz et al.
Developmental Neurobiology. DOI 10.1002/dneu
tributed along the lateral axis of the cerebellum and is
not related to the parasagittal compartmentation of
the PC population (Eisenman and Hawkes, 1993;
Bailly et al., 1995). Nevertheless in favor of the exis-
tence of cell-specific differential sensitivity of PCs to
Dpl neurotoxicity, PC loss was increased in the ante-
rior cerebellum. This suggests that Dpl neurotoxicity
varies along the rostrocaudal axis of the cerebellum
and could be related to the anteroposterior compart-
mentation of the PC population (Duchala et al.,
2004). However, since PC survival in the anterior and
posterior cerebellum of the NP0/0:Bax2/2 was simi-
lar, the rescue effect of Bax knock-out did not change
between anterior and posterior PCs, suggesting that
BAX-mediated effect of Dpl is not related to the ros-
trocaudal compartmentation of PC population.
The structural properties shared by Dpl and PrPc
and the increasing amount of data connecting PrPc
and apoptosis (Bounhar et al., 2001; Roucou et al.,
2003 2004; Diarra-Mehrpour et al., 2004; Kim et al.,
2004; Paitel et al., 2004; Solforosi et al., 2004) sug-
gest that the analysis of Dpl-induced neurodegenera-
tion might help to understand the biology and pathol-
ogy of prior proteins (Aguzzi and Polymenidou,
2004). However, the molecular basis of Dpl and PrPc
antagonism still have not been clarified (Hundt and
Weiss, 2004). Dpl and PrPc might compete for a com-
mon but still unknown ligand provisionally termed
LPrP whose binding with Dpl might cause cell death.
Or Dpl and PrPc may have noncompetitive antagonis-
tic functions and Dpl might cause cell death in the ab-
sence of PrPc opposition (Behrens, 2003).
In both cases, according to our present results,
Dpl-induced cell death would include BAX-depend-
ent as well as BAX-independent pathways. Besides
signal transduction and antioxidant activity, PrPc is
neuroprotective like BCL-2 as a potent BAX inhibi-
tor. Although not exactly acting like BCL-2, PrPc
could functionally replace it when BCL-2 decreases
in the aging brain (see review in Roucou et al., 2005).
Interestingly, BAX has been recently shown to medi-
ate neuronal apoptosis of cerebellar granule cells
induced by the 14 octapeptide repeats-containing
Tg(PG14)PrP (Chiesa et al., 2005). The survival of
PCs could be explained by the fact that the transgenic
vector does not drive the expression of the pathogenic
Tg(PG14)PrP in these neurons (Fischer et al., 1996).
On the other hand, BAX-induced apoptosis cannot be
counteracted by PrPc devoid of its N-terminal octa-
peptide repeats, suggesting that this domain, partially
homologous to the BH2 domain of the BCL-2 family
of proteins (Yin et al., 1994; Roucou et al., 2004), is
crucial for the neuroprotective functions of PrPc.
Interestingly, an important function of BCL-2 is to
antagonize the proapoptotic effect of BAX through
direct interaction at this BH2 domain (Oltvai et al.,
1993; Gross et al., 1999; Cheng et al., 2001), which is
lacking in both Dpl and DPrP (Shmerling et al., 1998;
Flechsig et al., 2003) and impaired in Tg(PG14)PrP
(Chiesa et al., 1998). A direct interaction of PrPc with
BAX is however not likely the mechanism by which
PrPc prevents Bax-mediated apoptosis, since cellular
compartmentalization would prevent a direct interac-
tion between PrPc and the BCL-2 family of proteins.
Nevertheless, cytosolic localization of PrPc has been
recently described and could interfere directly with
Bax-mediated death (Ma and Lindquist, 2001; Yedi-
dia et al., 2001; Roucou et al., 2003).
Bax Deletion Rescues NP0/0 Astrocytes
from Activation
In the present study, we observed increased immuno-
labeling for GFAP in the cerebellum of 4-month-old
NP0/0:Baxþ/þ mutants, indicating activation of astro-
cytes which agrees with previous observations (Atar-
ashi et al., 2001). At this age, astrogliosis occurred in
patches with a stripy shape reminiscent of the para-
sagittal compartments delineated by PC clusters in
the cerebellar cortex (Eisenman and Hawkes, 1993;
Bailly et al., 1995). By 10 months and beyond, astro-
gliosis propagated throughout the cerebellar cortex
following a parallel time course with PC loss.
The presence of abnormally high GFAP mRNA
levels, well before PC injury could be detected by the
decrease of IP3R1 mRNA levels in the cerebellar cor-
tex of the NP0/0:Baxþ/þ mouse, has led to the sugges-
tion that in the absence of PrPc, Dpl originating either
from the astrocytes (Atarashi et al., 2001) or from the
neurons (Radovanovic et al., 2005) could actively
induce gliosis in the brain of these mutants. Thus, ei-
ther induced intrinsically by astroglial Dpl or by ec-
topic Dpl expressed on the neuronal surface, glial-
cell activation, together with the loss of PrPc, may in
turn contribute to neurodegeneration. In addition,
microglia are thought to be involved in the etiology
of various neurodegenerative conditions. They are
known to be activated in the CNS of NP0/0:Baxþ/þ
mice and they may play a role in PC death (Atarashi
et al., 2001).
As an alternative to the glial-mediated neuronal
death hypothesis exposed earlier, the recent demon-
stration that astrocytic activation itself was unable to
induce neuronal death in vivo (Mallucci et al., 2003)
makes conceivable that gliosis occurs as a conse-
quence of PC damage in the cerebellum of the NP0/0:
Baxþ/þ mice. This is supported by the topographic
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coincidence of astrogliosis and PC loss evidenced by
the present study. In all cases, regions with gliosis
overlapped PC-free areas whereas regions with nor-
mal GFAP fluorescence of glial cells contained sur-
viving PCs, suggesting that activation of astrocytes
could result from PC degeneration signals. Even in
the cerebellar cortex of the 4-month-old NP0/0:Baxþ/þ
mice where the present global quantitative analysis
could not detect significant PC loss, we showed that
the astrocytic areas contained fewer PCs than regions
with unreactive astroglia. This indicates that neuronal
death and astrocyte activation follow the same tempo-
ral and regional patterns. The activation of astrocytes
was greatly moderated by Bax deletion in the cerebel-
lar cortex of the NP0/0:Bax2/2 mice. Consistent glial
expression of BAX could not be detected in mouse
and human brain (Hara et al., 1996; Shin et al., 2000),
suggesting that Bax deletion indirectly represses
astrocytic activation through a primary effect coun-
teracting Dpl neurotoxicity in PCs. Nevertheless, a
direct antagonistic effect of Bax knock-out in acti-
vated astrocytes cannot be definitely ruled out since
ischemia has been shown to upregulate Bax in astro-
cytes (Imura and Shimohama, 2000; Giffard and
Swanson, 2005). Further investigations to elucidate
the mechanisms of glial cell activation in NP0/0:Baxþ/þ
mice might provide insight into PrPc and Dpl physiol-
ogy as well as pathogenesis of prion diseases.
We thank Laure Rondi-Reig for footprint tests expertise
and Jean-Luc Dupont for immunofluorescence experiments.
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ABSTRACT: The pro-apoptotic factor BAX has
recently been shown to contribute to Purkinje cell (PC)
apoptosis induced by the neurotoxic prion-like protein
Doppel (Dpl) in the prion-protein-deficient Ngsk Prnp0/0
(NP0/0) mouse. In view of cellular prion protein (PrPc)
ability to counteract Dpl neurotoxicity and favor neuro-
nal survival like BCL-2, we investigated the effects of
the anti-apoptotic factor BCL-2 on Dpl neurotoxicity by
studying the progression of PC death in aging NP0/0-Hu-
bcl-2 double mutant mice overexpressing human BCL-2
(Hu-bcl-2). Quantitative analysis showed that signifi-
cantly more PCs survived in NP0/0-Hu-bcl-2 double
mutants compared with the NP0/0 mutants. However,
number of PCs remained inferior to wild-type levels and
to the increased number of PCs observed in Hu-bcl-2
mutants. In the NP0/0 mutants, Dpl-induced PC death
Correspondence to: S. Heitz (heitz@neurochem.u-strasbg.fr).
Contract grant sponsor: G.I.S. Maladies a` Prions.
Contract grant sponsor: National Institute of Health; contract
grant number: NS34309.
Contract grant sponsor: Neurex Network.
' 2007 Wiley Periodicals, Inc.
Published online 17 December 2007 in Wiley InterScience (www.
interscience.wiley.com).
DOI 10.1002/dneu.20555
332
occurred preferentially in the aldolase C-negative para-
sagittal compartments of the cerebellar cortex. Activa-
tion of glial cells exclusively in these compartments,
which was abolished by the expression of Hu-bcl-2 in the
double mutants, suggested that chronic inflammation is
an indirect consequence of Dpl-induced PC death. This
partial rescue of NP0/0 PCs by Hu-bcl-2 expression was
similar to that observed in NP0/0:Bax/ double mutants
with bax deletion. Taken together, these data strongly
support the involvement of BCL-2 family-dependent ap-
optotic pathways in Dpl neurotoxicity. The capacity of
BCL-2 to compensate PrPc deficiency by rescuing PCs
from Dpl-induced death suggests that the BCL-2-like
property of PrPc may impair Dpl-like neurotoxic path-
ways in wild-type neurons. ' 2007 Wiley Periodicals, Inc.
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INTRODUCTION
Doppel (Dpl) is the first identified homolog of the cel-
lular prion protein, PrPc, which is implicated in the
pathogenesis of transmissible spongiform encephalo-
pathies (TSE) (Prusiner, 1998). Dpl is an N-truncated
form of PrPc with common structural features and
function roles in cellular trafficking pathways (Weiss-
mann and Aguzzi, 1999; Silverman et al., 2000;
Flechsig et al., 2003; Qin et al., 2003; Massimino
et al., 2004). Targeted disruptions of the PrPc coding
gene (Prnp) that extend into the upstream region of
intron 2 result in cis-activation of the Dpl gene
(Prnd). Ectopic Dpl neuronal expression in Prnp0/0
mouse lines such as Ngsk (Sakaguchi et al., 1996),
Rcm0 (Moore et al., 1995), ZH-II (Rossi et al., 2001),
and Rikn (Yokoyama et al., 2001) causes late onset
Purkinje cell (PC) degeneration and ataxia. Dpl
shares 25% identity with PrPc, but lacks its flexible
N-terminal sequence. Expression of the N-terminal
truncated form of PrP (DPrP) in Prnp-ablated mouse
lines (Flechsig et al., 2003) causes neurodegenerative
effects in PCs similar to the overexpression of Dpl
(Anderson et al., 2004; Yamaguchi et al., 2004), and
the neurotoxic effects of Dpl and DPrP are both
antagonized by PrPc (Nishida et al., 1999; Cui et al.,
2003; Flechsig et al., 2003; Anderson et al., 2004;
Yamaguchi et al., 2004). These results suggest that
Dpl and DPrP may cause cell death by the same
mechanism, perhaps by interfering with a cellular sig-
naling pathway essential for cell survival and nor-
mally controlled by full-length PrPc (Shmerling et al.,
1998; Anderson et al., 2004).
To date, only a few studies have investigated the
mechanism by which Dpl kills neurons. PrP-deficient
cells have been shown to undergo Dpl-induced apo-
ptosis in a dose-dependent, cell autonomous manner
(Sakudo et al., 2005). Furthermore, oxidative stress
may play a role in the death of neurons because NOS
activity is induced by Dpl both in vitro and in vivo
(Wong et al., 2001; Cui et al., 2003). In addition, an
activation of glial cells is associated with ectopic
expression of Dpl in Ngsk Prnp0/0 (NP0/0) mice
(Atarashi et al., 2001).
PrPc itself has recently been shown to have neuro-
protective function. PrPc, either expressed endoge-
nously or applied exogenously, inhibited Dpl-induced
apoptosis (Cui et al., 2003) and introduction of a
Prnp transgene rescued the NP0/0 phenotype (i.e. PC
degeneration and ataxia, Sakaguchi et al., 1996; Nish-
ida et al., 1999). Quantitative analysis of the PC pop-
ulation in the cerebellum of the NP0/0:Bax/ double
mutant mice significantly improved PC survival,
demonstrating the contribution of the pro-apoptotic
factor BAX to Dpl neurotoxicity (Heitz et al., 2007).
Interestingly, overexpression of the bcl-2 gene can
also rescue PrP-deprived hippocampal cell lines from
serum deprivation-induced apoptosis (Kuwahara
et al., 1999). PrPc also binds to BCL-2 in the yeast
two-hybrid system (Kurschner and Morgan, 1995)
and both PrPc and BCL-2 protect yeast (Li and Har-
ris, 2005) and neurons (Bounhar et al., 2001; Roucou
et al., 2003) from BAX-induced apoptosis suggesting
that the BAX-dependent component of Dpl neurotox-
icity could be antagonized by PrPc as well as BCL-2.
Here, we investigate the mechanism underlying
Dpl-induced apoptosis and PrPc neuroprotective prop-
erties. The ability of exogenous BCL-2 overexpres-
sion to antagonize Dpl neurotoxicity was tested in
NP0/0-Hu-bcl-2 double mutant mice obtained by
crossing NP0/0 mice with NSE73a Hu-bcl-2 mice
(Martinou et al., 1994). The survival of cerebellar PCs
was analyzed in these mice during adulthood (i.e. 4–
24 months) including the period of PC death in NP0/0
mice (i.e. 4–16 months). In parallel, the activation of
astrocytes in the cerebellar cortex of the NP0/0-Hu-
bcl-2 double mutant mice was analyzed by immuno-
histochemistry in order to determine if Hu-bcl-2 over-
expression affected astrogliosis induced by the NP0/0
condition (Atarashi et al., 2001; Heitz et al., 2007).
MATERIALS AND METHODS
Animals and Genotyping
As previously reported, Hu-bcl-2 mice from the NSE73a
strain were generated by injecting embryos with the EB-2
BCL-2 in Doppel-Induced Purkinje Cell Death 333
Developmental Neurobiology. DOI 10.1002/dneu
construct in the cloning vector pSK+ containing the human
BCL-2 coding region (Tsujimito and Croce, 1986; Martinou
et al., 1994). Further breeding strategies were designed tak-
ing in account that Hu-bcl-2 females are sterile. Hu-bcl-2
detection by Southern blot was achieved using a BamH1-
Pst1 253 bp probe (Martinou et al., 1994). NP0/0 mice were
generated by deleting the entire open reading frame (ORF)
of the Prnp gene, located in exon 3, as well as 50 and 30
non-coding flanking regions (Sakaguchi et al., 1995). The
deleted sequences were replaced by a Neo cassette. The
Prnp ORF was identified using the following primers: for-
ward 50-CCGCTACCCTAACCAAGTGT-30 and reverse
50-CCTAGACCACGAGAATGCGA-30, both located with-
in Prnp ORF. NP0/0 mutants were identified using the
following primers: forward 50-TGCCGCACTTCTTTG
TGAAT-30 and reverse 50-CGGTGGATGTGGAATGTGT-30
(within Neo cassette).
For this study, founding mice were first backcrossed
with C57BL/6 mice for at least 10 generations. NP0/0
females (gift from S. Katamine) were then crossed with
Hu-bcl-2 males and offspring were identified using the
aforementioned probes and primer sets. NP+/0-Hu-bcl-2
males were further crossed with NP0/0 females to generate
NP0/0-Hu-bcl-2 offspring. Mice were bred at the animal fa-
cility of the IFR37 de Neurosciences in Strasbourg and
maintained according to the NIH guidelines (NIH Publica-
tion 80-23, revised 1996) and the European Communities
Council Directive of November 24, 1986 (86/609/EEC). A
minimal number of animals were used (Table 1) and
handled with maximum care to minimize their suffering.
Footprint Analysis
All mice used in this study were submitted for footprint
analysis. Ink was applied to the fore (green) and hind (red)
paws of individual mice. Mice were induced to walk for-
ward on a white paper in a dark narrow alley. Ataxic gait
was detected when the line linking the middle of the step
Table 1 Age and Number of Mutants and Normal Mice, Mean Area and Long Diameter 6 SD of Purkinje Cell Nuclei
and Mean Number 6 SD of Purkinje Cells Counted in Groups of Age- and Genotype-Matched Mice
Genotype
Age in
Months
Number of
Mice
Mean Area of
PC Nuclei (lm2)
Mean Long Diameter
of PC Nuclei (lm)
Mean Number
of PCs
Wild-Type 6 3 Not done Not done 142,7286 3356
12 3 93.52 6 7.41 12.936 0.73 135,5546 6760
16 3 Not done Not done 145,2716 6657
18 3 96.26 6 6.24 13.086 0.47 147,8846 9094
21 3 77.56 6 13.32 11.866 1.06 143,3036 8905
Hu-bcl-2 6 3 Not done Not done 202,7206 6508
12 3 105.63 6 0.43 13.626 0.01 170,7906 6722
16 3 Not done Not done 158,2286 7895
21 3 97.45 6 13.2 13.26 0.35 157,8236 14745
NP0/0 4 3 85.92 6 8.82 12.946 0.07 145,0146 10,472
6 3 Not done Not done 112,9186 8419
10 3 Not done Not done 79,8366 1853
12 3 93.47 6 11.58 13.206 0.88 61,2366 671
16 3 Not done Not done 48,7886 763
18 3 100.69 6 5.32 13.756 0.21 40940 6 1695
21 3 76.91 6 10.5 12.486 0.32 36757 6 3464
NP0/0-Hu-bcl-2 4 3 92.11 6 6.85 13.016 0.32 159,7376 12,424
10 3 Not done Not done 97,4166 24,930
12 3 90.81 6 3.7 12.756 0.44 86,7496 3269
16 3 Not done Not done 62,5856 608
18 3 86.13 6 5.73 12.356 0.36 70,5726 11,701
21 3 81.8 6 5.91 12.076 0.51 64,4946 2035
24 3 Not done Not done 68,4816 1158
In brief, the PC nuclei profiles were counted along the entire length of the PC layer in each section. PCs were identified as neurons in the PC
layer with a large soma and some portion of their nuclei in the plane of the section (black arrowheads in Fig. 1 C, F, I, L). The total number of
PCs was estimated by graphing the number of visible PC nuclei per section as a function of the distance of each section from the midline and
then integrating the area under the polygon to calculate the raw total. The raw total was adjusted for double counting errors using the Hendry
correction (Hendry, 1976) because it was specifically designed to account for experimental changes in the size of the cells being counted. The
Hendry correction factor was calculated in each cerebellum from measurements of the nuclear profile area and long diameter of over 300 PCs
using ImageJ. We chose to use this classical correction factor for our cell counts, instead of more recently developed stereological techniques,
since the profile counting method provides data on the transversal distribution of PCs. None of the nuclear profile area and long diameter mea-
surements varied significantly between age-matched groups of different genotypes and between groups of the same genotype at different ages.
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width (left-right distance) of the hind paws swerved from
the straight line gait of the non-ataxic animal.
Histology
All mice (Table 1) were anaesthetized with sodium pento-
barbital (0.15 mL/100 g i.p., Sanofi), after which brains
were dissected and immersed overnight in Carnoy’s fixative
(60% ethanol, 30% chloroform, 10% acetic acid). Brains
were dehydrated, embedded in paraffin, and sectioned in
the sagittal plane at 10 lm.
Size of the Cerebellar Vermis
The size of the cerebellar vermis was estimated by meas-
uring the mean area of 7 sagittal cresyl violet-stained sec-
tions (Image J) separated from each other by 400 lm (total
sampling distance 2470 lm) in the 12-, 18-, and 21-month-
old wild-type, NP0/0, NP0/0-Hu-bcl-2, and Hu-bcl-2 mice
(n ¼ 3/genotype).
Cell Counts
The PC population was quantified in all mice aged 4–24
months (Table 1). The cresyl violet-stained PCs were
counted in 10 lm-thin paraffin sections using a 363 objec-
tive (final magnification 3630) in every 40th sagittal sec-
tion (from a random start) through the entire cerebellum as
described previously (Wetts and Herrup, 1982; Herrup and
Sunter, 1986; Zanjani et al., 2004; Heitz et al, 2007 and
Table 1). In brief, the PC nuclei profiles were counted along
the entire length of the PC layer in each section. PCs were
identified as neurons in the PC layer with a large soma and
some portion of their nuclei in the plane of the section
[white arrowheads in Fig. 1(C,F,I,L)]. The total number of
PCs was estimated by graphing the number of visible PC
nuclei per section as a function of the distance of each sec-
tion from the midline and then integrating the area under
the polygon to calculate the raw total. The raw total was
adjusted for double counting errors using the Hendry cor-
rection (Hendry, 1976) because it was specifically designed
to account for experimental changes in the size of the cells
being counted (Zanjani et al., 2004). The Hendry correction
factor was calculated in each cerebellum from measure-
ments of the nuclear profile area and long diameter of over
300 PCs using Image J. We chose to use this classical cor-
rection factor for our cell counts instead of more recently
developed stereological techniques since the profile count-
ing method provides data on the transversal distribution of
PCs. None of the nuclear profile area and long diameter
measurements varied significantly between age-matched
groups of different genotypes and between groups of the
same genotype at different ages (Table 1). The ratio of ante-
rior (lobules I–V) to posterior (lobules VI–X) Purkinje cell
numbers in corresponding sagittal levels (two levels/hemi-
sphere and seven vermal levels) was calculated in order to
compare the rostro-caudal distribution of PC survival in
age-matched NP0/0-Hu-bcl-2 double mutants versus NP0/0
mutants (Fig. 4A). The lateral distribution of PC survival
was estimated in age-matched NP0/0 mutants versus NP0/0-
Hu-bcl-2 double mutants by comparing Purkinje cell num-
bers between corresponding sagittal levels (two levels/
hemisphere and seven vermal levels). To investigate a pos-
sible link between Dpl neurotoxicity and the aldolase C-
specific parasagittal compartmentation of the PC population
(Hawkes and Leclerc, 1987), we compared the PC loss esti-
mated in the aldolase C-positive and -negative compart-
ments of the wild-type and NP0/0 cerebellar cortex. This
was achieved in one of three transverse cerebellar cryostat
sections cut at seven levels along the rostro-caudal dimen-
sion of the cerebellum (Eisenman and Hawkes, 1993) and
double stained for aldolase C and cresyl violet.
All the PC counts were performed by the same person
(S.H.) with the genetic identity of the animals masked.
Statistics
Data are given as mean values 6 standard deviation (SD).
Statistical comparisons of group means (cerebellar size, PC
number, PC number anterior/posterior ratio, PC nuclear
area and long diameter, n ¼ 3 mice per group) were per-
formed with Minitab 13.20. Depending on context, either
two-way ANOVA (factors ‘‘genotype,’’ ‘‘aldolase C expres-
sion,’’ ‘‘age’’ and within factors ‘‘brain region,’’ ‘‘parasagit-
tal levels’’ and ‘‘Aldolase C compartments’’) or one-way
ANOVA (factor ‘‘genotype,’’ factor ‘‘age’’) was used, fol-
lowed by post hoc Tukey test for multiple comparisons
when justified. Missing values in the experimental design
precluded a global statistical analysis comparing the four
genotypes at all ages. The significance threshold was set at
p ¼ 0.05. Aldolase positive/negative PC number ratios
between 12-month-old wild-type and NP0/0 mice were com-
pared with Student’s test (p < 0.05).
Immunohistochemistry
Immunoperoxidase Detection of GFAP. Brain sections of
18-month-old wild-type, NP0/0, NP0/0-Hu-bcl-2, and Hu-
bcl-2 mice were deparaffinized in toluene and rehydrated in
decreasing concentrations of ethanol. The sections were
incubated in 1% H2O2 in 0.1 M phosphate buffer saline
(PBS) for 20 min. After rinsing in PBS, the sections were
pre-incubated for 45 min in blocking solution made of
0.5% Triton X-100, 3% normal horse serum (NHS) in PBS
(PBST). The sections were then incubated overnight at 48C
in PBST containing 0.3% NHS and mouse monoclonal anti-
body against GFAP (Sigma) diluted 1/500. The sections
were then rinsed in PBS (2x, 10 min) and incubated with bi-
otinylated horse anti-mouse immunoglobulins (Vector
Labs). The GFAP-bound biotinylated horse anti-mouse
immunoglobulins were visualized using the ABC method
(Hsu et al., 1981) with 3, 30-diamino-benzidine tetra-hydro-
chloride (Fast-DAB, Sigma) as the chromogen. Stained sec-
tions were rinsed in PBS, dehydrated in graded ethanol and
toluene and mounted with Eukitt. The sections were exam-
ined with a light microscope equipped with differential in-
BCL-2 in Doppel-Induced Purkinje Cell Death 335
Developmental Neurobiology. DOI 10.1002/dneu
terference contrast illumination (Axioskop-II, Zeiss, Jena,
Germany).
Immunofluorescent Detection of CaBP. Brain sections of
18-month-old wild-type, NP0/0, NP0/0-Hu-bcl-2, and Hu-
bcl-2 mice were deparaffinized in toluene and rehydrated in
decreasing concentrations of ethanol before rinsing in PBS
and pre-incubating for 45 min in blocking solution made of
0.5% Triton X-100 and 3% normal goat serum (NGS) in
PBS (PBST). The sections were then incubated overnight at
Figure 1 Histology of the cerebellum of the 18-month-old wild-type (A,B,C), Hu-bcl-2 (D,E,F),
NP0/0 (G,H,I), and NP0/0-Hu-bcl-2 (J,K,L) mice. Cresyl violet-stained sagittal sections in the me-
dian vermis (A,C,D,F,G,I,J,L) and immunofluorescence staining for CaBP (B,E,H,K). A,D,G,J: The
cerebellum appears smaller in the NP0/0 and the NP0/0-Hu-bcl-2 than in the wild-type and Hu-bcl-2
genotypes. B–L: The Purkinje cells (white arrowheads) form a dense monolayer between the mo-
lecular (ML) and the internal granular (IGL) layers in the wild-type (B) and Hu-bcl-2 (E) cerebellar
cortex. Purkinje cell loss is moderate in the NP0/0-Hu-bcl-2 cerebellar cortex (K) and almost com-
plete in the NP0/0 (H) cerebellar cortex. In all genotypes, Purkinje cells display a normal aspect and
location between ML and IGL (C,F,I,L). Black arrowheads point to nuclei of presumptive astro-
cytes the number of which is increased around Purkinje cell soma in the NP0/0 (I) and NP0/0-Hu-
bcl-2 (L) mice. A,D,G,J:317; bar, 1 mm; B,E,H,K:3200; bar, 50 lm. C, F,I,L:3630; bar, 20 lm.
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48C in PBST containing 0.3% NGS and mouse monoclonal
antibody against CaBP (Sigma) diluted 1/500. The next
day, sections were rinsed in PBS (2x, 10 min) and then
incubated with secondary antibody: green fluorescent Alexa
488 goat anti-mouse immunoglobulins (Molecular Probes)
diluted 1/500 in PBS containing 0.3% NGS. After rinsing
in PBS, the sections were mounted in Mowiol before exam-
ination with a fluorescence microscope (Axioskop-II, Zeiss,
Jena, Germany).
Immunoperoxidase Detection of Hu-bcl-2. Brain sections
of 12-month-old NP0/0-Hu-bcl-2, and Hu-bcl-2 mice were
deparaffinized in toluene and rehydrated in decreasing con-
centrations of ethanol. The sections were post-fixed in para-
formaldehyde 4% in 0.1 M phosphate buffer (PB) for 20
min. An antigene unmasking treatment was applied by heat-
ing the sections in 10 mM citrate buffer pH 6 in a 750 W
microwave for 15 min. After 30 min cooling and rinsing in
PBS, the sections were pre-incubated for 1 h in a blocking
solution made of 10% NHS in PBST before incubation
overnight at 48C in PBST containing 2% NHS and Hu-bcl-
2-specific mouse monoclonal antibody (1/50, BD Bioscien-
ces). Immunoperoxidase staining was then processed
according to the ABC method described above for GFAP
(Vectastain ABC staining kit, Vector Labs). In order to
detect differences of PC immunostaining intensity between
the mutants, the sections were incubated together in the
same solutions throughout the whole immunohistochemical
procedure.
Immunoperoxidase Detection of Aldolase C. Frozen trans-
verse brain sections of paraformaldehyde-perfused 12-
month-old wild-type (n ¼ 3) and NP0/0 (n ¼ 3) mice were
rinsed in PBS and then processed for aldolase C immuno-
peroxidase staining as described by Sugihara and Shinoda
(2004) using anti-aldolase C rabbit polyclonal antibodies
(160 ng/mL) followed by ABC immunoperoxidase staining.
The sections were counter-stained with cresyl violet and
mounted as described above.
Double Immunofluorescent Detection of Aldolase C and
GFAP. Paraffin transverse brain sections of paraformalde-
hyde-perfused 6-month-old NP0/0 mice were rehydrated as
described above and pre-incubating for 45 min in blocking
solution made of 0.25% Triton X-100 and 3% NGS in PBS.
The sections were then incubated overnight at 48C in PBST
containing 0.3% NGS, anti-aldolase C rabbit polyclonal
antibodies (160 ng/mL) and anti-GFAP mouse monoclonal
antibody diluted 1/500. The next day, sections were rinsed
in PBS (2x, 10 min) and then incubated with secondary
antibody: green fluorescent Alexa 488 goat anti-rabbit and
red fluorescent Alexa 546 goat anti-mouse immunoglobu-
lins (Molecular Probes) diluted 1/500 in PBS containing
0.3% NGS. After rinsing in PBS, the sections were mounted
in Mowiol before examination.
Negative controls of all immunohistochemical reactions
were performed by omitting either the primary or the sec-
ondary antibodies in the staining protocols.
Digital Images
Digital micrographs were stored using Zeiss Axiovision
software. Photoshop 7.0 was used for final adjustments of
contrast and brightness.
RESULTS
Hu-bcl-2 Overexpression Rescues NP0/0
PCs from Doppel Neurotoxicity
Hu-bcl-2 Overexpression Cannot Rescue Ataxia
and Cerebellar Atrophy in NP0/0 Mice. The abnor-
mal cerebral expression of Dpl has been shown to be
responsible for the premature death of PCs in the
PrP-deficient mice of the Ngsk line (Moore et al.,
2001; Anderson et al., 2004). Interestingly, whereas
PrPc displays neuroprotective BCL-2-like properties,
the PC degeneration phenotype can be partially res-
cued either by introduction of a Prnp transgene
(Rossi et al., 2001; Yamaguchi et al., 2004) or by
knocking-out the pro-apoptotic Bax gene (Heitz et
al., 2007) in NP0/0 mice. To determine whether the
anti-apoptotic factor BCL-2 is able to substitute for
the protective effects of PrPc, we analyzed selected
features of the motor behavior and cerebellar anat-
omy of NP0/0-Hu-bcl-2 double mutants and controls
through the period of cerebellar degeneration in NP0/
0 mutants. All pups developed normally up to the
12th postnatal month when NP0/0 mutants and double
mutants began to exhibit motor impairment character-
istic of the NP0/0 condition as shown by hind foot-
print analysis (a trembling of the hindquarters on ini-
tiation of movement and during walking; Sakaguchi
et al., 1996). No difference was observed in the tim-
ing of the onset of ataxia between NP0/0-Hu-bcl-2,
and NP0/0 mutants (data not shown). The folial pat-
tern and cytoarchitecture of the cerebellum of the Hu-
bcl-2, NP0/0, and NP0/0-Hu-bcl-2 mutants were nor-
mal compared with that of wild-type mice at all ages
studied (Fig. 1). There were no obvious differences
between the wild-type and Hu-bcl-2 mice in the over-
all size of the cerebella (Fig. 2) or in the histological
aspect of the molecular and internal granular layers
[Fig. 1(B,E)]. The size of the cerebellar vermis was
significantly reduced in the 18 (data not shown) and
21 (Fig. 2) month-old NP0/0 mice. Finally, the cere-
bellar vermis of the NP0/0-Hu-bcl-2 double mutants
was larger than the cerebellar vermis of the NP0/0
mutants at 18 and 21 months, although for the sample
size this difference was not significant. In all mutants,
PCs were distributed normally at the interface
between the molecular and the internal granular
layers [Fig. 1(E,F,H,I,K,L)], and they were indistin-
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guishable from wild-type PCs [Fig. 1(B,C)]. How-
ever, the PC monolayer appeared to contain fewer
neurons in the NP0/0 [Fig. 1(H)] and NP0/0-Hu-bcl-2
mice [Fig. 1(K)] than in the wild-type [Fig. 1(B)] and
Hu-bcl-2 [Fig. 1(E)] mice.
Overexpression of Hu-bcl-2 Partially Protects PCs
from Doppel-Induced Apoptosis. The apoptotic
mechanism triggered by Dpl in the PrP-deprived PCs
was investigated by comparing the total number of
PCs between NP0/0-Hu-bcl-2, NP0/0, Hu-bcl-2, and
wild-type mice (Table 1, Fig. 3).
When comparing NP0/0-Hu-bcl-2 and NP0/0, a
two-way ANOVA test showed that a significant
decrease of the PC number occurred between 4 and
21 months in both mutants (effect of age: F5,24
¼ 109.02, p < 0.001; Fig. 3). Thus, some PC loss still
occurred in the NP0/0-Hu-bcl-2 double mutant in spite
of Hu-bcl-2 overexpression. However, the PC number
was always higher in NP0/0-Hu-bcl-2 double mutant
than in NP0/0 mutant (effect of genotype: F1,24
¼ 58.99, p < 0.001; Fig. 3). This difference did not
change significantly with time (interaction term: F5,24
¼ 1.60, p ¼ 0.2). However, in relative terms, the cer-
ebellum of the 12-month-old NP0/0-Hu-bcl-2 double
mutants contained 41% more PCs than that of the
NP0/0 mutants at the same age, and the ratio increased
with age up to 80% at 21–24 months, suggesting that
Hu-bcl-2 overexpression protects some PCs from
Dpl-mediated toxicity. Nevertheless by 21 months,
the number of surviving PCs in NP0/0 mutants was
25.6% of wild-type compared with 45% in the NP0/0-
Hu-bcl-2 double mutants indicating that overexpres-
sion of Hu-bcl-2 rescued 20% of the wild-type num-
ber of PCs.
Spatial Extent of Neuroprotection Mediated by Hu-
bcl-2 Overexpression. This loss of PCs in NP0/0 and
NP0/0-Hu-bcl-2 mutants compared with wild-type
mice was also analyzed with two-way repeated meas-
ures ANOVA (taking into account a between-subject
factor ‘‘genotype’’ and a within-subject factor ‘‘brain
region’’). The results showed a significant rostro-cau-
dal difference that, in absolute terms, was similar in
the three groups at 12 months (data not shown) and
at 18 months [Fig. 4(B); factor genotype: F2,12
¼ 127.36, p < 0.001; factor region: F1,12 ¼ 136.74,
p < 0.001; interaction term: F2,12 ¼ 2.81, p ¼ 0.1]. In
addition, calculation of the anterior/posterior ratio for
each mouse indicated a significantly lower ratio in
the NP0/0 mice than in wild-type, at 12 (data not
shown; F2,6 ¼ 8.5, P < 0.05) and at 18 months [Fig.
4(C); F2,6 ¼ 8.26, p < 0.05]. This reveals that the an-
terior (I–V) cerebellar lobules lost relatively more
PCs than the posterior (VI–X) ones [Fig. 4(A)]. The
anterior/posterior PC number ratios of NP0/0 and NP0/0
-Hu-bcl-2 were not significantly different at 12 and
18 months, suggesting that Hu-bcl-2 overexpression
rescued PCs evenly throughout the rostro-caudal axis
of the cerebellum.
Significant PC loss occurred at each parasagittal
level in the NP0/0 cerebellum at all ages studied [Fig.
5(A)]. However, normalizing the values of PC num-
bers at the different parasagittal levels counted in the
cerebellar vermis and hemispheres of the 12, 16, and
18 [Fig. 5(B)] month-old NP0/0 and wild-type mice
did not disclose any significant differences in PC loss
Figure 2 At 12 months of age, all genotypes have the
same cerebellar size, estimated by the mean area of 7 sagit-
tal sections in the vermis (one-way ANOVA; F3,8 ¼ 3.66,
p > 0.05). The 21-month-old NP0/0 and NP0/0-Hu-bcl-2
mice have a significantly smaller cerebellum than the wild-
type and HuBcl-2 (F3,8 ¼ 28.24, p < 0.001). The cerebellar
sizes of the NP0/0 and the NP0/0-Hu-bcl-2 mice are not sig-
nificantly different.
Figure 3 Time course of Purkinje cells mean numbers in
the cerebellum of wild-type and different mutant mice dur-
ing adulthood and aging.
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along the transversal dimension of the NP0/0 cerebel-
lum (Heitz et al., 2007). A significant PC rescue oc-
curred at each parasagittal level in the NP0/0-Hu-bcl-2
cerebellum at all ages studied [Fig. 5(A)]. However,
normalizing the values of PC numbers at the different
parasagittal levels counted in the cerebellar vermis
and hemispheres of the 12, 16, and 18 [Fig. 5(B)]
month-old NP0/0 and NP0/0-Hu-bcl-2 mice did not
disclose significant differences in relative PC rescue
along the transversal dimension of the NP0/0-Hu-bcl-
2 cerebellum.
To determine a possible link between Dpl neuro-
toxicity and parasagittal compartmentation of the PC
population in the cerebellar cortex, the transversal
distribution pattern of PC loss was further investi-
gated by comparing aldolase C-positive versus aldol-
ase C-negative PC numbers [Fig. 6(A,B)] through-
out the cerebellum of 12-month-old wild-type and
Figure 4 Purkinje cell numbers in the cortex of the ante-
rior (lobules I–V) and posterior (lobules VI–X) cerebellum
of the 18-month-old wild-type, NP0/0 and NP0/0-Hu-bcl-2
mice. Mean numbers from three mice per genotype were
estimated in sagittal cerebellar sections separated from each
other by 400 lm (two sections in the right and in the left
hemispheres and seven sections in the vermis). A: Sagittal
section through the median line in the cerebellar vermis
showing the 10 lobules and the fissura prima (fp) separating
the anterior cerebellum from the posterior cerebellum
between lobule V and lobule VI. B: The posterior (black)
cerebellar cortex contains many more PCs than the anterior
(white) cerebellar cortex in all genotypes. C: Significantly
different wild-type and NP0/0 anterior/posterior PC numbers
ratios show a greater PC loss in the anterior NP0/0 cerebel-
lum. The anterior/posterior PC numbers ratios in the NP0/0
and NP0/0-Hu-bcl-2 cerebella are not significantly different
indicating that Hu-bcl-2 overexpression rescues PC evenly
along the rostro-caudal dimension of the cerebellum.
Figure 5 A: At any of the 11 parasagittal levels analyzed
in the cerebellar vermis (V) and left (LH) and right (RH)
hemispheres PC numbers are significantly different in the
18-month-old wild-type (n), NP0/0-Hu-bcl-2 (~) and NP0/0
(&) mice (factor genotype: F2,66 ¼ 484.52, p < 0.001; fac-
tor parasagittal level: F10,66 ¼ 16.02, p < 0.001; interaction
term: F20,66 ¼ 2.97, p < 0.001). B: In the cerebellum of the
18-month-old wild-type (n), NP0/0-Hu-bcl-2 (~), and
NP0/0 (&) mice, PC number values at parasagittal levels of
the vermis and hemispheres were normalized to the mean
value of PC numbers (n ¼ 3) at the sagittal level. No signif-
icant differences between genotypes were found at any
level analyzed (factor genotype: F2,66 ¼ 2.96, p ¼ 0.06;
factor parasagittal level: F10,66 ¼ 15.34, p < 0.001; effect
of interaction: F20,66 ¼ 1.64, p ¼ 0.07).
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12- and 18-month-old NP0/0 mice. Two-way repeated
measures ANOVA with factors ‘‘group’’ (between;
F2,12 ¼ 72.6, p < 0.001) and ‘‘aldolase C expression’’
(within; F1,12¼ 62.6, p < 0.001) showed a significant
effect of both factors [Fig. 6(C)]. Doppel-induced PC
loss occurred in both aldolase C-positive and -nega-
tive PC subpopulations but the proportion of aldolase
C-negative PCs decreased from 41.4% in wild-type
to 36.5% in 12-month-old NP0/0 and 12.7% in 18-
month-old NP0/0. This indicated that relatively more
aldolase C-negative PCs were lost from 12 to 18
months in the NP0/0 cerebellum.
To further investigate the heterogeneity of this dif-
ferential PC loss, we focused PC quantitative analysis
to the cerebellar vermis where aldolase C compart-
mentation is best delineated [Fig. 6(D); Sugihara and
Quy, 2007]. Two-way repeated measures ANOVA
with factors ‘‘group’’ (between; F2,48 ¼ 62.4, p
< 0.001) and ‘‘aldolase C compartment’’ (within;
F7,48¼ 15.5, p < 0.001) confirmed that PC loss
increased with age in aldolase C-negative compart-
ments. The loss of aldolase C-positive PCs described
in Figure 6(C) was found in the 1+ compartment, but
not in other aldolase C-positive compartments.
In the NP0/0 cerebellar cortex, GFAP immunohis-
tofluorescent patches of PC death-related astrogliosis
appeared exclusively in the aldolase C-negative com-
partments as early as 6 months in agreement with a
stronger neurotoxic effect of Dpl in these compart-
ments (Fig. 7). An alternative hypothesis is that Hu-
bcl-2 expression levels in the aldolase C-negative
PCs are lower than in the aldolase C-positive PCs.
This is not likely to be the case because Hu-bcl-2
immunohistochemistry did not reveal any variations
in staining intensities of PCs across the transversal
dimension of the cerebellar cortex in either Hu-bcl-2
mutant or NP0/0-Hu-bcl-2 double mutant mice (data
not shown).
Supernumerary PCs of the Hu-bcl-2
Transgenic Mice Die During Aging and
Cannot Account for the Protective
Effect of Hu-bcl-2 Overexpression
on the NP0/0 PCs
Overexpression of Hu-bcl-2 has been previously
shown to increase cerebellar PC numbers by 43% in
6-month-old mice and 25% in 12-month-old mice,
which supports the hypothesis that Hu-BCL-2 is able
to counteract naturally occurring PC death (Martinou
et al., 1994; Zanjani et al., 1996). After comparingHu-
bcl-2 and wild-type mice at 6, 12, 16, and 21 months
with a two-way ANOVA test, significant effects were
measured for genotype (F1,16¼ 82.44, p< 0.001), age
(F3,16 ¼ 9.66, p < 0.01) and their interaction (F3,16
¼ 10.62, p < 0.001). In our 6- and 12-month-old Hu-
bcl-2 mice, the PC population was respectively 42.5%
and 25% larger than that of wild-type mice (Fig. 3)
indicating that the number of supernumerary PCs
decreased during aging. The number of PCs inHu-bcl-
2mutants and wild type mice was not significantly dif-
ferent at 16 months (Fig. 3). The decline in PC num-
bers in Hu-bcl-2 mutants between 6 and 16 months
(Fig. 3) suggests that Hu-bcl-2 overexpression is no
longer sufficient to maintain the survival of the super-
numerary PCs in aging mice. In contrast, this was not
the case in the NP0/0-Hu-bcl-2 double mutant, possibly
due to an upregulation of Hu-bcl-2 expression in the
NP0/0 condition which permitted supernumerary PCs
to survive longer than in the Hu-bcl-2 mutant. Never-
theless, similarities in the intensity of Hu-bcl-2 immu-
noperoxidase staining of PCs in the cerebellar cortex
of both the Hu-bcl-2 mutant and the NP0/0-Hu-bcl-2
double mutant mice (data not shown) do not support
this hypothesis.
One possible explanation for the rescue of PCs in
the NP0/0-Hu-bcl-2 double mutants is that it is simply
due to the presence of supernumerary Hu-bcl-2 PCs
rescued from developmental cell death. Global two-
way ANOVA on the four genotypes at 12, 16, and 21
months confirmed the significant effects of genotype
(F3,24 ¼ 523.01, p < 0.001), age (F2,24 ¼ 8.62, p
< 0.001) and their interaction (F6,24 ¼ 6.22, p
< 0.001). However, in comparison to wild-type mice,
the significantly higher increase in PCs in the cerebel-
lum of the NP0/0-Hu-bcl-2 double mutant relative to
the Hu-bcl-2 mutant (42% vs. 25%, Fig. 3), is in con-
tradiction with this explanation. Finally, between 16
and 21 months, when the Hu-bcl-2 cerebellum con-
tains similar numbers of PCs as wild-type mice, the
NP0/0-Hu-bcl-2 double mutant contains significantly
more PCs than the NP0/0 mutants at 16 months (28%,
p < 0.01), 18 months (57%) and 21 months (80%,
p < 0.01) (Fig. 3) suggesting that the survival of these
cells results from a specific rescue effect of Hu-bcl-2
overexpression.
Hu-bcl-2 Overexpression Prevents
Abnormal Activation of NP0/0
Astrocytes
Glial cells (including astrocytes) become activated in
the cerebellar cortex of the NP0/0 mutants as early as
the third postnatal week as shown by increased GFAP
and lysozyme M (LM) mRNA levels and by intense
GFAP immunohistochemical staining of astrocytes at
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the 20th month (Atarashi et al., 2001). In a recent
GFAP immunohistochemical study, the cerebellar
cortex of the 4-month-old NP0/0 mice has been shown
to display activation of astrocytes in restricted areas
of the molecular and internal granular layers (Heitz
et al., 2007). Correlation of astrogliosis and PC death
kinetics was strongly suggested by the fact that these
areas contained fewer PCs than areas with normal
GFAP immunoreactivity and by the progressive
extension of astrogliosis throughout the cerebellar
cortex during aging. The systematic overlapping of
astrogliosis and PC loss in the cerebellar cortex of the
Figure 6 (See legend on following page)
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NP0/0 mice further strengthened gliosis as a conse-
quence of PC loss (Heitz et al., 2007).
In the present study, astrogliosis occurred mostly
in the aldolase C-negative compartments of the NP0/
0 cerebellar cortex as soon as 4 months, but it could
not be detected in the cerebellar cortex of the Hu-
bcl-2 mice at any of the ages studied [Fig. 8(A,B)]
indicating that Hu-bcl-2 overexpression itself has no
effect on astrocytes. In the cerebellar cortex of the
21-month-old NP0/0-Hu-bcl-2 double mutant mice
[Fig. 8(D)], GFAP immunohistochemistry revealed
a much less intense, patchy astrogliosis than in age-
matched NP0/0mice [Fig. 8(C)]. This indicated that
Hu-bcl-2 overexpression can prevent the activation
of astrocytes in the presence of ectopic Dpl in NP0/0
mutants.
Figure 7 A: PC-deficient area (black arrowheads) between surviving PCs (white arrowheads) in
the cerebellar cortex of the 6-month-old NP0/0 mouse. ML, molecular layer; IGL internal granular
layer. Cresyl violet staining. Bar, 50 lm. B: Aldolase-C immunohistofluorescence shows immuno-
positive PCs (white arrowheads) in the aldolase C-positive 1+ and 2+ compartments. Aldolase C-
negative 1 compartment is included in the PC-deficient area viewed in A (black arrowheads).
White arrow shows medial line of the cerebellum. C: The aldolase C-negative 1 compartment dis-
plays intense GFAP immunofluorescent astrogliosis. D: Merge of B and C.
Figure 6 Aldolase C parasagittal compartmentation of the NP0/0 PC population. A, B: Aldolase
C immunoperoxidase in the cerebellar cortex of the wild-type (A) and NP0/0 (B) mice. A: Immuno-
peroxidase staining of the PC somata (black arrowheads) and dendrites of the aldolase C-positive
1+ compartments in the ventral side of the lobule IX in the median cerebellar vermis. White arrow-
heads point to unlabeled PC soma in the left and right aldolase C-negative 1 compartments flank-
ing the 1+ compartments. ML, Molecular layer; IGL, Internal Granular Layer; white arrow at bot-
tom points to the medial line of the cerebellum. B. NP0/0 mutant mouse. Same legend as in A. See
the dramatic loss of aldolase C-positive PCs (black arrowheads) in the 1+ compartments and of
unlabeled PCs in the 1 compartments (white arrowhead). Bar, 50 lm. C: Aldolase C-positive and
aldolase C-negative PCs in the cerebellum of the wild-type (n ¼ 3) and the 12- and 18-month-old
NP0/0 mutants (n ¼ 3 per age) mice. In any case, many more aldolase CP age positive than aldolase
C-negative PCs were counted throughout the transverse extent of the cerebellum (*). Aldolase C-
positive as well as aldolase C-negative PCs were lost in the 12- and 18-month-old NP0/0 cerebellar
cortex (#). D: PC numbers in the vermal aldolase C compartments of the wild-type and NP0/0 cere-
bellum. Although NP0/0 PC loss is observed in almost all aldolase C compartments, the difference
with wild-type is not significant in any of the eight compartments.
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DISCUSSION
To investigate whether the anti-apoptotic factor BCL-
2 is capable of preventing the premature death of cer-
ebellar PCs in NP0/0 mice caused by overexpression
of the prion protein paralog Dpl (Moore et al., 1999;
Weissmann and Aguzzi, 1999; Li et al., 2000), we
crossed NP0/0 mutants with Hu-bcl-2 overexpressing
mutants and analyzed PC numbers and glial activa-
tion in their cerebella. Our analysis of Hu-bcl-2
mutants and NP0/0-Hu-bcl-2 double mutants suggest
the following conclusions. Firstly, overexpression of
Hu-bcl-2 rescues many PCs from Dpl-induced cell
death in the NP0/0-Hu-bcl-2 double mutant. Secondly,
overexpression of Hu-bcl-2 prevents the activation of
astrocytes induced by the NP0/0 deletion. Finally, Dpl
neurotoxicity in PCs varies according to their aldol-
ase C expression.
These studies confirm the contribution of a BAX-
dependent mitochondrial pathway to Dpl-mediated
PC death in the prion protein-deficient NP0/0 mice.
Furthermore, the capacity of Hu-BCL-2 to rescue
some PCs from Dpl-induced neurotoxicity suggests
that PrPc may similarly protect neurons from Dpl in a
BCL-2-like manner.
Hu-bcl-2 Overexpression Partially
Rescues NP0/0 PCs from Doppel
Neurotoxicity
Our previous study of NP0/0 mutants showed a signif-
icant reduction in PC numbers in the cerebellum at 6
months, but motor impairments were revealed by
footprint analysis at 12 months only (Heitz et al.,
2007). This suggested either that substantial numbers
Figure 8 GFAP staining of radial Bergmann glia (black arrowheads) in the molecular layer
(ML) and astrocytes in the internal granular layer (IGL) is weak in the 18-month-old wild-type (A)
and Hu-bcl-2 (B) cerebellar cortex. Gliosis disclosed in the ML and throughout the IGL of the 18-
month-old NP0/0 cerebellar cortex (C) is abolished by Hu-bcl-2 which has restored normal intensity
of GFAP immunoreactivity in ML of the 18-month-old NP0/0-Hu-bcl-2 cerebellar cortex (D)
although astrogliosis still occurs in parts of ML and throughout IGL. Arrow shows nonspecific
GFAP staining of blood vessel walls in all mice. Bar, 50 lm, 3200.
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of PCs must be lost before ataxia becomes apparent
or that the development of the ataxic phenotype also
depends on neurodegeneration in other parts of the
brain. As observed in the NP0/0:Bax/ double
mutants, the NP0/0-Hu-bcl-2 mice displayed ataxia at
the same time as the NP0/0 mice. This suggests that
this phenotype is not solely a function of the number
of surviving PCs, because both NP0/0:Bax/ and
NP0/0-Hu-bcl-2 double mutants have more PCs than
NP0/0 mutants at 12 months (Heitz et al., 2007).
The double transgenic mice NP0/0-Hu-bcl-2 con-
tain many more PCs than the single NP0/0 mutants
during the period studied (10–21 months). Whereas
the number of PCs in the Hu-bcl-2 mutant declines
significantly from 6 to 21 months (Zanjani et al.,
2004 and present data), the number of PCs in the
NP0/0-Hu-bcl-2 mutant is stable from 12 to 24
months. Thus, the long-lasting effect of Hu-bcl-2
overexpression on the NP0/0 PC population cannot be
explained by the rescue of PCs from developmental
cell death by overexpressing Hu-bcl-2. Our previous
data showed that BAX contributes to Dpl-mediated
cell death (Heitz et al., 2007) and that increased lev-
els of BCL-2 enable some PCs to resist Dpl neurotox-
icity. This suggests that the NP0/0 PCs rescued by
Hu-bcl-2 overexpression are likely to be the same
PCs rescued by deletion of the Bax gene (Heitz et al.,
2007), providing further evidence that Dpl activates a
BCL-2 family-mediated cell death pathway. Indeed,
the number of rescued PCs in the NP0/0-Hu-bcl-2 and
in the NP0/0:Bax/ double mutants was not signifi-
cantly different between 10 and 21 months. An NP0/0-
specific upregulation of Hu-bcl-2 expression remains
to be explored as a possible reason for increased PC
survival in the NP0/0-Hu-bcl-2 double mutant since it
could sustain PC rescue from developmental cell
death longer than in the Hu-bcl-2 single mutant.
However, this seems unlikely because PC survival
has similar kinetics in both NP0/0:Bax/ and NP0/0-
Hu-bcl-2 double mutants. In addition, the intensity
of Hu-bcl-2 immunoperoxidase staining was not
increased in the NP0/0-Hu-bcl-2 PCs compared to the
Hu-bcl-2 PCs at 12 months when Hu-bcl-2 expression
levels are known to be decreased (Zanjani et al.,
2004), indicating that Hu-bcl-2 expression is not
modified by the NP0/0 condition.
Neither Bax deficiency with normal Bcl-2 expres-
sion (Heitz et al., 2007) nor Hu-bcl-2 overexpression
with normal Bax and Bcl-2 expression (Zanjani et al.,
2004 and present results) is able to sustain supernu-
merary PCs survival during adulthood. Thus, mecha-
nisms independent of the BAX/BCL-2 couple are
likely to be responsible for supernumerary PC death
in both Bax/ and Hu-bcl-2 mice. Furthermore, the
gradual decline in the NP0/0-Hu-bcl-2 PC population
during this 20-month-long study indicated that over-
expression of Hu-bcl-2 alone is not sufficient to coun-
teract Dpl-mediated apoptosis of all PCs. As early as
10 months, the number of PCs in NP0/0-Hu-bcl-2
mice was significantly less than in wild-type mice.
This suggests that BCL-2-insensitive death mecha-
nisms can be specifically activated by Dpl in the
prion protein-deficient Ngsk PCs. Anyway, the PC
survival in Zu¨rich-1 (ZH-I) (Bu¨eler et al., 1993) and
Edbr (Manson et al., 1994) Prnp-knock-out mice that
do not overexpress Dpl rules out PrP-deficiency as a
BCL-2-insensitive cause of PC death in the NP0/0-
Hu-bcl-2 mice. Thus the BCL-2-like neuroprotective
properties of PrPc (Bouhnar et al., 2001; Li and Har-
ris, 2005; Bounhar et al., 2006) are probably not re-
sponsible for its anti-Dpl activity (Nishida et al.,
1999; Yamaguchi et al., 2004).
Whereas PC survival was the same in NP0/0 and
wild-type mice at 4 months, PC numbers were
reduced in the NP0/0-Hu-bcl-2 double mutants com-
pared with the Hu-bcl-2 mutants. This suggested that
PCs are more sensitive to Dpl neurotoxicity in Hu-
bcl-2 than the wild-type mice. The loss of NP0/0-Hu-
bcl-2 PCs at 4 months is probably provoked by PC
fragility due to excessive number of PCs overexpress-
ing Hu-bcl-2. This decline in supernumerary PC num-
bers during adulthood in the Bax/ and Hu-bcl-2
overexpressing mice suggests that the PCs in NP0/0-
Hu-bcl-2 mice which overexpress Hu-bcl-2 and have
a Bcl-2+/+ background that is highly neuroprotective,
are likely to die by a mechanism independent of the
BCL-2 family of pro-apoptotic factors.
According to our present and previous (Heitz
et al., 2007) results, the ectopic expression of Dpl in the
NP0/0 mice may induce BAX/BCL-2-dependent and
BAX/BCL-2-independent mechanisms in the same
PCs. Alternatively, the two pathways could be mutu-
ally exclusive such that Dpl may selectively stimulate
one pathway or the other in different PCs. Against
this hypothesis, neither Dpl-induced PC loss nor PC
rescue induced by either Bax deletion or Hu-bcl-2
overexpression showed significant variations along
the lateral axis of the cerebellum in the NP0/0, NP0/0:
Bax/, and NP0/0-Hu-bcl-2 mice suggesting that the
neurotoxicity of Dpl and in particular its BAX-medi-
ated component, is evenly distributed along the lat-
eral axis of the cerebellum. However, PC loss was
significantly different between aldolase C-positive
and -negative compartments in the 18-month-old
NP0/0 cerebellum, suggesting that acuity of Dpl neu-
rotoxicity is modulated by specific properties of PCs
in the aldolase C compartments (Gravel et al., 1987;
Wassef et al., 1992; Bailly et al., 1995; Voogd and
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Ruigrok, 2004; Sugihara and Quy, 2007). Alterna-
tively, the NP0/0 condition may have a differential
effect on Hu-bcl-2 expression level as a function of
aldolase C expression. In other words, the transgene
Hu-bcl-2 is selectively upregulated in the aldolase C-
positive PCs which display the strongest resistance to
Dpl neurotoxicity. However, the similar intensity of
Hu-bcl-2 immunostaining of aldolase C-positive and
-negative PCs does not support this possibility. As
early as 6 months, PC-death-induced reactive astro-
gliosis was detected exclusively in the molecular
layer of the aldolase C-negative compartments where
the most of PCs were lost. Such a causal relationship
between PC loss and astrogliosis has previously been
suggested by the topographical coincidence of PC
death and astrogliosis in the NP0/0 cerebellar cortex
(Heitz et al., 2007).
Favoring the existence of cell-specific differential
sensitivity of PCs to Dpl neurotoxicity, PC loss was
increased in the anterior cerebellum (Heitz et al.,
2007). This suggests that Dpl neurotoxicity varies
along the rostro-caudal axis of the cerebellum and
could be related to the antero-posterior compartmen-
talization of the PC population (Duchala et al., 2004).
However, since PC survival was similar in the ante-
rior and posterior cerebellum of the NP0/0: Bax/
and NP0/0-Hu-bcl-2 as well, the rescue effect of Bax
knock-out and of Hu-bcl-2 overexpression did not
change between anterior and posterior PCs suggesting
that the BAX/BCL-2-mediated effect of Dpl is not
related to the rostro-caudal compartmentalization of
PC population. Rather, since aldolase-C negative PCs
are more sensitive to Dpl neurotoxicity, the increased
PC loss in the anterior cerebellum is likely to be
related to the aldolase-C negative/aldolase-C positive
ratio of PC population in the anterior cerebellum.
Aside from signal transduction and antioxidant
activities, PrPc is neuroprotective because of its
BCL-2-like activity and acts as a potent BAX inhibi-
tor. In favour of an antagonistic function of PrPc on
mitochondrial apoptotic pathways, PrPc protects
against cell death by preventing the conformational
change of BAX that occurs during BAX activation
(Roucou et al., 2005). Although not exactly identical
to BCL-2, PrPc may functionally replace BCL-2
when it decreases in the aging brain (see review in
Roucou et al., 2005; Bounhar et al., 2006). On the
other hand, BAX-induced apoptosis cannot be coun-
teracted by PrPc devoid of its N-terminal octapeptide
repeats suggesting that this domain, partially homol-
ogous to the BH2 domain of the BCL-2 family of
proteins (Yin et al., 1994; Roucou et al., 2004), is
crucial for the neuroprotective functions of PrPc.
Interestingly, an important function of BCL-2 is to
antagonize the pro-apoptotic effect of BAX through
direct interaction at this BH2 domain (Oltvai et al.,
1993; Gross et al., 1999; Cheng et al., 2001), which
is missing in both Dpl and mutated neurotoxic forms
of PrP: DPrP (Shmerling et al., 1998; Flechsig et al.,
2003; Li et al., 2007) and Tg(PG14)PrP (Chiesa et
al., 1998). Indeed, fusion of Dpl to a BH2-containing
octapeptide repeat and the N-terminal half of hydro-
phobic region of PrPc confer resistance to serum de-
privation (Lee et al., 2006). Interestingly, N-termi-
nally deleted forms of PrPc have been recently
shown to activate both Bax-dependent and Bax-inde-
pendent apoptotic pathways (Li et al., 2007). A
direct effect of Hu-BCL-2 on BAX is the most likely
mechanism involved in the NP0/0 PC rescue reported
in the present study. Although PrPc is mainly present
at the cell surface (Fournier et al., 2000; Bailly et
al., 2004), it has recently been localized in the cyto-
plasm where it could directly interfere with BAX-
mediated cell death (Ma and Lindquist, 2001; Yedi-
dia et al., 2001; Roucou et al., 2003).
Hu-bcl-2 Overexpression Rescues NP0/0
Astrocytes from Activation
Increased immunolabeling for GFAP is displayed by
astrocytes in the cerebellar cortex of the 4 month-old
NP0/0 mutants indicating astroglial activation (Atar-
ashi et al., 2001; Heitz et al., 2007). At this age, astro-
gliosis occurred in patches reminiscent of parasagittal
compartments delineated by PC clusters in the cere-
bellar cortex (Bailly et al., 1995; Sugihara and Quy,
2007). From 10 months on, astrogliosis propagated
throughout the cerebellar cortex following a time
course parallel with PC loss.
Since activation of astrocytes in vivo does not
induce neuronal death (Mallucci et al., 2003), gliosis
is likely to be a consequence of PC damage in the
cerebellum of the NP0/0 mice. In the present study,
Hu-bcl-2 is under control of the NSE promoter and
therefore specifically expressed in neurons. Thus, the
only explanation is that PC rescue by Hu-bcl-2
expression leads to decreased gliosis in the cerebellar
cortex of NP0/0-Hu-bcl-2 mice. This is also supported
by the topographic coincidence of astrogliosis and
PC loss demonstrated in our previous study (Heitz
et al., 2007). In all cases, regions with gliosis over-
lapped PC-free areas, whereas regions with normal
GFAP fluorescence of glial cells contained surviving
PCs, suggesting that activation of astrocytes could
result from degeneration signals from PCs. The acti-
vation of astrocytes was greatly moderated by Bax
deletion in the cerebellar cortex of the NP0/0: Bax/
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mice (Heitz et al., 2007). Although a direct antago-
nistic effect of Bax knock-out in activated astrocytes
cannot be ruled out since ischemia has been shown
to upregulate Bax in astrocytes (Imura and Shimo-
hama, 2000; Giffard and Swanson, 2005), consistent
glial expression of BAX could not be detected in
mouse and human brain (Hara et al., 1996; Shin
et al., 2000) suggesting that Bax deletion indirectly
represses astrocyte activation by directly counteract-
ing Dpl neurotoxicity in PCs. In agreement with this
hypothesis, our present observations in the NP0/0-
Hu-bcl-2 show that BCL-2, a direct BAX antagonist
sustaining NP0/0 PC survival, has a similar repressor
effect on glial activation. Thus, our data suggest that
Bax-dependent PC death is an astrocyte-activating
cell death mechanism. Gliosis is almost completely
rescued in the cerebellum of the NP0/0-Hu-bcl-2 dou-
ble mutant in spite of the loss of a great number of
PCs by a Bax-independent mechanism, suggesting
that this latter mechanism does not activate gliosis.
According to our data, astrogliosis is triggered by
Bax-induced PC death starting in the aldolase
C-negative compartments.
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Dear Editor, 
We are pleased to submit our revised article “Autophagy and cell death of Purkinje cells 
overexpressing Doppel in Ngsk Prnp-deficient mice” by Heitz S., Grant N. J, Leschiera R., 
Haeberlé A.-M., Demais V., Bombarde G., Bailly Y. for publication as a research article in 
Brain Pathology. 
All concerns of reviewer 1 and reviewer 2 have been taken into account and modifications of 
the manuscript appear in red in the revised text. In addition, you will find our specific 
responses to the reviewer’s comments in the space provided in the electronic submission 
form.  
Briefly, an extensive semi-quantitative analysis of autophagic nerve profiles has been 
achieved at the ultrastructural level in both cerebellar cortex and deep cerebellar nuclei to 
demonstrate a major autophagic stress at axon terminal level. In addition, double 
immunohistofluorescence labelling of autophagy and lysosomes is presented to show that 
autophagy-associated lysosomal recruitment occurs in the NP0/0 PCs. Finally, RT-PCR 
analysis of LC3B and p62 mRNAs confirms unchanged synthesis but rather decreased protein 
degradation of autophagic products in these PCs. 
These new data indicate that autophagic flux is impaired in NP0/0 PCs which could contribute 
to neuronal loss. 
 
We thank you for considering our revised manuscript for publication in Brain Pathology and 
remain 
Yours sincerely    
The authors 
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ABSTRACT 
In Ngsk prion protein (PrP)-deficient mice (NP0/0), ectopic expression of PrP-like protein 
Doppel (Dpl) in central neurons induces significant Purkinje cell (PC) death resulting in late-
onset ataxia. NP0/0 PC death is partly prevented by either knocking-out the apoptotic factor 
BAX or overexpressing the anti-apoptotic factor BCL-2 suggesting that apoptosis is involved 
in Dpl-induced death. In this study, Western blotting and immunohistofluorescence show that 
both before and during significant PC loss, the scrapie responsive gene 1 (Scrg1), potentially 
associated with autophagy, and the autophagic markers LC3B and p62 increased in the NP0/0 
PCs while RT-PCR shows stable mRNA expression, suggesting that degradation of 
autophagic products is impaired in NP0/0 PCs. At the ultrastructural level, autophagic-like 
profiles accumulated in somato-dendritic and axonal compartments of NP0/0, but not wild-type 
PCs. The most robust autophagy was observed in NP0/0 PC axon compartments in the deep 
cerebellar nuclei suggesting that it is initiated in these axons. Our previous and present data 
indicate that Dpl triggers autophagy and apoptosis in NP0/0 PCs. As observed in amyloid 
neurodegenerative diseases, upregulation of autophagic markers as well as extensive 
accumulation of autophagosomes in NP0/0 PCs are likely to reflect a progressive dysfunction 
of autophagy which could trigger apoptotic cascades. 
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INTRODUCTION 
 
Doppel (Dpl) was the first identified homologue of the cellular prion protein PrPc which is 
implicated in the pathogenesis of transmissible spongiform encephalopathies (TSE) (48). 
Large deletions in the PrPc gene Prnp, for example in the Ngsk Prnp0/0 (NP0/0) mouse line, 
result in the ectopic expression of Dpl in brain neurons (51) that induces significant levels of 
cerebellar Purkinje cell (PC) death as early as 6 months after birth (26). PrP-deficient cells 
have been shown to undergo Dpl-induced apoptosis in a dose-dependent, cell autonomous 
manner (40, 51, 54). Expression of the N-terminal truncated form of PrP (∆PrP) in Prnp-
ablated mouse lines (21) has neurodegenerative effects in PCs, similar to those observed when 
Dpl is over-expressed (1, 64). Moreover, the neurotoxic effects of Dpl and ∆PrP are both 
antagonized by PrPc (1, 11, 21, 64) suggesting that Dpl and ∆PrP may cause cell death by 
similar mechanisms, perhaps by interfering with a cellular signalling pathway essential for 
cell survival and normally controlled by full-length PrPc (1, 56, 61). To date, only a few 
studies have investigated the mechanism by which Dpl kills neurons. Oxidative stress linked 
with glial activation may play a role in the death of neurons because NOS activity is induced 
by Dpl both in vitro and in vivo (2, 11, 62).  
In a recent study which investigated the involvement of the mitochondrial pro-apoptotic factor 
BAX in the Dpl-induced apoptosis of PCs, we have shown that deletion of Bax expression 
rescues many PCs from Dpl-induced cell death in NP0/0:Bax-/- double knockout mutant mice 
(26).  Since PrPc has the ability to counteract Dpl neurotoxicity and has BCL-2-like properties 
which promote neuronal survival, we also examined the capacity of the anti-apoptotic factor 
BCL-2 to prevent Dpl neurotoxicity in-vivo. Hu-bcl-2 overexpression in NP0/0-Hu-bcl-2 
double mutants was found to rescue PCs in similar proportions to that observed when Bax was 
deleted in NP0/0:Bax-/- double knock-out mutants (27). The capacity of BCL-2 to compensate 
PrPc deficiency and rescue PCs from Dpl-induced death suggests that this BCL-2-like 
Page 4 of 41
Brain Pathology Editorial Office, Blackwell Publishing, Oxford, UK
Brain Pathology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
4 
property of PrPc impairs Dpl-like neurotoxic pathways in wild-type neurons. These studies 
indicate that the pro-apoptotic factor BAX contributes to the neurotoxic mechanisms triggered 
by Dpl in the NP0/0 PCs and that the anti-apoptotic factor BCL-2 can counteract this 
neurotoxic mechanism. However, NP0/0 PC numbers are not fully restored to wild type levels 
suggesting that the ectopic expression of Dpl induces both BAX-dependent and BAX-
independent cell death pathways. 
A Dpl-activated, BAX-independent cell death mechanism may involve neuronal autophagy 
since NP0/0 PCs have been recently shown to express Scrg1, a novel protein having a potential 
link with autophagy (18). Indeed, neuronal Scrg1 mRNA and protein levels are increased in 
prion-diseased brains (12, 13, 17). At the ultrastructural level, Scrg1 is associated with 
dictyosomes of the Golgi apparatus and autophagic vacuoles in degenerating neurons of 
scrapie-infected Scrg1-overexpressing transgenic and wild-type mice (18). Indeed, autophagy 
was first reported in experimentally-induced scrapie a long time ago (6), and recently has 
been implicated in an alternative cell death program in prion diseases (35).  
For this reason, we investigated the expression of Scrg1 and two characteristic markers of 
autophagy, LC3B and p62, (5, 4, 37, 63) prior to significant PC loss in the 3-4 month-old 
NP0/0 cerebellum and, when PC degeneration peaks in the 6-8 month-old NP0/0 cerebellum 
(26). We also looked for ultrastructural signs of autophagy in the dendrites, axons and somata 
of PCs in the cerebellar cortex and deep cerebellar nuclei of NP0/0 mice.  
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MATERIALS AND METHODS 
 
Animals and genotyping 
As previously reported, NP0/0 mice were generated by deleting the entire open reading frame 
(ORF) of the Prnp gene, located in exon 3, as well as 5’ and 3’ non-coding flanking regions 
(48). The deleted sequences were replaced by a Neo cassette. The Prnp ORF was identified 
using the following primers: forward 5'CCGCTACCCTAACCAAGTGT3' and reverse 
5'CCTAGACCACGAGAATGCGA3', both located within Prnp ORF. The following primers 
were used to identify the NP0/0 mutants: forward 5'TGCCGCACTTCTTTGTGAAT3' and 
reverse 5'CGGTGGATGTGGAATGTGT3' (within Neo domain).  
For this study, founding mice (NP0/0 gift from S. Katamine) were first backcrossed with 
C57BL/6 mice for at least 10 generations. These mice were then intercrossed and NP0/0, and 
wild-type (WT) pups were selected and bred at the animal facility of the Neurosciences IFR37 
in Strasbourg, according to the NIH guidelines (NIH Publication 80-23, revised 1996) and the 
European Communities Council Directive of November 24, 1986 (86/609/EEC). 
 
Western Blot analysis of LC3B, p62 and Lamp1 
3-4 and 6-8 month-old wild-type (n = 3/age) and NP0/0 (n = 3/age) littermates were 
anaesthetized with a mixture of ketamine 5% and xylazine 2% (0.1 mL of the mix per 30 g by 
i.p.) and then killed by decapitation. Cerebella were dissected and first homogenized in cold 
extraction TX-DOC buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 2mM EDTA (ethylene-
diamine-tetra-acetic acid), 0.5% sodium deoxycholate, 0.5% Triton X-100, 1/500 Sigma 
Protease Inhibitor Cocktail). After centrifugation, the cleared extracts were taken up in 
Laemmli sample buffer (10mM Tris pH 7.0, 1mM EDTA, 3% SDS (sodium dodecyl sulfate), 
10% Glycerol, 20mM DTT (dithiotreithol), 10% bromophenol blue) before heat denaturation. 
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6 
The remaining protein pellets were washed with phosphate-buffered saline (PBS) before 
extraction with 2% SDS-containing sample buffer (insoluble fraction). An equivalent of 100 
µg of brain tissue per well was run on 4-20% (LC3B and p62) and 4-12% (p62 and Lamp1) 
Nupage gels (Invitrogen). Proteins were transferred onto nitrocellulose membrane following 
the manufacturer’s recommendations and routinely monitored with Ponceau S staining. Blots 
were pre-incubated for 1h in blocking solution (5% milk powder (Sigma), 0.1% Tween-20 in 
0.1 M phosphate buffer saline pH 7.3 PBS). Antibodies were diluted in blocking solution and 
blots were incubated overnight with anti-actin mouse monoclonal antibody (1/10000, Sigma-
Aldrich), anti-Lamp1 rabbit polyclonal antibody (1/1000, Abcam), anti-LC3B mouse 
monoclonal antibody (1/200, Nanotools) and anti-p62 mouse monoclonal antibody (1/1000, 
BD Transduction Labs). The anti-LC3B antibody was directed against the N-terminal end of 
the LC3B molecule and reacts with both LC3B-I and LC3B-II proteins. The anti-p62 antibody 
was directed against amino acids 257- 437 sequence of the human p62 molecule. The anti-
Lamp1 antibodies were directed against a synthetic peptide within residues 350 to the C-
terminus of human Lamp1 (100% identity with mouse Lamp1). Immunoreactivity was 
revealed using the SuperSignal West Dura Extended Duration Substrate reagent kit (Pierce) 
and images were obtained with a Chemi-Smart 5000 camera using the Chemi-capt software 
(Vilber-Lourmat). Quantification of protein bands was done using the Bio1D software 
(Vilber-Lourmat). Values have been corrected for variation in actin values and are expressed 
as a percentage of the values obtained for control animals. 
  
RT-PCR analysis of LC3B and p62 
Total RNA was extracted from isolated cerebellum from 3 and 6 month-old control wild-type 
mice and age-matched NP0/0 mice with the GenElute Kit (Sigma-Aldrich), and mRNA was 
transcribed into cDNA using oligo(dT) and Superscript RNase H- Moloney murine leukemia 
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7 
virus reverse transcriptase (Invitrogen). PCR amplification was performed using specific 
primers for p62: forward: 5’GATGTGGAACATGGAGGGAAGAG3’ and reverse: 
5’AGTCATCGTCTCCTCCTGAGCA3’; PCR product 246 bp (GI: 118130186), for LC3: 
forward: 5’ATGCCGTCCGAGAAGACCTTC3’ and reverse: 
5’TTACACAGCCATTGCTGTC3’; PCR product 377 bp (GI: 141601716) and for actin: 
forward: 5’GTGGGCCGCTCTAGGCACCAA3’ and reverse: 
5’CTCTTTGATGTCACGCACGATTTC3’; PCR product 540 bp (GI: 141601716). PCR 
cycles consisting of 94°C for 45sec, 55°C, (except for actin 60°C) for 30sec and 70°C for 
30sec were varied between 18 and 27 cycles for β-actin and 21 and 33 cycles for p62 and 
LC3. Aliquots of PCR products were then migrated on 2% agarose gels and stained with 
ethidium bromide. The relative expression of the autophagic markers produced in the 
exponential phase of the PCR amplifications was calculated by a semi quantitative analysis 
using the Image J program. Similar measurements on the endogenous reference gene β-actin 
served as a control for the quantity of RNA input.  
 
Immunohistofluorescence 
Wild-type (n = 2) and NP0/0 (n = 3) mice aged of 6-8 months were anaesthetized as described 
above and transcardiacally perfused with 4% paraformaldehyde (PAF) in 0.1M phosphate 
buffer, pH 7.3 (PB).  The cerebellum was dissected and immersed in the same fixative at 4°C. 
After immersion in isobutanol for 4 days, the cerebella were embedded in paraffin and sagittal 
sections (10 µm-thick) were cut with a microtome (Leica). The sections were deparaffinized 
in toluene and rehydrated in ethanol. After rinsing in PBS, the sections were pre-incubated for 
45 min in blocking solution (3% normal goat serum (NGS) in 0.5% Triton X-100 PBS; 
PBST). The sections were incubated overnight at 4°C in PBST containing 0.3% NGS and 
mouse monoclonal antibodies against LC3B (Nanotools) diluted 1/10 and rabbit polyclonal 
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8 
antibodies against 28 kDa calcium binding protein (CaBP; gift from Dr Thomasset) diluted 
1/1000 or rabbit polyclonal antibodies against Lamp1 (Abcam) diluted 1/100 for double 
immunohistofluorescence or with mouse monoclonal antibodies against p62 (BD 
Transduction Labs) diluted 1/100. The sections were then rinsed in PBS and incubated with 
Alexa 488-coupled goat anti-mouse and Alexa 546-coupled goat anti-rabbit immunoglobulins 
(Molecular Probes) diluted 1/1000 in PBS containing 0.3% NGS. After rinsing in PBS, the 
sections were mounted in Mowiol and examined by epifluorescence (Axioskop-II, Zeiss, 
Jena, Germany). 
 
Scrg1 immunocytochemistry 
Tissue preparation and sampling 
Wild-type (8 month, n = 2) and NP0/0 (3, 6, 8 months, n = 2/age) mice were anaesthetized as 
described above and transcardiacally perfused with PAF 1% in PB. The cerebellum was 
dissected and immersed in the same fixative at 4°C for 4 h. 
 
Immunohistofluorescence 
The cerebellum was cryoprotected in sucrose 0.44 M in PB overnight at 4°C before freezing 
in liquid nitrogen. Sagittal sections (10 µm-thick) were cut with a cryostat (Leica), rinsed in 
PBS and pre-incubated for 45 min in blocking solution (3% NGS in PBST). After overnight 
incubation at 4°C in PBST containing 0.3% NGS and rabbit polyclonal antibody against 
Scrg1 diluted 1/60 (gift from M. Dron) (28), the sections were rinsed in PBS and incubated 
with goat anti-rabbit immunoglobulins coupled to Alexa 488 (Molecular Probes) diluted 
1/500 in PBS containing 0.3% NGS. The sections were then rinsed in PBS and processed for 
fluorescence microscopy as described above. 
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Control sections processed either without the anti-LC3 and anti-Scrg-1 primary antibodies or 
the fluorescent secondary antibodies were devoid of any specific fluorescent signal.  
 
Quantitative analysis of Scrg1-immunofluorescent PCs in the NP0/0 cerebellum 
Scrg1 immunofluorescent PCs were counted in 7 sagittal sections separated from each other 
by 400 µm (total sampling distance = 2470 µm) in the cerebellar vermis of the 8 month-old 
wild-type (n = 2) and NP0/0 mice (n = 3). Data are given as mean ± standard deviation (SD).  
 
Pre-embedding immunogold for electron microscopy 
Transversal vibratome sections (60 µm-thick) of 1% PAF-fixed cerebellum were cut and 
processed, as previously described (16). Briefly, sections were pre-incubated in a blocking 
solution (0.5% bovine serum albumin, BSA, 0.1% cold water fish skin gelatine and 0.5% 
NGS in PB) before being rinsed in PBS containing 0.15% acetylated BSA (BSAc, Aurion, the 
Netherlands) and incubated overnight at 4°C with anti-Scrg1 antibodies (1/50 in PBS-BSAc). 
After washing in PBS-BSAc, the sections were incubated in Ultra small nanogold F(ab’) 
fragments of goat anti-rabbit IgG (H and L chains, Aurion) diluted 1/100 in PBS-BSAc. After 
several rinses in PBS-BSAc and in PB, sections were post-fixed in glutaraldehyde 2% in PB 
before washing in PB and distilled water. Gold particles were then silver enhanced using the 
R-Gent SE-EM kit (Aurion) before being washed in distilled water and PB. Finally, the 
sections were postfixed in 0.5% OsO4 in PB before classical processing for Araldite 
embedding and ultramicrotomy. The ultrathin sections were counterstained with uranyl 
acetate and observed with a Hitachi 7500 transmission electron microscope equipped with an 
AMT Hamamatsu digital camera. In control sections processed without anti-Scrg-1 primary 
antibodies or gold-labelled secondary antibodies no gold particles were observed.  
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Postembedding immunogold for detection of GABA 
Deep cerebellar nuclei (DCN) were sampled from transverse cerebellar vibratome sections of 
10 month-old NP0/0 mice (n=2) perfused with a mixture of 2% PAF and 2% glutaraldehyde in 
0.1 M PB. After embedding in Araldite, ultrathin sections were submitted to a standard 
postembedding immunogold protocol for the detection of GABA (15). The sections were 
immersed in 1% sodium borohydride and after rinsing in distilled water and Tris-buffered 
saline (TBS) they were incubated with 10% normal goat serum (NGS) in TBS and then with 
the GABA-specific primary antiserum (0.5 mg/ml; overnight at 4°C) in TBS containing 1% 
NGS. The sections were rinsed in TBS and incubated in goat anti-rabbit IgG coupled to 15 nm 
gold particles (Aurion,) diluted 1/200 in TBS containing 1% NGS. After rinsing in TBS and 
distilled water, sections were counterstained with 1% uranyl acetate. Substitution of the 
primary antiserum with pre-immune serum or TBS abolished labelling, as did omission of the 
gold conjugated secondary antibodies. Axonal varicosities establishing asymmetric synapses 
were always devoid of labelling. Non-specific or background labelling was very low in these 
preparations. 
 
Semi-quantitative ultrastructural analysis of PC autophagy 
Tissue preparation and sampling  
Cerebellar cortex and DCN were sampled from transverse vibratome sections of 3 and 6 
month-old NP0/0 and wild-type mice (n=2/genotype and age) perfused with a mixture of 2% 
PAF and 2% glutaraldehyde in 0.1 M PB. Regions of cerebellar cortex were randomly 
sampled in the cerebellar lobules either in the vermis or in the right or left hemispheres in one 
section of the anterior cerebellum (1 block) and in one section of the posterior cerebellum (1 
block). Regions in the fastigial, interposed and dentate nuclei was randomly sampled in 
sections from the anterior, median and posterior levels (1 block/level) of each right or left 
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nucleus. After embedding in Araldite, ultrathin sections were obtained from each block. In the 
cerebellar cortex, 100 PCs in the anterior cerebellum and 100 PCs in the posterior cerebellum 
were examined. In the deep cerebellar nuclei, 7,000 µm² were examined in the synaptic 
neuropile between the deep cerebellar neurons and an equivalent area in the synaptic 
neuropile close to the DCN. This was done at the anterior, median and posterior levels of the 
three DCN. The deep cerebellar neurons were identified by their large size (mean maximum 
diameter: 23.07 ± 0.36 µm) and by absence of GABA immunogold labelling. Autophagy was 
considered to be activated in the neuronal profiles which displayed recognizable structural 
features of the macroautophagic process. These included isolation membranes or phagophores 
surrounding neuroplasm with or without organelles and autophagic vacuoles such as complete 
double membraned autophagosomes and autolysosomes or autophagolysosomes (47).  
 
Semi quantitative analysis of autophagic profiles in the NP0/0 cerebella 
In the cerebellar cortex, activation of autophagy was estimated by the number of PC soma 
exhibiting abnormal numbers of autophagic features (at least 3 autophagic vacuoles per soma) 
as a percentage of the total number of PCs examined in each animal. In the DCN, activation 
of autophagy was estimated by the number of PC presynaptic and pre-terminal axonal profiles 
exhibiting abnormal numbers of autophagic features (at least 2 autophagic vacuoles per 
profile) as a percentage of the total number of PC axonal profiles examined in each nucleus. 
 
RESULTS 
Scrg1, LC3B, p62 and Lamp1 are upregulated in NP0/0 PCs 
Since expression of Scrg1 has been previously reported to be a potential marker of autophagy 
and to increase in central neurons of scrapie-infected mice and in PCs of 12 month-old NP0/0 
mice (18), we first investigated the immunohistochemical distribution of Scrg1 in the 
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12 
cerebellar cortex of young, 6-8 month-old NP0/0 mice. In these mutants, intense Scrg1 
immunofluorescence accumulated in large dots in the apical pole of the soma of a few PCs, 
reminiscent of Golgi apparatus staining (Fig. 1A). No or very weak labeling was seen in the 
PC dendrites. Scrg1 labeling was observed in less than 10 PCs per sagittal cerebellar section 
and was absent in PCs from wild-type age-matched littermates (Fig. 1B, C). 
To further substantiate the occurrence of autophagy in the NP0/0 PCs, the cerebellar 
expression of LC3B, a newly discovered autophagy-related variant of LC3, the classical 
marker of autophagy (63), and in parallel, the expression of p62, a functional autophagic 
ligand of LC3 (5, 45) were analyzed (Fig. 2). Firstly, RT-PCR analysis of mRNA levels did 
not reveal any differences in the expression of either LC3B or p62 in the cerebellum of 3 and 
6 month-old NP0/0 mice compared with wild-type mice (Fig. 2A). Next, changes in the LC3 
and p62 protein levels were analyzed by Western blot. The results indicated an increase in the 
levels of both the autophagy-specific LC3B-II fragment (4.6 fold) and its ligand p62 (3 fold) 
in the Triton X-soluble fraction (Fig. 2B) but not in the insoluble fraction (data not shown) of 
the cerebellar extracts from the 3-4 and 6-8 month-old NP0/0 mice compared to age-matched 
wild-type littermates. This increased expression of LC3B-II in the cerebellar cortex of the 
NP0/0 mutants was confirmed in histological sections (Figs. 3, 4). LC3B (Fig. 3D-I) and p62 
(Fig. 4B) staining was observed in the soma of NP0/0 PCs, but was barely detected in wild-
type PCs (Figs. 3A-C, 4A). In addition, CaBP-positive axon terminals of PCs displayed LC3B 
(Fig. 3M-O) and p62 (Fig. 4D) immunohistofluorescence in the DCN of the NP0/0 mice 
whereas LC3B (Fig. 3J-L) and p62 (Fig. 4C) could not be immuno-detected in wild-type 
DCN. In agreement, the level of expression of the lysosomal marker Lamp1 was increased 
(4.1 fold) in the cerebellar extract of all NP0/0 mice (Fig. 2B) implicating an upregulation of 
lysosome recruitment. This was confirmed using Lamp1 and LC3B double 
immunohistofluorescence which showed  colocalization of LC3B- and Lamp1-positive 
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13 
granules in NP0/0 PCs somata in the cerebellar cortex (Fig. 5C) and, in NP0/0 PC axonal 
profiles in the DCN (Fig. 5L). 
 
Scrg1 immunogold labels autophagic NP0/0 PC somata but not axon terminals. 
Ultrastructural immunogold labelling of PCs from 6-8 month-old NP0/0 mice revealed the 
association of Scrg1 with vesicles and saccules of dictyosomes in the somatic Golgi 
apparatus. The labelled dictyosomes sometimes had a normal ultrastructural appearance (Fig. 
6A), but in most cases, double membrane saccules and intertwined membrane shapes were 
evident (Fig. 6B-F). Unlabelled autophagic vacuoles, membrane whorls and concentric arrays 
of membranes (phagophores) also seemed to be derived from other organelles, such as 
multivesicular bodies, ergastoplasmic saccules (Fig. 7G) and mitochondria (Fig. 6H). Profiles 
of neurodegeneration were rarely observed in the molecular layer, although autophagosomes 
and autophagolysosomes were found in some PC dendrites (Fig. 6I). At the nuclear level, no 
ultrastructural features of apoptotic cell death, such as chromatin condensation and nuclear 
fragmentation were observed. Presumptive PC myelinated axons exhibiting GABA 
immunogold labelling and dystrophic shapes contained phagophores, autophagosomes and 
autophagolysosomes in the deep molecular layer (Fig. 6J), as well as in the granule cell layer 
and the cerebellar white matter (Fig. 7C-E). None of these dendritic and axonal autophagic 
profiles displayed Scrg1 immunogold. Although most PCs containing autophagic profiles did 
not display any other ultrastructural signs of neurodegeneration, some soma clearly displayed 
features of advanced neurodegeneration, including shrunken soma and a condensed 
neuroplasm filled with unlabelled phagophores, autophagosomes and autophagolysosomes 
(Fig. 7A-B). 
In all of the DCN, PC axon terminals make inhibitory synapses on the dendrites and soma of 
the deep cerebellar neurons. Many of these PC pre-synaptic varicosities displayed GABA 
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immunogold labelling (Fig. 8C) and contained autophagic vacuoles at all ages studied (3-8 
months, Fig. 8A-E), but other terminals displayed normal ultrastructural characteristics (Fig. 
8D, F), similar to those of PC terminals in the DCN of wild-type animals (Fig. 8G). Scrg1 
immunogold did not label autophagic vacuoles in NP0/0 PC axon terminals.  
 
Presynaptic autophagy in NP0/0 PCs 
Semi-quantitative estimation of the percentage of autophagic PCs somata and axon terminals 
clearly indicated that autophagy was more prevalent in axons and terminal varicosities (14%, 
Fig. 9A) than in soma and dendrites (2%, Fig. 9A) of the NP0/0 PCs at both ages studied (3 
and 6 months). No autophagic PC soma and axons were observed in the wild-type cerebella. 
These results indicate that autophagy is already activated in 3 month-old NP0/0 PCs prior to 
significant PC loss (Fig. 9B) (26). Furthermore, the semi-quantitative data suggest that 
autophagy is largely restricted to the axonal compartment of the 3-6 month-old NP0/0 PCs, 
whereas the somato-dendritic compartment displays a quasi normal ultrastructure with only 
discrete alterations including Golgi-derived autophagic-like shapes. 
 
DISCUSSION 
The mechanisms by which the prion protein-like Dpl provokes premature PC death in the 
PrP-deficient NP0/0 mice are still poorly understood. Neither Prnd knock-out mice nor Prnp 
and Prnd double knock-out mice exhibit overt neurological phenotypes indicating that PCs 
survive in these mutants and that Dpl is responsible for PC death in NP0/0 mice (23, 44). Here, 
we investigated whether neuronal autophagy is activated during Dpl-induced PC death in 
NP0/0 mice. 
Using immunochemistry at the biochemical, histological and ultrastructural levels to evaluate 
this possibility, we demonstrate that NP0/0 PCs undergo autophagy as indicated by the 
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15 
upregulation of Scrg1, a presumed autophagy-associated protein, and two mediators of 
autophagic degradation LC3B-II and p62, as well as the presence of ultrastructural autophagic 
profiles in all PC compartments.  
 
Upregulation of Scrg1 and p62/LC3 reflects different phases of autophagy in 
degenerating NP0/0 PCs. 
The microtubule-associated light chain 3 (LC3) is an essential component of autophagy (29) 
which acts as an adaptor protein between microtubules and autophagosomes through its N-
terminal domain (33). Three isoforms LC3, LC3A and LC3B, have been shown to be 
associated with autophagic membranes (63) and thus can be used as autophagosomal markers. 
The punctuate LC3B immunoreactivity observed in the soma of NP0/0 but not wild-type PCs 
is likely to indicate the formation of autophagic organelles resulting from the activation of the 
autophagic machinery in the mutant PCs. In agreement with immunohistochemical data, the 
Western blot analysis clearly showed that the autophagic membrane-bound marker LC3B-II 
was increased in the NP0/0 cerebellum. Furthermore, the increased expression of p62 whose 
interaction with LC3 is instrumental in mediating autophagic degradation (5, 45) confirms 
that autophagy is abnormally activated in the NP0/0 cerebellum (see below). The very early 
increase of these two markers at 3-4 months when PC loss is not yet significant (26) suggests 
that autophagy precedes apoptosis. In agreement, PCs with clear ultrastructural signs of 
advanced autophagy can be found in the cerebellar cortex of the 3 month-old NP0/0 mice. In 
the NP0/0 cerebellum, the increases of p62 and LC3B-II protein levels observed with age are 
likely to reflect both an increased number of autophagic PCs as indicated by increased PC loss 
at this age (26), and a decreased cerebellar mass as previously shown by the reduced size of 
the NP0/0 cerebellum (26). In many NP0/0 PCs, this increase may correspond to enhanced 
cleavage of LC3B-I to form LC3B-II. This would take place only in those PCs which have 
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entered a stage of advanced neurodegeneration as indicated at the ultrastructural level by 
robust formation and accumulation of autophagic structures in a fraction of PC population at 
this time. However, LC3 has been shown to be incorporated into intracellular inclusion bodies 
induced in a number of pathological conditions indicating that LC3-labeled dots do not 
necessarily represent autophagic structures (34). In the NP0/0 PCs, this possibility is unlikely 
because inclusion bodies were not particularly abundant at the ultrastructural level in these 
neurons and the quantity of p62 protein in the soluble NP0/0 cerebellar fraction increases in 
parallel. The high levels of p62 and LC3B-II in NP0/0 cerebellum may not only reflect an 
augmentation in the density of autophagic PCs, but may also be due to an impairment in the 
autophagic flux (10) (see below). In agreement with this latter possibility, the absence of any 
detectable changes in the mRNA levels of LC3B and p62 in the NP0/0 cerebellum compared to 
wild-type cerebellum strongly argues for a deficient autophagic degradation.  
Scrg1, a gene primarily expressed in brain neurons, has been recently shown to be 
upregulated in several conditions of brain injury, following prion infection of human and 
animal brains, as well as in the cerebellum of the NP0/0 mutant mouse (18). In scrapie-infected 
central neurons of both wild-type and Scrg1-overexpressing transgenic mice, Scrg1 was 
associated with dictyosomes of the Golgi apparatus and autophagic vacuoles (12) which are 
hallmarks of prion-induced degeneration (6, 28, 36). In the cerebellum of the 8-12 month-old 
NP0/0 mice (18), upregulation of Scrg1 protein was immunodetected in fewer PCs than 
p62/LC3B-II, but not in any PCs of the wild-type cerebellum. Scrg1-labelling and p62/LC3B-
II production was detected only in a few NP0/0 PCs at any given time, indicating that the 
proteins may be involved in restricted phases of Dpl-induced stress. These two events may 
represent distinct steps in the neurodegenerative process because the ultrastructural data 
indicate that immunogold labelling for Scrg1 was mostly associated with Golgi complexes in 
NP0/0 PC somata which display aberrant structures suggesting inaugural signs of autophagy. 
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Interestingly, the Golgi apparatus of both NP0/0 and prion-infected PCs displayed similar 
ultrastructural alterations suggesting that Scrg1 labels Golgi apparatus of PCs that are likely to 
later undergo autophagy. In NP0/0 PCs, upregulation of Scrg1 at the dictyosomes may be an 
early sign of Golgian autophagy which precedes p62/LC3B-II production since very little, if 
any, Scrg1 labelling of phagophores (25, 42, 37), autophagosomes and autophagolysosomes 
was observed in these neurons. Nevertheless, the chronology of the two events could not be 
more accurately determined because simultaneous immunohistochemical staining of Scrg1 
and LC3B markers is not possible due to the incompatibility of the fixation protocols required 
to reveal Scrg1 (light 1% PAF tissue fixation) and LC3B (strong 4% PAF tissue fixation).  
The specific Golgian localization confirms the spatial restriction of Scrg1 in the degenerative 
process of NP0/0 PCs and is distinct from the more generalized association of LC3 with 
autophagosomal membranes (29). Thus, upregulation of Scrg1 and LC3 are not only 
chronologically, but also spatially distinct events. To date, the relationship of Scrg1 with 
autophagy remains circumstantial and the functional significance to the autophagic process is 
unknown. Although a potential role in the autophagic machinery was not confirmed by Scrg1 
overexpression in transgenic mice further investigations in knock-out mice are merited. 
 
Autophagic stress is a hallmark of NP0/0 PC death 
In addition to its known induction during starvation, differentiation and normal growth control 
(9, 30, 59), autophagy has been demonstrated in various neurodegenerative disorders 
including Alzheimer’s disease and prion disease (31, 35, 37, 41). Here, autophagic vacuoles 
were revealed by electron microscopy in both somato-dendritic and axonal compartments of 
GABA immunogold-labeled NP0/0 PCs suggesting that autophagy is concomitant to Dpl-
induced cell death mechanisms. Nevertheless, the increased concentration of autophagic 
vacuoles is not necessarily correlated with increased autophagic activity. Instead the striking 
Page 18 of 41
Brain Pathology Editorial Office, Blackwell Publishing, Oxford, UK
Brain Pathology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
18 
accumulation of autophagic profiles in degenerating neurons often reflects an imbalance 
between the rates of autophagic sequestration and completion of the lysosomal degradation 
process (31). Increased or continued requirements for autophagy coupled with an impairment 
of the late phases of autophagic flux may lead to autophagic stress (10). This is likely to occur 
in known neurodegenerative conditions such as Alzheimer’s disease (66) and in the NP0/0 
cerebellum where the accumulation of cytoplasmic autophagic profiles in PCs and increased 
p62 protein levels without apparent changes in mRNA expression are likely to reflect a deficit 
in autophagic flux (67). Robust autophagy may be detrimental, particularly when successful 
recycling of cellular components is impaired leading to the accumulation of cytoplasmic 
autophagic vacuoles and contributing to neuronal death (10). The electron dense content of 
many autophagic vacuoles and phagophores found in the NP0/0 PCs are features of 
autolysosomal stages which suggest that autophagolysosome formation occurs in NP0/0 PCs 
(16). Indeed, an increased lysosomal recruitment is signalled by the upregulation of Lamp1 in 
NP0/0 PCs. Furthermore, double immunohistofluorescence for LC3B and Lamp1 shows a 
colocalization of both molecules in the same granules within NP0/0 PCs suggesting that 
formation of autophagolysosomes does occur. Thus, the upregulation of autophagic and 
lysosomal markers as well as the extensive accumulation of autophagosomes and 
autophagolysosomes in the NP0/0 PCs probably reflect a subsequent blockade of autophagic 
proteolysis. As observed in amyloid neurodegenerative diseases and in other neurological 
disorders such as ceroid lipofuscinosis (7), leakage of hydrolases induced by membrane 
destabilization of autophagolysosomes and lysosomes could trigger apoptotic cascades in the 
NP0/0 PCs. Along this line, a genetic deficiency of the glycogen-degrading lysosomal enzyme 
acid-alpha glucosidase in Pompe-diseased mice induces severe skeletal and cardiac myopathy 
involving a massive autophagic buildup in myofibers (22, 49). In this case, autophagy is 
induced, but the muscle pathology manifests as a functional autophagic deficit due to 
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impaired autophagosomal-lysosomal fusion which leads to an accumulation of autophagic 
substrates (50). 
In the cerebellum of the NP0/0 mutants, there are both intact PCs, as well as PCs exhibiting 
different degrees of macroautophagy. This ranges from PCs with Scrg1-labelled Golgi 
dictyosomes and moderate amounts of all types of unlabelled autophagic profiles to PCs filled 
with phagophores, autophagosomes and autophagolysosomes, probably in a late step of cell 
death. This differential autophagic status of PCs suggests that PC death is asynchronous in 
NP0/0 cerebellum. Also autophagic NP0/0 PCs displayed differential intracellular distribution 
of autophagic profiles which were semi-quantitatively estimated to be more frequent in the 
axonal compartment (i.e. PC axons and terminals in the deep cerebellar white matter and 
nuclei) than in the somato-dendritic compartment. In NP0/0 PC, the higher frequency of 
autophagic presynaptic terminals forming synapses on the deep cerebellar neurons compared 
with relatively few autophagic PCs found in the cerebellar cortex suggests that at least some 
of the axon terminals displaying autophagic profiles have an intact somato-dendritic 
compartment. This may indicate that in NP0/0 PCs, axonal autophagy precedes somato-
dendritic autophagy. Indeed, axonal autophagy has been previously reported in other cases of 
degenerating central neurons (31, 68), including the PCs of the Lurcher mutant mouse where 
autophagosomes form in axons before being transported to the soma (60, 67). Since Scrg1 
labelling was restricted to somatic dictyosomes in NP0/0 PCs, the chronology of axonal 
autophagy and somatic Scrg1 upregulation could not be determined (see above). With our 
current state of knowledge, we cannot tell if autophagy in the axon terminals of the NP0/0 PCs 
is an initial step of a Dpl-induced autophagic cell death mechanism or a protective reaction of 
neurons to maintain axonal homeostasis (32) in response to Dpl-induced stress. Nevertheless, 
the early autophagic destruction of axons observed in the white matter and deep cerebellar 
nuclei of the 3 month-old NP0/0 mice, well before significant PC loss, argues for a 
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contribution of an autophagy-dependent mechanism (see above) for Dpl-induced PC death 
rather than for autophagy as an epiphenomenon. To date, the precise subcellular localization 
of Dpl is unknown although its close structural homology with PrPc (38, 58) suggests that 
both proteins should have a similar subcellular expression pattern at the plasma membrane of 
axons and terminals (3). At these sites, Dpl may induce rapid physiological alterations within 
axons that locally trigger the autophagic machinery.  
 
Dpl-induced PC death: apoptosis and/or autophagy? 
To date, little is known about how Dpl kills neurons. Our recent data show that Bax knockout 
or overexpression of Bcl-2 partly rescues PCs from Dpl-induced cell death in NP0/0:Bax-/- (26) 
and NP0/0-Hu-bcl-2 (27) double mutant mice. This partial recovery suggests that Bcl-2 family-
dependent apoptotic pathways are not the only death mechanism implicated in Dpl 
neurotoxicity. According to the present results, another possibility may be related to non-
apoptotic autophagic cell death. Indeed, Dpl has been shown to induce the production of 
reactive oxygen species (ROS) (11, 62), which are able to activate both apoptosis (43) and 
autophagy (55). However, the respective contribution of apoptosis and autophagy to Dpl-
induced cell death remains unclear. There are several explanations for the occurrence of both 
autophagy and Bax-dependent apoptosis of PCs in the cerebellum of the NP0/0 mouse. Firstly, 
intrinsic differences between PCs could make them susceptible to different cell death 
pathways in response to Dpl-induced stress. Supporting this hypothesis, PCs exhibit different 
resistance levels to Dpl toxicity related to both their anterior versus posterior position and 
their aldolase C expression in the NP0/0 cerebellum (27). This may determine a differential 
specificity of Dpl-triggered cell death program among PCs. Secondly, a defective autophagic 
flux in NP0/0 PCs may ultimately trigger apoptotic cell death. Indeed, recent findings obtained 
both in non-neuronal cells (19, 24, 39, 57, 65) and neurons (8), argue against a clear-cut 
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distinction between autophagy and apoptotic cell death. Recognition of the extensive cross 
talk between different cell death pathways is beginning to provide insight into the complex 
patterns of neuronal cell death seen in nervous system diseases (42). Recent data highlight the 
ability of BCL-2 to not only function as an anti-apoptotic factor, but also as an anti-
autophagic factor via its inhibitory interaction with Beclin1 (46). This could contribute to 
NP0/0 PC survival in the NP0/0-Hu-bcl-2 double mutants (27). In these mutants, the NP0/0 PCs 
which die in spite of Bcl-2 overexpression are likely to undergo Bcl-2-independent cell death 
processes which need further investigations.  
To conclude, our results reveal that the autophagic machinery is activated early in the process 
leading to Dpl-induced neuronal death in NP0/0 PCs. This shows that autophagy is related to 
Dpl-induced PC neurodegeneration. In this way, NP0/0 PCs display many signs of impaired 
autophagic flux which could convert an initial autophagic defence reaction to Dpl 
neurotoxicity into a neurodegenerative mechanism. Our present data support emerging 
concepts in the field of neuronal death such as axonal initiation of neuronal autophagy and 
crosstalk between autophagic and apoptotic pathways. Designing specific drugs to modulate 
autophagy are challenging but promising avenues for future therapy of neurodegenerative 
diseases. 
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Figure 1. Immunohistofluorescence of Scrg1 in the 8 month-old cerebellar cortex of NP0/0 and wild-
type mice. A. A few PCs (arrowheads) display Scrg1 fluorescence in the cerebellar cortex of a NP0/0 
mouse. B. PCs remain devoid of Scrg1 fluorescence in the cerebellar cortex of the wild-type mouse. 
A and B, bar = 50µm. C. Quantitative analysis of Scrg1-immunofluorescent PCs. The number of 
Scrg1-immunoreactive PCs per 7 sagittal cerebellar sections sampled in each of 3 wild-type (WT) 
and 3 NP0/0 mice is plotted on a y axis.  
300x99mm (150 x 150 DPI)  
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Figure 2. A. RT-PCR analysis of mRNA expression of p62 and LC3 in the NP0/0 cerebellum. mRNA 
levels of LC3B and p62 in both 3 month-old (lane 3) and 6 month-old mice (lane 4) are equivalent 
to the wild-type (lane 2). The expression of β-actin was analyzed as an internal control. Negative 
control samples which were not reverse transcribed (RT-) are shown (lane 1). B. Western blot 
analysis of the LC3B, p62 and Lamp1 proteins in the NP0/0 cerebellum. The 16-kDa LC3B-II 
protein, the 62 kDa p62 protein and the 110 kDa Lamp1 protein are increased in both 3-4 month-
old (lane 2) and 6-8 month-old (lane 3) extracts of cerebellum from NP0/0 mice compared with 
adult WT (lane 1). As a control for equivalent protein loading, 42-kDa actin was revealed.  
85x43mm (300 x 300 DPI)  
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Figure 3. Immunohistofluorescence for LC3B and CaBP in the cerebellum of the 6-8 month-old 
NP0/0 and wild-type mice. In the cerebellar cortex, double immunohistofluorescence for CaBP (A, D, 
G, J, M, red) and LC3B (B, E, H, K, N, green) shows that the NP0/0 PC somata contain a punctuate 
LC3B staining (arrows in E, F, H, I). Some NP0/0 PCs do not display LC3B fluorescence 
(arrowheads) like wild-type PCs (B, C). In a deep cerebellar nucleus, some NP0/0 PC axon terminals 
close to deep cerebellar neurons (asterisks) display red CaBP (M, O) and green LC3B (N, O) 
immunohistofluorescence. Some other CaBP-positive PC terminals do not display LC3B labeling in 
the merged image (O). All CaBP-labelled PC axon terminals (J, L) are LC3B-negative (K, L) in the 
wild-type. Bar = 20µm in A to O.  
352x549mm (150 x 150 DPI)  
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Figure 4. Immunohistofluorescence for p62 in the cerebellum of 6-8 month-old NP0/0 and wild-type 
mice. A, B. In the cerebellar cortex, p62 appears as cytoplasmic dots in the soma of NP0/0 PCs 
(arrows) displays. Some NP0/0 PCs as well as wild-type PCs (A) do not disp ay p62 fluorescence 
(arrowheads). C, D. P62 immunofluorescence of presumptive PC axon terminals is observed in the 
deep cerebellar nucleus of NP0/0 mouse (arrows, D) but not wild-type mouse (C). Asterisks indicate 
deep cerebellar neurons soma. Bar = 20µm in A to D.  
202x210mm (150 x 150 DPI)  
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Figure 5. Immunohistofluorescence for Lamp1 and LC3B in the cerebellum of 6 month-old NP0/0 
and wild-type mice. Double immunohistofluorescence for LC3B (A, D, G, J, green) and Lamp1 (B, E, 
H, K, green) shows colocalization of Lamp1 and LC3B staining in a NP0/0 PC soma (arrowhead in C). 
Some NP0/0 PCs do not display LC3B fluorescence (arrows in A, C) like wild-type PCs (D, F). In a 
deep cerebellar nucleus, some NP0/0 PC axon terminals close to deep cerebellar neurons (asterisks) 
display red Lamp1 (arrowheads in H, I) and green LC3B (arrowheads in G, I) 
immunohistofluorescence. All PC axon terminals in wild-type mice are LC3B- (J, L) and Lamp1-
negative (K, L). Bar = 20µm in A to L.  
354x450mm (150 x 150 DPI)  
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Figure 6. Autophagy in the somato-dendritic and axonal compartments of Scrg1-immunogold 
labelled Purkinje cells of the NP0/0 mouse. A-H. Purkinje cell soma. A. Immunogold particles 
(arrows) label saccules and vesicles of an apparently intact dictyosome of the Golgi apparatus. B-F. 
Golgi apparatus dictyosomes with Scrg1-immunogold labelling (arrows) and autophagic-like double 
membrane vacuoles and membrane whorls (asterisks). White asterisks in B, lysosomes. ER in D, 
rough endoplasmic reticulum. Star in F, multivesicular body. G. A multivesicular body (white star) is 
engaged in autophagic-like membrane wrapping with a rough ER saccule. m, mitochondria. H. 
Mitochondria (m) around autophagic-like membrane whorls (asterisk). None of the organelles in G 
and H are labelled with Scrg1 immunogold. I, J. Molecular layer. I. Fusion of an autophagosome 
(white star) with lysosomes (white asterisks) in a Scrg1-negative Purkinje cell primary dendrite 
(PCD). J. Autophagosomes (white stars) and autophagolysosomes (white asterisks) and in a Scrg1-
negative myelinated presumptive Purkinje cell recurrent axon collateral (ax). Note the fusion of a 
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lysosome with a double membrane autophagosome (black asterisk). pf, parallel fibres. Bars: 500 
nm in A-F, I, J; 100 nm in G, H.  
195x269mm (150 x 150 DPI)  
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Figure 7. Autophagy in the soma and axons of NP0/0 Purkinje cells. Immunogold electron 
microscopy did not reveal Scrg1 in any of the areas shown. A. A degenerating autophagic Purkinje 
cell (PC) filled with autophagosomes, autophagolysosomes (white asterisks) and lysosomes (white 
stars) and has a shrunken shape. B. High magnification of neuroplasmic content of an autophagic 
Purkinje cell soma. m, mitochondria; white asterisks, autophagic vacuoles; asterisk, phagophore. C-
D. Degenerating myelinated Purkinje cell axons in the white mater surrounding the fastigial deep 
cerebellar nucleus. C. A phagophore made of concentric wrapping of membrane around a core of 
axoplasm (white asterisk) fills a myelinated axon profile. D. Collapsed autophagic-like vacuoles 
(arrowheads) in a myelinated axon (asterisk). Black asterisks show intact myelinated axons in C 
and D. E. A dystrophic axon (star) with features of acute autophagy: thinned myelin sheath, swollen 
shape and numerous autophagic vacuoles at different stages of maturation and electron-dense 
lysosomes (see higher magnification in inset). Compare with surrounding intact myelinated axons. 
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F. Numerous reticular phagophores (white arrowhead) encircling axoplasmic material, 
autophagosomes (black arrowheads) and autophagolysosomes (white stars) reflect advanced stages 
of axonal autophagy. Bars: 500 nm in A-D, inset E and F; 2 µm in E.  
195x284mm (400 x 400 DPI)  
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Figure 8. Purkinje cell axon terminals in the fastigial deep cerebellar nucleus of NP0/0 (A-F) and 
wild-type (G) mice. A-F. NP0/0 mouse. Immunogold electron microscopy does not reveal Scrg1 in 
any of these areas. A-B. Early stages of autophagy in presynaptic PC terminals making symmetric 
axo-somatic (A) and axo-dendritic (B) synapses (white arrowheads) on fastigial neurons (DCN). 
Black arrowheads point to autophagic double-membrane and small vacuoles within the PC 
terminals. Asterisk indicates a postsynaptic fastigial dendritic spine. C. Immunogold labelling for 
GABA. In a GABA-immunolabelled preterminal PC axon terminal close to a DCN, cytoplasmic 
material is isolated by an endoplasmic saccule (arrowhead) in an autophagic-like manner featuring 
an early stage of autophagy. See the surrounding double membrane autophagic-like vacuole 
(arrowhead). Asterisks show intact myelinated axons. D. An autophagic PC axon terminal containing 
autophagosomes (arrowheads) and many autophagolysosomes (white stars). This PC terminal 
makes an symmetric synapse (white arrowhead) on a postsynaptic fastigial dendrite (DCN) similar 
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to that made by an intact PC terminal (white PC) on the opposite side of the dendrite. E. Huge 
autophagosome featured by multiple membrane wrapping around cytoplasmic material (white star) 
in a PC terminal making a symmetric synapse (white arrowhead) on a fastigial dendrite (DCN). F. 
Two intact presynaptic PC axon terminals make symmetric synapses (white arrowheads) on a 
fastigial dendrite (DCN). G. Six intact presynaptic PC axon terminals make symmetric synapses 
(white arrowheads) on a large fastigial dendrite (DCN). Bars: 500 nm.  
195x287mm (150 x 150 DPI)  
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Figure 9. A Semi-quantitative analysis of autophagic PC somata and axon terminals in the cerebellar 
cortex and deep cerebellar nuclei of the 3 and 6 month-old wild-type and NP0/0 mice. The 
percentage of autophagic somata (black) and axon terminals (white) in the wild-type and NP0/0 
mice is plotted on y axis. B. Autophagosomes (black arrowheads) and autophagolysosomes (white 
stars) in the somatic neuroplasm of a PC in the cerebellar cortex of a 3 month-old mouse. Bar = 2 
µm.  
135x298mm (300 x 300 DPI)  
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Résumé 
 
Les neuropathologies mettent en jeu l’apoptose et l’autophagie, deux mécanismes de mort 
cellulaire programmée qui requièrent l’activation de voies signalétiques spécifiques. L’identification 
au niveau moléculaire des voies spécifiques de mort cellulaire déclenchées par des situations 
pathologiques variées dans les différents types neuronaux sensibles est d’une importance critique dans 
l’élaboration de stratégies destinées à prévenir la perte des neurones centraux. 
Mes recherches s’intéressent aux cellules de Purkinje du cervelet dans des modèles murins de 
mutations affectant spécifiquement ces neurones. La mort des cellules de Purkinje a été étudiée chez 
des souris Lurcher et  hotfoot présentant des mutations du gène Grid2 codant pour le récepteur 
glutamatergique GluR 2 et dans la souris mutante Nagasaki Prnp0/0 (NP0/0)  déficiente en protéine 
prion et sur-exprimant son paralogue neurotoxique Doppel. 
Le récepteur muté GluR 2Lc induit l’autophagie avant la mort excitotoxique des cellules de 
Purkinje chez la souris mutante hétéroallélique GluR 2Lc/ho. Mes études en culture organotypique de 
cervelet révèlent un lien entre l’autophagie et l’excitotoxicité dans les cellules de Purkinje GluR 2Lc/+ 
qui sont protégées de la mort cellulaire excitotoxique et ne présente plus d’autophagie après traitement 
avec l’agent bloquant de canaux cationiques NASP. La synaptogenèse excitatrice des cellules de 
Purkinje avec les fibres parallèles et grimpantes implique GluR 2. En effet, mes résultats indiquent 
que la translocation somato-dendritique des fibres grimpantes au cours du développement postnatal 
des cellules de Purkinje pourrait être soumise au contrôle de la croissance dendritique des cellules de 
Purkinje par GluR 2. 
En l’absence de protéine prion chez la souris mutante Nagasaki, son paralogue Doppel induit 
une perte progressive des cellules de Purkinje qui implique BAX, un membre de la famille de Bcl-2, 
dans la voie apoptotique intrinsèque. La survie d’une partie des cellules de Purkinje chez les double 
mutants NP0/0:Bax-/- et NP0/0-Hu-bcl-2 révèle la contribution d’une voie de mort cellulaire 
indépendante de BAX. Ce processus pourrait mettre en jeu soit l’autophagie qui est détectée très tôt 
dans les axones au niveau ultrastructural et par l’augmentation de l’expression de marqueurs 
autophagiques soit un mécanisme apoptotique extrinsèque encore non identifié.  
Mes résultats suggèrent que des stimuli pathogènes différents déclenchent des modalités de 
mort cellulaire différentes qui mettent en jeu l’apoptose et l’autophagie dans un même neurone. 
L’interaction entre ces voies multiples de mort cellulaire programmée demande à âtre étudiée plus 
avant dans des modèles animaux de maladies neurodégénératives afin d’ouvrir de nouvelles voies 
thérapeutiques.  
 Abstract 
 
Neuropathologies often involve apoptosis and autophagy, two mechanisms of 
programmed cell death which require activation of specific signaling pathways. Determining 
the specific death pathways operating in different types of neurons in various pathological 
situations is important to gain insight into the strategies for preventing loss of central neurons. 
My investigations were focused on cerebellar Purkinje cells in mouse models of 
mutations specifically affecting these neurons. Purkinje cell death was investigated in Lurcher 
and hotfoot mice with mutations in the Grid2 gene coding for the glutamatergic receptor 
GluR 2, and in the Nagasaki Prnp
0/0
 (NP
0/0
) mutant mouse deficient for the prion protein and 
overexpressing its neurotoxic paralogue Doppel.  
The mutated glutamatergic receptor GluR 2
Lc
 was shown to induce autophagy 
preceding excitotoxic cell death in the Purkinje cells of the heteroallelic GluR 2
Lc/ho
 mutant 
mouse. The present studies in organotypic cerebellar cultures elucidate a link between 
autophagy and excitotoxicity in the GluR 2
Lc/+
 Purkinje cells which are rescued from 
excitotoxic cell death and do not display autophagy anymore after treatment with the channel 
blocker NASP. Excitatory synaptogenesis of Purkinje cells with parallel and climbing fibers is 
known to involve GluR 2. Indeed, my present data indicate that somato-dendritic 
translocation of climbing fibers during postnatal development of Purkinje cells could be 
regulated by a GluR 2-dependent control of Purkinje cell dendritic growth.  
In the absence of prion protein in the Nagasaki mutant mouse, its paralogue Doppel 
induces progressive Purkinje cell loss that involves Bcl-2 family members of the intrinsic 
apoptotic pathway such as BAX. The partial rescue of Purkinje cells in NP
0/0
:Bax
-/- 
and NP
0/0
-
Hu-bcl-2 double mutants indicate the contribution of a BAX-independent cell death pathway. 
This process may occur either by autophagy which is detected early at the axonal level as 
evidenced by increased expression of autophagic markers and electron microscopy or by an 
unidentified extrinsic apoptotic mechanism. 
These data suggest that different pathogenic stimuli trigger different cell death 
modalities involving apoptosis and autophagy in the same neuron. The interplay between 
these multiple pathways of programmed cell death needs to be further investigated in animal 
models of neurodegenerative diseases to provide new therapeutic approaches.  
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